data_2ndb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ndb _Structure_validation_residue.Date_analyzed 2017-09-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 6' ' ' ILE . 23.5 p . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.774 0.321 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.519 ' N ' ' SG ' ' A' ' 5' ' ' CYS . 2.5 pp -127.25 174.0 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.522 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.414 ' O ' ' OD1' ' A' ' 9' ' ' ASP . . . -114.3 -11.59 12.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.615 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 10' ' ' TYR . 51.1 mttt -58.14 -25.62 61.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.517 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 7' ' ' ALA . 1.5 m-20 68.07 -66.68 0.21 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.456 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.413 ' N ' ' O ' ' A' ' 8' ' ' LYS . 47.5 m-85 -137.22 162.31 33.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.436 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 99.1 -135.95 12.42 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.61 ' H ' ' HE ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER -39.61 111.06 0.16 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.731 0.301 . . . . 0.0 110.829 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.552 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 24.3 p -147.26 148.71 31.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.689 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -145.23 119.67 9.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.574 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -34.98 71.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.529 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.85 1.85 61.6 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -141.22 -134.07 2.99 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 18' ' ' THR . 6.6 p -39.07 102.74 0.26 Allowed Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 110.633 -0.136 . . . . 0.0 110.633 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 18' ' ' THR . 53.1 Cg_exo -50.89 -170.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.902 1.734 . . . . 0.0 112.48 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 6.5 t -153.44 80.93 1.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.236 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -40.1 -67.97 0.2 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.654 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.08 140.59 37.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.45 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.501 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 79.76 88.81 0.5 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.48 ' CZ ' ' O ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -81.94 -7.35 59.6 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.684 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.65 67.23 0.17 Allowed Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 24' ' ' ARG . 8.6 t -96.92 101.16 12.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.873 0.368 . . . . 0.0 110.352 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.6 tt -124.43 151.08 29.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.289 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 5.4 m -120.01 161.12 21.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.813 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.6 m -64.97 -177.03 0.32 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.554 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.8 tp -62.86 -30.79 50.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.822 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.3 mtm -80.35 -26.35 38.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.767 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.53 62.1 1.9 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.2 t -147.39 -29.53 0.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 110.6 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -90.47 53.73 2.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.511 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.5 m -73.64 103.67 4.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.695 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -117.51 144.5 45.01 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.975 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.552 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -91.91 117.48 29.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.494 179.631 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.6 148.9 40.74 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.332 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo . . . . . 0 N--CA 1.494 1.519 0 C-N-CA 122.176 1.917 . . . . 0.0 111.983 179.859 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.8 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.712 0.291 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.481 ' O ' ' CB ' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -118.96 6.59 6.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.766 -179.182 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.481 ' CB ' ' O ' ' A' ' 6' ' ' ILE . . . 79.37 -55.57 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.303 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -80.6 -142.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.207 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 7.1 p-10 -131.9 -112.65 0.24 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.09 0.471 . . . . 0.0 111.043 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.478 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.8 m-30 -58.29 147.38 30.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.565 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.442 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 164.51 -157.61 30.04 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.318 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.0 ptm85 -71.61 125.23 26.56 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.815 0.34 . . . . 0.0 111.072 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -145.36 142.5 29.43 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.644 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.95 130.26 33.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.531 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -48.76 -34.39 12.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.568 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -112.92 24.69 12.55 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.64 -127.37 2.89 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.2 p -85.14 146.93 46.39 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.369 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.07 -159.61 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.444 2.096 . . . . 0.0 112.142 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -171.97 95.47 0.16 Allowed 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.905 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -42.52 -85.07 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.294 -179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.83 122.32 22.27 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.273 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.41 87.19 1.97 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -85.1 -23.58 28.42 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.885 0.374 . . . . 0.0 110.131 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.05 75.48 0.12 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 4.6 t -92.48 111.78 23.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.115 0.483 . . . . 0.0 110.25 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.469 ' CG1' ' N ' ' A' ' 28' ' ' CYS . 10.7 tt -125.76 162.5 28.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.656 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 1.7 t -144.76 -171.86 3.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.777 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.08 170.65 9.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.513 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.0 tp -52.06 -27.24 9.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.576 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.8 mtp -83.56 -38.91 21.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.608 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.26 48.0 2.7 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.459 ' CG2' ' N ' ' A' ' 34' ' ' ASN . 10.1 t -122.97 -50.7 1.92 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.757 0.313 . . . . 0.0 110.45 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.459 ' N ' ' CG2' ' A' ' 33' ' ' THR . 2.9 t-20 -76.77 51.66 0.78 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.201 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.623 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 3.7 m -84.66 123.53 30.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.988 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -139.77 148.5 42.32 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.732 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 11' ' ' GLY . 0.7 OUTLIER -91.17 117.51 29.68 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.796 178.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.56 164.53 41.99 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.203 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--N 1.307 -1.609 0 C-N-CA 122.564 2.176 . . . . 0.0 112.253 179.754 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.719 0.295 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.4 pp -112.99 -174.36 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.272 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -106.63 -5.19 18.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.456 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.514 ' NZ ' ' O ' ' A' ' 12' ' ' ARG . 4.9 pttt -111.84 -119.73 0.29 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.561 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 23.9 p-10 -173.72 -42.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.45 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.469 ' CZ ' ' O ' ' A' ' 22' ' ' ARG . 69.0 m-85 -140.98 165.36 27.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.757 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 105.58 -152.58 17.2 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.244 -0.743 . . . . 0.0 111.244 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.514 ' O ' ' NZ ' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -37.42 130.31 0.96 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.848 0.356 . . . . 0.0 111.022 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.586 ' SG ' ' N ' ' A' ' 14' ' ' LYS . 0.8 OUTLIER -160.28 157.58 28.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.606 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.586 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 8.3 tttm -156.7 108.67 2.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.382 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 33.1 m95 -48.97 -27.3 3.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.623 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.12 -31.7 16.42 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.96 -104.38 2.07 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.0 p -90.22 144.02 30.48 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.597 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.1 -160.43 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.287 1.992 . . . . 0.0 111.956 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 12.8 t -160.98 90.45 0.83 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.933 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -49.81 -83.01 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.817 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.469 ' O ' ' CZ ' ' A' ' 10' ' ' TYR . 1.1 mpt_? -78.41 101.33 7.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.839 0.352 . . . . 0.0 110.431 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.493 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 112.83 116.45 3.4 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.455 ' C ' ' H ' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -110.91 4.81 20.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.782 0.325 . . . . 0.0 110.363 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.6 40.93 1.15 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 56.2 m -71.73 88.88 1.0 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.786 0.327 . . . . 0.0 110.296 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.3 tt -115.54 156.81 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.545 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.629 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.5 OUTLIER -137.45 -172.47 3.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.829 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 31' ' ' MET . 1.6 t -98.55 161.01 13.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.553 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.3 tp -42.19 -24.57 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.445 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.44 ' N ' ' O ' ' A' ' 29' ' ' SER . 2.8 mtt -81.66 -47.37 13.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.507 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.18 50.59 1.72 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.819 -0.913 . . . . 0.0 110.819 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.443 ' CG2' ' N ' ' A' ' 34' ' ' ASN . 8.9 t -131.15 -49.54 1.01 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.769 0.319 . . . . 0.0 110.659 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.443 ' N ' ' CG2' ' A' ' 33' ' ' THR . 72.0 m-80 -77.12 46.27 0.48 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.443 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.629 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 7.9 m -75.86 121.4 22.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.671 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -135.42 155.7 50.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.004 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 1.2 t -98.75 114.73 27.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.257 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -113.44 146.81 36.14 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.547 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 N--CA 1.495 1.616 0 C-N-CA 122.384 2.056 . . . . 0.0 112.147 179.607 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.531 0.217 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.528 ' CD1' ' H ' ' A' ' 9' ' ' ASP . 2.4 pp -135.23 -167.65 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.376 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -127.56 -17.56 4.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.752 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.497 ' CD ' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -61.42 -42.48 98.81 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.856 -0.337 . . . . 0.0 110.289 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.528 ' H ' ' CD1' ' A' ' 6' ' ' ILE . 15.5 m-20 61.18 135.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.83 0.348 . . . . 0.0 110.108 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 9' ' ' ASP . 15.2 m-85 49.99 176.35 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.529 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.521 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 83.21 -153.52 30.7 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -42.48 143.73 0.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.816 0.341 . . . . 0.0 110.82 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 36' ' ' GLU . 28.9 p -147.33 168.91 20.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.526 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -160.72 104.88 1.39 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.287 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -53.75 -19.16 3.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.37 . . . . 0.0 110.744 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.55 -8.54 52.16 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -147.72 -112.62 0.7 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.9 p -38.84 101.88 0.24 Allowed Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 110.453 -0.202 . . . . 0.0 110.453 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -79.1 -22.88 8.19 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.195 1.93 . . . . 0.0 112.567 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' A' ' 21' ' ' CYS . 0.4 OUTLIER 66.17 91.05 0.09 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.565 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 6' ' ' ILE . 89.3 m -36.25 -73.08 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.521 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -94.66 125.34 39.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.491 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.7 100.9 2.62 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -96.16 -2.22 46.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.745 0.307 . . . . 0.0 110.482 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 38' ' ' LYS . . . -68.4 64.26 0.41 Allowed Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 47.1 t -85.39 71.23 10.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.288 0.566 . . . . 0.0 110.452 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.6 tt -86.27 145.56 7.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.754 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.572 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -126.93 166.17 18.02 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.965 -179.833 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.0 168.75 18.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.656 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -54.38 -26.86 16.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.674 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.2 mtm -85.14 -41.19 15.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.463 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 106.64 59.91 0.59 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.0 t -142.25 -30.43 0.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.336 . . . . 0.0 110.576 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -84.5 46.34 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.367 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.572 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 23.5 m -75.26 110.97 10.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.655 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.591 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 9.4 mt-10 -143.21 136.64 28.31 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.462 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' A' ' 11' ' ' GLY . 0.5 OUTLIER -74.26 120.65 20.12 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.429 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 25' ' ' GLY . 0.7 OUTLIER -101.53 146.91 33.05 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.387 -179.594 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo . . . . . 0 N--CA 1.495 1.559 0 C-N-CA 122.452 2.101 . . . . 0.0 112.198 179.888 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 6' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.856 0.36 . . . . 0.0 110.473 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.426 ' O ' ' O ' ' A' ' 5' ' ' CYS . 2.6 pp -51.34 -172.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.969 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -149.26 63.45 1.03 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.628 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.3 pttt -169.11 -13.72 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.779 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.411 ' O ' ' O ' ' A' ' 10' ' ' TYR . 2.7 m-20 65.04 127.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.41 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.411 ' O ' ' O ' ' A' ' 9' ' ' ASP . 18.9 m-85 50.0 178.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.563 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.95 -109.82 2.77 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.7 ttp85 -114.76 137.97 51.29 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.811 0.339 . . . . 0.0 110.403 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.2 p -143.01 178.3 7.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.658 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -157.18 116.97 3.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.988 0.423 . . . . 0.0 110.689 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.53 ' C ' ' H ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -51.19 139.36 18.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.363 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.88 -37.17 0.62 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.53 ' H ' ' C ' ' A' ' 15' ' ' TRP . . . -93.19 -145.0 16.01 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 17' ' ' GLY . 31.2 p -36.02 95.66 0.09 OUTLIER Pre-proline 0 CA--C 1.536 0.405 0 O-C-N 123.579 0.223 . . . . 0.0 110.696 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.41 ' N ' ' O ' ' A' ' 17' ' ' GLY . 24.5 Cg_exo -61.87 156.88 46.17 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.105 1.87 . . . . 0.0 112.023 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -111.82 102.49 10.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.375 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -50.35 -71.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.544 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.9 mmp_? -104.25 107.77 18.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.273 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.47 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 133.68 77.83 0.11 Allowed Glycine 0 CA--C 1.52 0.381 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -79.39 5.37 12.78 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 120.934 0.397 . . . . 0.0 110.512 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.88 66.88 0.92 Allowed Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.497 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 19.2 m -97.26 102.78 14.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.0 0.428 . . . . 0.0 110.643 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.2 tt -109.31 157.08 9.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.802 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.52 175.92 8.89 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.681 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.2 166.81 14.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.645 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.6 tp -47.29 -27.48 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.904 0.383 . . . . 0.0 110.623 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.3 mtt -89.5 -46.07 8.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.589 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.92 68.93 1.01 Allowed Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -146.23 -12.15 0.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.714 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -118.05 40.62 3.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.378 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.522 ' SG ' ' NE1' ' A' ' 15' ' ' TRP . 3.6 m -56.14 105.82 0.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.739 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -103.67 134.88 46.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.661 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.497 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 4.3 t -84.78 97.09 9.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.215 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -97.53 148.75 34.89 Favored Pre-proline 0 C--O 1.235 0.341 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.971 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo . . . . . 0 C--N 1.317 -1.087 0 C-N-CA 122.482 2.121 . . . . 0.0 112.407 179.462 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.436 ' SG ' ' N ' ' A' ' 6' ' ' ILE . 7.2 p . . . . . 0 N--CA 1.461 0.083 0 CA-C-O 120.715 0.293 . . . . 0.0 110.817 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.436 ' N ' ' SG ' ' A' ' 5' ' ' CYS . 2.2 pp -129.62 176.23 8.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.512 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.44 -19.0 10.28 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.017 0.437 . . . . 0.0 110.488 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -89.54 58.39 4.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.925 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 10' ' ' TYR . 1.1 m-20 -36.62 133.9 0.52 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.782 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 9' ' ' ASP . 88.3 m-85 56.51 158.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.512 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.05 -105.25 1.21 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -99.46 144.72 28.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.901 0.382 . . . . 0.0 110.853 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -158.35 141.97 15.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.553 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.1 tptm -147.71 120.94 8.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.485 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.93 -17.97 62.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.445 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.73 9.72 34.81 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -134.85 -113.23 1.32 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 p -88.78 151.36 47.44 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.473 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.07 -159.86 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.394 2.063 . . . . 0.0 112.017 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.6 t -160.93 81.72 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.221 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -39.45 -68.82 0.15 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.803 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.8 mtt-85 -104.7 88.0 2.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.606 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.491 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 157.4 94.95 0.1 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.61 -7.79 27.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.71 0.291 . . . . 0.0 110.554 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.89 53.55 4.26 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.567 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 91.8 m -75.98 93.72 3.3 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.1 tt -104.35 149.3 8.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.143 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.2 OUTLIER -134.52 -179.36 5.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.795 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.88 172.59 8.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.293 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.3 tp -55.2 -24.88 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.725 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.9 mtp -87.89 -16.81 32.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.617 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.42 64.5 3.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.6 t -140.77 -33.66 0.53 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.78 0.324 . . . . 0.0 110.533 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.422 ' ND2' ' OE1' ' A' ' 36' ' ' GLU . 3.2 t30 -95.71 47.58 1.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.331 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.623 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 59.4 m -69.79 107.91 3.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.728 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.422 ' OE1' ' ND2' ' A' ' 34' ' ' ASN . 10.9 mt-10 -111.66 146.66 37.08 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.055 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.567 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -94.44 116.41 28.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.557 179.712 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.431 ' CB ' ' CD ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -126.85 179.46 1.2 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.562 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' A' ' 38' ' ' LYS . 22.1 Cg_exo . . . . . 0 N--CA 1.495 1.592 0 C-N-CA 122.483 2.122 . . . . 0.0 112.028 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.409 ' SG ' ' N ' ' A' ' 6' ' ' ILE . 11.5 p . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.768 0.318 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.483 ' O ' ' CB ' ' A' ' 7' ' ' ALA . 1.1 pp -108.43 0.83 9.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.772 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 6' ' ' ILE . . . 79.27 -61.95 0.31 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.514 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -65.55 -164.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.542 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -139.53 133.33 30.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.354 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 52.38 178.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.622 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 109.14 -123.99 7.13 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.446 ' NH1' ' O ' ' A' ' 33' ' ' THR . 3.9 tpt180 -98.31 146.94 25.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.64 0.257 . . . . 0.0 110.551 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.455 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 3.7 p -145.89 175.71 10.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.478 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 17' ' ' GLY . 24.9 tttm -151.51 96.73 2.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.334 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -45.87 -21.62 0.14 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.76 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.76 36.28 4.33 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 14' ' ' LYS . . . 169.43 -124.72 1.18 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 19' ' ' PRO . 71.6 p -37.28 100.01 0.19 Allowed Pre-proline 0 N--CA 1.464 0.269 0 O-C-N 123.443 0.143 . . . . 0.0 110.84 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 18' ' ' THR . 39.6 Cg_exo -54.32 -145.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.529 2.152 . . . . 0.0 112.516 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.98 90.31 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.201 0.524 . . . . 0.0 110.709 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -45.68 -79.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.423 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 -95.04 126.73 40.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.358 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.499 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 99.88 82.02 1.64 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.415 ' H ' ' CD ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -85.76 11.88 10.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.637 0.256 . . . . 0.0 110.603 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.96 49.74 4.29 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.8 t -81.46 103.42 11.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.923 0.392 . . . . 0.0 110.913 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.7 tt -113.77 148.18 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.288 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -129.71 161.65 30.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.77 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.51 165.68 14.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.746 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 tp -52.3 -28.44 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.635 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.6 mtt -83.49 -40.64 18.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.76 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.41 62.97 0.73 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.446 ' O ' ' NH1' ' A' ' 12' ' ' ARG . 3.5 t -143.51 -24.36 0.59 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.762 0.315 . . . . 0.0 110.746 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -98.74 54.44 1.03 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.429 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.612 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 60.4 m -77.68 94.97 4.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.391 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -110.2 138.0 47.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.785 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -92.8 118.73 31.41 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.679 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -127.84 150.64 73.94 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.754 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo . . . . . 0 N--CA 1.495 1.581 0 C-N-CA 122.554 2.17 . . . . 0.0 112.106 179.608 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 120.767 0.317 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.456 ' CG2' ' HZ3' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -101.24 -13.73 8.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.664 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 9' ' ' ASP . . . 71.4 -55.45 0.65 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.868 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.456 ' HZ3' ' CG2' ' A' ' 6' ' ' ILE . 9.3 pttt -52.86 -4.51 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.815 0.34 . . . . 0.0 111.188 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.553 ' H ' ' C ' ' A' ' 7' ' ' ALA . 26.8 t0 63.44 -75.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.503 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.534 ' CE1' ' OD1' ' A' ' 9' ' ' ASP . 82.9 m-85 -115.92 159.52 21.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.586 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 134.57 -154.94 21.68 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.428 ' O ' ' NE ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -55.57 117.18 3.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.589 0.233 . . . . 0.0 110.796 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.604 ' SG ' ' N ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -119.02 168.57 10.69 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.711 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.604 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -141.58 96.09 2.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.484 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -54.95 120.36 6.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.956 0.408 . . . . 0.0 110.443 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.83 -20.64 49.9 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -103.32 -68.81 0.79 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.2 p -89.89 144.52 31.65 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.777 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.41 -18.25 18.03 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.156 1.904 . . . . 0.0 112.342 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.2 t 47.41 90.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.341 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -39.4 -86.0 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.878 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.517 ' O ' ' CZ ' ' A' ' 10' ' ' TYR . 41.0 mtm180 -109.14 106.55 16.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.9 0.381 . . . . 0.0 110.386 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.507 ' N ' ' NH1' ' A' ' 24' ' ' ARG . . . 155.5 70.87 0.01 OUTLIER Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.507 ' NH1' ' N ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -80.67 6.09 13.76 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.537 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -103.74 55.19 0.63 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.0 t -83.13 109.29 17.04 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.06 0.457 . . . . 0.0 110.683 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.3 tt -109.84 143.93 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.409 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.9 m -125.05 167.58 14.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.745 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.41 178.7 1.48 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.58 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 tp -61.32 -28.85 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.69 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.9 mtt -84.64 -35.98 22.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.544 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.39 62.51 0.77 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.9 t -142.63 -38.59 0.36 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.776 0.322 . . . . 0.0 110.615 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -79.64 49.68 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.534 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.9 m -72.71 123.71 23.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.644 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -138.17 121.02 16.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.898 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.507 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -70.14 115.1 8.95 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.338 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -125.27 149.89 65.51 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.716 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo . . . . . 0 N--CA 1.494 1.536 0 C-N-CA 122.599 2.2 . . . . 0.0 112.09 179.869 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.462 0.16 0 CA-C-O 120.633 0.254 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.524 ' CD1' ' H ' ' A' ' 9' ' ' ASP . 1.8 pp -129.61 -170.71 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.27 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.15 -30.78 5.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.437 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.456 ' O ' ' CB ' ' A' ' 9' ' ' ASP . 8.5 mtmt -43.71 -67.06 0.31 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.6 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.552 ' OD1' ' CE1' ' A' ' 10' ' ' TYR . 6.9 t0 78.82 117.35 0.06 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.48 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.562 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 42.4 m-85 53.76 168.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.468 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.21 -127.69 9.33 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.1 ttt-85 -72.41 140.6 48.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.838 0.351 . . . . 0.0 110.615 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.617 ' SG ' ' N ' ' A' ' 14' ' ' LYS . 0.7 OUTLIER -152.08 158.93 43.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.653 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.617 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 6.9 mttt -157.65 123.83 4.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.241 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.528 ' CZ2' ' SG ' ' A' ' 28' ' ' CYS . 1.0 OUTLIER -52.47 -24.87 8.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.582 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -112.34 14.08 25.59 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.07 -117.15 2.07 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.9 p -90.2 141.19 27.51 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.762 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 20' ' ' CYS . 58.9 Cg_endo -74.0 -32.69 6.8 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.554 2.17 . . . . 0.0 112.273 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.602 ' O ' ' N ' ' A' ' 22' ' ' ARG . 1.6 t 80.73 27.39 0.24 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.6 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.1 t 34.4 -84.1 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.608 0.567 . . . . 0.0 111.431 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.602 ' N ' ' O ' ' A' ' 20' ' ' CYS . 76.2 mtt180 -99.93 122.77 43.35 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.594 ' H ' ' HE ' ' A' ' 24' ' ' ARG . . . 130.06 79.43 0.21 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.627 ' H ' ' NE ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -79.51 1.05 27.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.76 0.314 . . . . 0.0 110.421 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -75.86 35.27 1.23 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.483 ' H ' ' C ' ' A' ' 24' ' ' ARG . 20.4 m -67.17 82.78 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.775 0.321 . . . . 0.0 110.593 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.3 tt -122.21 153.55 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.535 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.528 ' SG ' ' CZ2' ' A' ' 15' ' ' TRP . 6.6 m -118.75 165.84 13.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.771 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.7 170.48 7.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.403 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.3 tp -54.12 -25.72 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.817 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.4 mtt -81.19 -37.39 28.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.646 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.68 58.48 0.94 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.5 t -148.76 -32.33 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 0.0 110.609 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -81.16 50.46 1.42 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.51 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.0 m -74.81 110.48 9.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.783 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -138.7 149.47 45.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.741 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -89.73 107.28 19.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.117 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -97.28 148.05 33.85 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.555 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 N--CA 1.493 1.458 0 C-N-CA 122.251 1.967 . . . . 0.0 112.114 179.869 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.162 0 CA-C-O 120.371 0.129 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.474 ' O ' ' CB ' ' A' ' 7' ' ' ALA . 2.0 pp -133.71 1.43 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 0.0 110.006 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' A' ' 6' ' ' ILE . . . 82.52 -62.41 0.14 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.067 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -60.73 -140.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.5 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 10' ' ' TYR . 11.8 m-20 -140.39 -149.97 0.3 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.533 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 9.5 m-85 -40.95 163.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.529 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.543 ' N ' ' SG ' ' A' ' 37' ' ' CYS . . . 138.51 -138.95 9.86 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -79.92 127.44 32.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.679 0.276 . . . . 0.0 110.706 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.3 p -134.81 -172.18 2.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.597 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -160.01 115.66 2.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.354 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 32.3 m95 -57.7 -12.9 3.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.507 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -134.81 31.84 2.68 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.1 -133.64 1.81 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 14' ' ' LYS . 63.4 p -39.82 104.59 0.33 Allowed Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -79.02 -163.93 0.25 Allowed 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.958 1.772 . . . . 0.0 112.429 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -153.4 105.06 2.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.867 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.8 m -38.15 -75.36 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.682 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 mtp85 -95.75 120.94 36.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.415 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.703 ' H ' HH11 ' A' ' 24' ' ' ARG . . . 122.72 92.85 1.12 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.703 HH11 ' H ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -88.39 -8.37 55.13 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.742 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.44 66.85 3.85 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.3 m -81.78 80.72 8.02 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.28 0.562 . . . . 0.0 110.229 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.2 tt -80.65 139.18 18.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.495 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.604 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -132.27 175.94 8.83 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.819 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.65 169.49 15.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.528 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.4 tp -53.45 -24.91 9.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.655 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.2 mtm -92.16 -35.61 13.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.574 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.26 56.98 0.86 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 t -131.95 -33.54 1.35 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.798 0.332 . . . . 0.0 110.524 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -86.49 42.52 1.01 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.344 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.604 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 45.6 m -69.2 120.11 14.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.585 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -142.54 129.11 20.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.882 0.373 . . . . 0.0 111.057 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' N ' ' A' ' 11' ' ' GLY . 0.8 OUTLIER -80.15 127.47 32.37 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.522 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -137.29 149.7 66.56 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.402 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo . . . . . 0 N--CA 1.494 1.552 0 C-N-CA 122.308 2.005 . . . . 0.0 112.211 179.869 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.428 ' O ' ' O ' ' A' ' 6' ' ' ILE . 7.2 p . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.822 0.344 . . . . 0.0 110.399 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.441 HG13 ' H ' ' A' ' 21' ' ' CYS . 2.1 pp -50.02 -178.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.331 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 6' ' ' ILE . . . -35.59 -89.94 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.872 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.445 ' O ' ' CB ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -175.7 73.28 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 120.9 0.381 . . . . 0.0 110.371 179.669 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.47 ' C ' ' CD1' ' A' ' 10' ' ' TYR . 0.8 OUTLIER 162.38 -109.33 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.997 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.552 ' CZ ' ' O ' ' A' ' 22' ' ' ARG . 43.6 m-85 -142.48 -162.4 1.41 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.199 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 118.42 -119.9 4.52 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.03 151.32 21.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.717 0.294 . . . . 0.0 110.554 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.568 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 1.5 t -123.05 179.96 4.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.334 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -160.12 91.89 0.97 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.428 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.412 ' C ' ' H ' ' A' ' 17' ' ' GLY . 4.9 m0 -49.51 -81.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.451 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.77 -14.68 1.11 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 15' ' ' TRP . . . -95.07 -134.4 7.65 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.421 ' H ' ' HG1' ' A' ' 18' ' ' THR . 0.7 OUTLIER -89.18 152.75 48.36 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.592 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.54 178.34 6.83 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.319 2.013 . . . . 0.0 112.364 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.568 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -102.78 127.54 49.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.388 179.635 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.441 ' H ' HG13 ' A' ' 6' ' ' ILE . 59.8 m -50.85 -97.2 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.916 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.552 ' O ' ' CZ ' ' A' ' 10' ' ' TYR . 4.7 mtt180 -83.65 24.8 0.83 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.428 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.91 151.13 17.7 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.95 -14.34 0.53 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.796 0.331 . . . . 0.0 110.701 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.26 47.75 3.89 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 95.4 m -77.19 105.86 8.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.723 0.297 . . . . 0.0 110.633 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.3 tt -119.36 145.73 25.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.293 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.9 m -131.8 -178.6 4.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.759 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.623 ' HG ' ' H ' ' A' ' 31' ' ' MET . 0.1 OUTLIER -83.83 168.75 15.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.652 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.576 ' N ' ' HG ' ' A' ' 29' ' ' SER . 8.5 tp -49.64 -25.56 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.578 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.623 ' H ' ' HG ' ' A' ' 29' ' ' SER . 1.5 mtt -86.93 -47.41 9.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.484 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.66 57.03 0.75 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.0 t -136.12 -24.78 1.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.749 0.309 . . . . 0.0 110.522 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -101.44 50.89 0.85 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.383 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 97.7 m -68.63 122.81 19.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.806 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -119.77 127.87 53.21 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.079 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.512 ' N ' ' O ' ' A' ' 11' ' ' GLY . 6.1 t -84.82 97.45 9.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.363 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.4 mtmt -107.96 147.0 34.62 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.743 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo . . . . . 0 N--CA 1.495 1.577 0 C-N-CA 122.371 2.047 . . . . 0.0 112.084 179.607 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.7 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.939 0.399 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.547 ' C ' ' H ' ' A' ' 8' ' ' LYS . 2.5 pp -54.92 -25.78 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.015 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.524 ' C ' ' H ' ' A' ' 9' ' ' ASP . . . 66.82 -36.6 0.27 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.547 ' H ' ' C ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -72.57 15.74 0.17 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 122.119 0.961 . . . . 0.0 110.726 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 7' ' ' ALA . 2.9 p-10 42.95 -110.39 0.15 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.924 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.491 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.4 m-30 -77.4 126.65 31.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.218 -178.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 159.04 -96.55 0.15 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.9 ttt85 -110.77 146.42 36.39 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.785 0.326 . . . . 0.0 110.752 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -158.03 143.75 17.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.617 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.582 ' NZ ' ' SG ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -137.34 126.01 23.81 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.997 0.427 . . . . 0.0 110.629 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -28.13 63.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.541 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.62 -6.85 57.16 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.75 -115.61 3.22 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.3 p -90.21 142.81 28.83 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.567 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.67 167.47 27.17 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.182 1.922 . . . . 0.0 112.396 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 1.5 t -103.48 107.18 17.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.958 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.31 -72.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.529 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.8 mtm-85 -100.08 122.57 43.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.486 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 82.26 109.78 0.43 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.676 ' N ' ' HE ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -102.88 19.34 19.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.661 0.267 . . . . 0.0 110.649 -179.952 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.02 53.48 4.75 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.561 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 38.0 m -73.97 113.29 10.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.992 0.425 . . . . 0.0 110.501 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.0 tt -126.11 148.03 30.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.084 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.555 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -126.16 168.17 14.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.577 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 31' ' ' MET . 4.3 m -77.44 157.38 30.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.569 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -42.19 -24.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.847 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.431 ' N ' ' O ' ' A' ' 29' ' ' SER . 1.2 mtp -88.28 -50.92 6.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.757 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.83 63.72 0.53 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.6 t -145.04 -17.52 0.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.779 0.323 . . . . 0.0 110.302 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -107.74 51.07 0.75 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.171 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.582 ' SG ' ' NZ ' ' A' ' 14' ' ' LYS . 31.3 m -73.39 86.22 1.5 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.23 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -102.16 152.2 21.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.449 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.561 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -98.98 120.87 40.15 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.616 179.304 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -129.54 159.65 68.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.427 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 38' ' ' LYS . 50.9 Cg_exo . . . . . 0 N--CA 1.493 1.46 0 C-N-CA 122.352 2.035 . . . . 0.0 112.21 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 6' ' ' ILE . 4.6 p . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 121.003 0.43 . . . . 0.0 110.722 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.419 ' N ' ' SG ' ' A' ' 5' ' ' CYS . 1.1 pp -139.26 -172.16 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.446 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.44 -30.19 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.774 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.628 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -51.7 -42.33 62.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.431 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 10' ' ' TYR . 4.8 m-20 58.92 125.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.47 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 9' ' ' ASP . 66.5 m-85 55.97 160.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.854 0.359 . . . . 0.0 110.795 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.18 -152.04 21.93 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.415 ' N ' ' OE2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -42.24 125.42 3.09 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.657 -0.32 . . . . 0.0 110.944 -179.807 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 2.9 t -154.73 150.46 27.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.649 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.5 ' H ' ' HG1' ' A' ' 18' ' ' THR . 25.3 tttp -155.88 103.7 2.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.534 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.41 ' C ' ' H ' ' A' ' 17' ' ' GLY . 13.8 m95 -42.05 154.95 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.412 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.46 -47.5 0.71 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 15' ' ' TRP . . . -84.96 -90.79 0.82 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.5 ' HG1' ' H ' ' A' ' 14' ' ' LYS . 3.9 p -90.19 112.98 55.61 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-O 119.448 -0.31 . . . . 0.0 110.75 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 18' ' ' THR . 52.0 Cg_exo -51.49 -161.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.12 1.88 . . . . 0.0 112.611 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 6.3 t -171.92 61.18 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.475 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -38.22 -42.4 0.68 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.807 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.4 mtt180 -120.36 99.81 6.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.44 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.499 ' O ' ' SG ' ' A' ' 20' ' ' CYS . . . 130.81 91.95 0.59 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.411 ' C ' ' H ' ' A' ' 26' ' ' CYS . 2.2 ptm180 -85.47 -12.43 51.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.85 0.357 . . . . 0.0 110.488 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.17 41.84 1.59 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.411 ' H ' ' C ' ' A' ' 24' ' ' ARG . 9.3 t -81.87 108.58 15.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.03 0.443 . . . . 0.0 110.685 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.8 tt -145.47 152.09 14.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.318 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.647 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 1.0 OUTLIER -129.84 177.1 7.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.699 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.15 165.93 21.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.417 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.1 tp -51.76 -25.9 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.64 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.9 mtt -86.34 -29.8 22.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.633 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.66 62.78 1.59 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -137.4 -36.06 0.66 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.785 0.326 . . . . 0.0 110.688 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -94.76 54.15 1.71 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.183 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.647 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 1.8 m -85.56 114.4 22.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.622 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.415 ' OE2' ' N ' ' A' ' 12' ' ' ARG . 9.2 mm-40 -137.74 154.3 49.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.803 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -98.76 111.3 23.72 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.191 179.356 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -102.06 147.04 33.36 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.643 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo . . . . . 0 N--CA 1.494 1.547 0 C-N-CA 122.339 2.026 . . . . 0.0 112.325 179.604 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 120.714 0.292 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.615 ' CD1' ' H ' ' A' ' 9' ' ' ASP . 1.5 pp -106.07 -5.07 9.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.536 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.446 ' C ' ' H ' ' A' ' 9' ' ' ASP . . . 73.64 -56.14 0.66 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.639 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 10' ' ' TYR . 30.9 mmtm -49.17 -14.04 0.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.713 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.615 ' H ' ' CD1' ' A' ' 6' ' ' ILE . 19.4 m-20 59.1 -76.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.524 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.538 ' N ' ' O ' ' A' ' 8' ' ' LYS . 52.0 m-85 -108.95 163.68 13.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.505 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.23 -156.67 15.51 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.529 HH12 ' N ' ' A' ' 35' ' ' CYS . 0.2 OUTLIER -39.68 130.66 1.87 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.838 0.351 . . . . 0.0 110.876 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.599 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 26.6 p -157.01 179.17 9.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.587 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -160.64 115.53 2.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.467 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -56.96 -39.63 74.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.762 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -98.91 28.13 16.65 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -147.0 -78.21 0.03 OUTLIER Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.2 p -90.4 148.07 38.12 Favored Pre-proline 0 C--N 1.325 -0.478 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.197 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.64 -31.72 10.42 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.386 2.057 . . . . 0.0 112.422 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 22' ' ' ARG . 17.2 t 58.16 87.26 0.07 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.359 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -37.17 -76.47 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.711 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.402 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -99.81 175.12 5.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.545 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.479 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 50.95 74.87 0.25 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -79.79 10.75 3.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.664 0.269 . . . . 0.0 110.442 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.14 49.84 4.3 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.405 ' SG ' ' C ' ' A' ' 13' ' ' CYS . 5.2 t -68.89 90.77 0.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.949 0.404 . . . . 0.0 110.387 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.2 tt -103.97 147.45 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.405 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 11.3 m -126.79 164.3 21.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.737 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 m -73.18 167.25 21.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.458 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.5 tp -51.55 -28.35 8.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.668 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.6 mtm -80.09 -33.66 38.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.625 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.04 65.22 1.39 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.0 t -150.21 -28.88 0.23 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.768 0.318 . . . . 0.0 110.663 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.408 ' C ' HH12 ' A' ' 12' ' ' ARG . 13.9 t-20 -93.85 53.93 1.88 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.446 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.529 ' N ' HH12 ' A' ' 12' ' ' ARG . 72.5 m -75.04 120.27 20.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.681 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.453 ' C ' ' SG ' ' A' ' 13' ' ' CYS . 56.3 mt-10 -135.56 138.42 42.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.62 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.599 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -83.8 105.38 14.66 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.22 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.52 149.69 40.62 Favored Pre-proline 0 C--O 1.236 0.368 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.574 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo . . . . . 0 N--CA 1.495 1.565 0 C-N-CA 122.597 2.198 . . . . 0.0 111.975 179.412 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.416 ' SG ' ' N ' ' A' ' 6' ' ' ILE . 14.0 p . . . . . 0 CA--C 1.523 -0.089 0 CA-C-O 120.865 0.364 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.416 ' N ' ' SG ' ' A' ' 5' ' ' CYS . 1.7 pp -104.09 1.33 10.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.902 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 68.6 -64.56 0.31 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.506 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -56.61 -164.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.665 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.409 ' O ' ' O ' ' A' ' 10' ' ' TYR . 3.8 p-10 -139.28 127.87 23.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.471 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.409 ' O ' ' O ' ' A' ' 9' ' ' ASP . 79.4 m-85 54.42 167.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.63 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.07 -113.48 1.75 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -108.91 136.96 47.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.667 0.27 . . . . 0.0 110.823 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 5.9 p -143.48 174.75 10.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.995 0.426 . . . . 0.0 110.935 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -160.4 108.14 1.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.385 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.544 ' C ' ' H ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -41.07 -67.41 0.25 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.849 -179.803 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.78 28.55 0.91 Allowed Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.544 ' H ' ' C ' ' A' ' 15' ' ' TRP . . . -145.34 -92.95 0.14 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.2 p -91.45 144.8 30.2 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.093 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.82 -32.7 7.1 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.128 1.885 . . . . 0.0 112.386 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.1 t 67.55 100.93 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.595 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -58.63 -83.97 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.599 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.4 mmt-85 -84.19 117.32 23.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.597 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.508 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 115.24 89.85 1.64 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -86.37 -24.13 25.9 Favored 'General case' 0 N--CA 1.44 -0.939 0 O-C-N 122.532 -0.393 . . . . 0.0 110.268 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.01 58.46 0.79 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.8 t -87.78 113.06 23.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.871 0.367 . . . . 0.0 110.259 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.1 tt -131.15 156.53 42.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.592 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.635 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.5 OUTLIER -135.73 174.62 10.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.541 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.1 t -79.95 158.41 26.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.441 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -42.96 -32.0 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 120.906 0.384 . . . . 0.0 110.092 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 16.6 mtm -79.31 -43.35 23.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.994 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.01 62.85 0.88 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 t -139.47 -35.02 0.55 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.81 0.338 . . . . 0.0 110.64 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -95.15 50.85 1.29 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.142 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.635 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 31.3 m -75.15 102.34 4.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.533 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -109.88 141.25 42.86 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.15 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.3 OUTLIER -97.09 103.49 15.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.227 179.562 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.89 162.1 47.36 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.436 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 C--N 1.31 -1.494 0 C-N-CA 122.514 2.143 . . . . 0.0 112.174 179.985 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.529 0.16 0 CA-C-O 120.726 0.298 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.464 ' O ' ' CB ' ' A' ' 7' ' ' ALA . 2.3 pp -141.95 -0.19 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.464 ' CB ' ' O ' ' A' ' 6' ' ' ILE . . . 80.35 -64.31 0.19 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.728 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 7' ' ' ALA . 10.1 mttp -53.61 -170.28 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.155 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -126.78 -155.22 0.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.66 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 13.4 m-85 -45.01 155.4 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.485 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 144.47 -103.28 0.29 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.506 HH11 ' HZ1' ' A' ' 14' ' ' LYS . 0.9 OUTLIER -123.32 134.7 54.02 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.788 0.328 . . . . 0.0 110.871 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -148.67 179.84 7.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.661 179.463 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.602 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 2.4 tttp -143.73 110.34 5.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.511 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.555 ' C ' ' H ' ' A' ' 17' ' ' GLY . 10.1 m95 -48.19 141.56 6.19 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.552 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.29 -36.31 0.26 Allowed Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.555 ' H ' ' C ' ' A' ' 15' ' ' TRP . . . -83.08 -91.29 0.67 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 19' ' ' PRO . 13.5 p -91.73 111.56 50.12 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-O 119.312 -0.375 . . . . 0.0 110.731 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 18' ' ' THR . 42.7 Cg_exo -52.46 -156.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.169 1.912 . . . . 0.0 112.672 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -165.27 92.77 0.57 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.296 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.6 m -41.45 -77.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.657 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 36.1 mtt85 -94.74 115.71 27.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.476 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.55 85.82 1.88 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.9 ptm85 -80.3 0.56 32.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.584 0.231 . . . . 0.0 110.773 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.36 98.25 2.4 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -121.06 108.74 14.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.235 0.54 . . . . 0.0 110.323 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.6 tt -114.58 155.9 15.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.782 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.8 m -132.35 177.58 7.48 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.899 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.667 ' N ' HD22 ' A' ' 34' ' ' ASN . 11.9 t -91.29 159.59 15.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.568 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.4 tp -40.67 -24.75 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.651 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.474 ' N ' ' O ' ' A' ' 29' ' ' SER . 3.1 mtt -80.76 -42.26 22.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.752 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 29' ' ' SER . . . 87.28 63.17 1.44 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 t -150.6 -31.33 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.838 0.352 . . . . 0.0 110.466 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.667 HD22 ' N ' ' A' ' 29' ' ' SER . 0.1 OUTLIER -89.44 32.22 0.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.464 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 90.3 m -51.46 105.11 0.1 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.657 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -107.59 132.83 52.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.309 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -87.48 130.11 34.82 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.544 179.335 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.32 162.28 43.33 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.47 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo . . . . . 0 N--CA 1.493 1.469 0 C-N-CA 122.668 2.245 . . . . 0.0 112.142 179.692 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 7' ' ' ALA . 1.8 m . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 120.641 0.257 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 pp -39.49 -28.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.679 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.499 ' C ' ' H ' ' A' ' 9' ' ' ASP . . . 68.05 -57.73 0.46 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.818 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.579 ' NZ ' ' CB ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -44.55 -16.57 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.944 0.402 . . . . 0.0 110.998 -179.415 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.499 ' H ' ' C ' ' A' ' 7' ' ' ALA . 0.8 OUTLIER 72.6 111.02 0.06 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.501 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 55.87 169.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.478 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.19 -105.68 1.05 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -111.19 145.05 39.35 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.813 0.339 . . . . 0.0 110.503 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.9 p -145.43 168.72 19.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.721 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.63 109.83 3.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.489 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -52.95 -40.88 64.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.943 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.55 27.37 20.6 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -168.54 -126.11 0.83 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -40.45 109.26 0.59 Allowed Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.841 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -76.1 152.45 35.78 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.96 1.773 . . . . 0.0 112.097 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.73 137.57 51.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.134 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -95.34 -79.47 0.43 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.485 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 70.7 mtt-85 -81.99 109.06 15.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.549 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.499 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 103.47 92.09 2.22 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.37 14.56 10.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.751 0.31 . . . . 0.0 110.643 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.56 56.73 4.17 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.0 t -79.94 113.49 18.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.728 0.299 . . . . 0.0 110.659 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.5 tt -126.02 148.44 30.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.315 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.1 m -126.33 174.15 8.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.605 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.12 169.44 17.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.49 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -52.36 -27.41 10.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.929 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.6 mtp -85.5 -25.58 26.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.66 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.84 66.04 1.66 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.0 t -145.18 -34.15 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.846 0.355 . . . . 0.0 110.547 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.62 53.8 2.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.324 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.7 m -72.13 98.29 2.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -105.31 140.64 38.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.819 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 0.7 OUTLIER -93.03 111.22 22.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.344 179.488 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.52 158.01 63.29 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.828 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo . . . . . 0 N--CA 1.494 1.555 0 C-N-CA 122.682 2.255 . . . . 0.0 112.07 179.72 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.547 ' SG ' ' N ' ' A' ' 6' ' ' ILE . 31.0 p . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 120.759 0.314 . . . . 0.0 110.413 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.547 ' N ' ' SG ' ' A' ' 5' ' ' CYS . 2.6 pp -119.76 -174.26 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.509 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.35 -1.57 2.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.575 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.411 ' O ' ' O ' ' A' ' 9' ' ' ASP . 1.4 pttm -83.93 -12.36 55.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.593 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.434 ' H ' HD11 ' A' ' 6' ' ' ILE . 0.1 OUTLIER 60.11 133.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.549 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.432 ' O ' ' O ' ' A' ' 9' ' ' ASP . 52.5 m-85 44.29 -170.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.686 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.95 -153.96 18.69 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.2 ttt-85 -80.15 153.59 28.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.737 0.303 . . . . 0.0 110.556 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.556 ' SG ' ' N ' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -156.3 -178.74 7.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.664 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.556 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -139.47 118.21 12.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.394 179.758 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -60.01 -11.28 5.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.728 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.2 25.84 4.81 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -170.28 -144.64 4.4 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.1 p -38.32 102.59 0.25 Allowed Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 121.314 -0.154 . . . . 0.0 110.916 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -79.97 -163.03 0.2 Allowed 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.403 2.069 . . . . 0.0 112.237 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 31.7 p -144.64 112.37 6.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.573 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -51.64 -81.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.636 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.03 118.4 19.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.58 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.504 ' O ' ' SG ' ' A' ' 20' ' ' CYS . . . 96.14 66.95 0.96 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -78.43 25.01 0.25 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 120.838 0.351 . . . . 0.0 110.6 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . -98.83 75.85 0.54 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -96.73 104.0 15.96 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.561 0.695 . . . . 0.0 110.784 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.6 tt -97.39 110.61 25.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.282 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.03 156.66 17.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.669 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.3 m -80.09 161.0 25.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.705 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.8 tp -44.27 -27.51 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.652 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.9 mtt -86.12 -40.46 15.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.601 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.22 65.06 0.74 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.8 t -158.74 -0.66 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.592 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -109.93 23.86 13.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.632 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.4 m -54.74 104.83 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.512 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -115.72 107.38 15.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.911 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 1.1 m -72.34 109.44 6.06 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.457 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.433 ' CB ' ' CD ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -125.48 177.5 1.87 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.877 -179.799 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' A' ' 38' ' ' LYS . 23.3 Cg_exo . . . . . 0 N--CA 1.496 1.631 0 C-N-CA 122.779 2.319 . . . . 0.0 112.231 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.5 m . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 121.006 0.431 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.546 ' C ' ' H ' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -120.95 -20.98 4.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.428 -179.522 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 68.61 -37.82 0.36 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.039 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.546 ' H ' ' C ' ' A' ' 6' ' ' ILE . 3.5 mttm -64.34 -30.67 71.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.661 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER 56.92 126.23 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.117 -179.52 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.564 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 2.4 m-30 64.11 114.56 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.433 0.635 . . . . 0.0 110.534 178.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 158.66 -144.51 10.43 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.791 -0.923 . . . . 0.0 110.791 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.516 ' O ' ' NH2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -83.52 156.34 22.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.878 0.37 . . . . 0.0 110.707 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.444 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 28.2 p -158.62 170.07 22.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.537 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.79 114.3 3.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.617 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -62.71 -11.8 19.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.707 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.33 10.28 14.84 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -139.56 -98.96 0.42 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.2 p -90.11 145.62 33.32 Favored Pre-proline 0 C--N 1.327 -0.399 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.918 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.9 -160.84 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.466 2.111 . . . . 0.0 112.155 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -165.27 103.01 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.54 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.43 -89.31 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.785 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -82.65 121.49 26.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.606 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.511 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 99.11 69.18 0.91 Allowed Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -79.45 27.89 0.26 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.982 0.42 . . . . 0.0 110.529 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . -93.37 66.56 1.76 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.582 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 56.4 m -84.6 87.56 7.28 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.348 0.594 . . . . 0.0 110.697 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.7 tt -80.07 96.96 2.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.495 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 94.4 m -92.16 154.99 18.33 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.472 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.407 ' C ' ' N ' ' A' ' 31' ' ' MET . 1.2 m -91.77 171.31 9.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.767 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 tp -51.8 -14.82 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.571 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' MET . . . . . 0.407 ' N ' ' C ' ' A' ' 29' ' ' SER . 4.7 mtm -106.98 -42.9 4.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.761 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.38 56.13 0.74 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 t -133.84 -22.44 1.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 0.0 110.446 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -94.26 13.18 24.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.576 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.6 m -49.49 91.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.681 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 34' ' ' ASN . 2.9 tt0 -107.31 123.2 47.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.582 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.582 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -77.73 99.6 5.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.361 179.892 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.9 mtmm -95.82 148.71 34.99 Favored Pre-proline 0 C--O 1.237 0.398 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.88 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 0 N--CA 1.493 1.479 0 C-N-CA 122.538 2.159 . . . . 0.0 112.146 179.653 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.234 0.237 0 CA-C-O 120.846 0.355 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.6 pp -130.96 -166.18 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.325 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' A' ' 9' ' ' ASP . . . -131.86 -24.93 2.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.758 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.623 ' CD ' ' H ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -71.76 12.52 0.37 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.79 -179.66 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.52 ' OD2' ' N ' ' A' ' 10' ' ' TYR . 6.7 p-10 36.2 -121.52 0.15 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.523 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.52 ' N ' ' OD2' ' A' ' 9' ' ' ASP . 60.5 m-85 -72.04 168.64 17.66 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.459 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.24 -145.86 17.46 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.447 ' NH1' ' NZ ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -37.74 119.26 0.73 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.853 0.358 . . . . 0.0 111.081 -179.688 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.488 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 26.9 p -151.9 171.54 17.62 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.688 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.447 ' NZ ' ' NH1' ' A' ' 12' ' ' ARG . 7.4 mttp -159.85 153.72 23.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.603 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.476 ' CZ2' ' SG ' ' A' ' 28' ' ' CYS . 0.9 OUTLIER -83.13 -52.57 6.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.783 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.48 -24.72 41.93 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.82 -119.88 0.17 Allowed Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.432 ' H ' ' HG1' ' A' ' 18' ' ' THR . 1.0 OUTLIER -88.56 151.64 48.35 Favored Pre-proline 0 C--N 1.326 -0.416 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.663 -179.677 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.52 -170.19 0.36 Allowed 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.568 2.179 . . . . 0.0 112.306 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.46 96.06 2.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.57 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 70.1 m -40.71 -84.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.582 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.515 ' O ' ' CE2' ' A' ' 10' ' ' TYR . 19.4 mtt85 -90.85 41.31 1.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.518 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.45 145.82 17.74 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.85 -25.62 0.5 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.749 0.309 . . . . 0.0 110.555 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.49 67.29 0.52 Allowed Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.426 ' O ' ' NE1' ' A' ' 15' ' ' TRP . 13.3 t -79.75 85.68 5.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.924 0.392 . . . . 0.0 110.348 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.9 tt -96.2 150.86 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.528 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.476 ' SG ' ' CZ2' ' A' ' 15' ' ' TRP . 3.7 m -130.56 177.73 7.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.769 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.92 174.7 11.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.664 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -53.79 -28.33 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.671 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.0 mtt -83.65 -46.14 12.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.721 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.9 62.38 0.82 Allowed Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.9 t -142.86 -25.73 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.796 0.332 . . . . 0.0 110.615 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -100.41 46.58 0.95 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.569 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.8 m -63.24 124.68 21.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.698 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.447 ' C ' ' SG ' ' A' ' 13' ' ' CYS . 41.3 mt-10 -130.62 138.68 50.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.52 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.488 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -87.1 122.87 31.52 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.173 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.59 148.06 63.07 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.805 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 N--CA 1.495 1.586 0 C-N-CA 122.452 2.102 . . . . 0.0 111.996 179.49 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.522 ' C ' ' H ' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.511 ' NZ ' ' NH2' ' A' ' 22' ' ' ARG . 10.4 mmtm 55.7 5.4 0.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.696 0.284 . . . . 0.0 110.647 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.522 ' H ' ' C ' ' A' ' 1' ' ' GLY . 4.7 mttp -76.09 10.38 1.97 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.616 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 2' ' ' LYS . 0.2 OUTLIER -122.03 -9.51 8.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.673 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 6' ' ' ILE . 23.5 p -135.05 -118.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.625 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.519 ' N ' ' SG ' ' A' ' 5' ' ' CYS . 2.5 pp -127.25 174.0 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.522 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.414 ' O ' ' OD1' ' A' ' 9' ' ' ASP . . . -114.3 -11.59 12.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.615 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 10' ' ' TYR . 51.1 mttt -58.14 -25.62 61.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.517 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 7' ' ' ALA . 1.5 m-20 68.07 -66.68 0.21 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.456 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.413 ' N ' ' O ' ' A' ' 8' ' ' LYS . 47.5 m-85 -137.22 162.31 33.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.436 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 99.1 -135.95 12.42 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.61 ' HE ' ' H ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER -39.61 111.06 0.16 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.731 0.301 . . . . 0.0 110.829 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.552 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 24.3 p -147.26 148.71 31.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.689 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -145.23 119.67 9.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.574 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -34.98 71.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.529 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.85 1.85 61.6 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -141.22 -134.07 2.99 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 18' ' ' THR . 6.6 p -39.07 102.74 0.26 Allowed Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 110.633 -0.136 . . . . 0.0 110.633 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 18' ' ' THR . 53.1 Cg_exo -50.89 -170.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.902 1.734 . . . . 0.0 112.48 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 6.5 t -153.44 80.93 1.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.236 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -40.1 -67.97 0.2 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.654 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.511 ' NH2' ' NZ ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -104.08 140.59 37.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.45 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.501 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 79.76 88.81 0.5 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.48 ' CZ ' ' O ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -81.94 -7.35 59.6 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.684 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.65 67.23 0.17 Allowed Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 24' ' ' ARG . 8.6 t -96.92 101.16 12.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.873 0.368 . . . . 0.0 110.352 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.6 tt -124.43 151.08 29.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.289 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 5.4 m -120.01 161.12 21.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.813 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.6 m -64.97 -177.03 0.32 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.554 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.8 tp -62.86 -30.79 50.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.822 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.3 mtm -80.35 -26.35 38.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.767 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.53 62.1 1.9 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.2 t -147.39 -29.53 0.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 110.6 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -90.47 53.73 2.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.511 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.5 m -73.64 103.67 4.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.695 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -117.51 144.5 45.01 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.975 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.552 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -91.91 117.48 29.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.494 179.631 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.6 148.9 40.74 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.332 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.77 -28.41 25.24 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.176 1.917 . . . . 0.0 111.983 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.4 mtp85 -64.8 141.83 58.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.666 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.654 ' H ' ' CD2' ' A' ' 41' ' ' LEU . 0.3 OUTLIER -81.44 -160.56 0.35 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.558 -179.647 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.11 -36.87 39.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.499 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.413 ' C ' ' H ' ' A' ' 45' ' ' GLY . 2.2 mpt? -61.01 109.07 0.98 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.622 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -80.71 23.99 0.5 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.708 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 43' ' ' MET . . . -168.19 -91.07 0.08 OUTLIER Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.552 ' CD1' ' N ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -129.39 -62.26 0.99 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.828 0.347 . . . . 0.0 110.66 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -165.92 49.6 0.27 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.0 tt -93.25 -45.3 7.91 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.483 179.845 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 69.48 149.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.904 0.383 . . . . 0.0 110.601 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.0 ttpp 66.09 62.95 0.58 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.525 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.408 ' NZ ' ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -134.62 -24.56 1.53 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.706 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.8 m -55.89 -78.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.694 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.481 ' O ' ' CB ' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -118.96 6.59 6.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.766 -179.182 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.481 ' CB ' ' O ' ' A' ' 6' ' ' ILE . . . 79.37 -55.57 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.303 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -80.6 -142.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.207 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.518 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 7.1 p-10 -131.9 -112.65 0.24 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.09 0.471 . . . . 0.0 111.043 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.478 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.8 m-30 -58.29 147.38 30.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.565 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.442 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 164.51 -157.61 30.04 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.318 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 5.0 ptm85 -71.61 125.23 26.56 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.815 0.34 . . . . 0.0 111.072 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -145.36 142.5 29.43 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.644 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.95 130.26 33.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.531 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -48.76 -34.39 12.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.568 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -112.92 24.69 12.55 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.64 -127.37 2.89 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.2 p -85.14 146.93 46.39 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.369 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.07 -159.61 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.444 2.096 . . . . 0.0 112.142 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -171.97 95.47 0.16 Allowed 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.905 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.408 ' SG ' ' NZ ' ' A' ' 4' ' ' LYS . 0.8 OUTLIER -42.52 -85.07 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.294 -179.358 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.83 122.32 22.27 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.273 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.41 87.19 1.97 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -85.1 -23.58 28.42 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.885 0.374 . . . . 0.0 110.131 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.05 75.48 0.12 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 4.6 t -92.48 111.78 23.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.115 0.483 . . . . 0.0 110.25 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.469 ' CG1' ' N ' ' A' ' 28' ' ' CYS . 10.7 tt -125.76 162.5 28.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.656 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 1.7 t -144.76 -171.86 3.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.777 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.08 170.65 9.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.513 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.0 tp -52.06 -27.24 9.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.576 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.8 mtp -83.56 -38.91 21.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.608 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.26 48.0 2.7 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.459 ' CG2' ' N ' ' A' ' 34' ' ' ASN . 10.1 t -122.97 -50.7 1.92 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.757 0.313 . . . . 0.0 110.45 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.459 ' N ' ' CG2' ' A' ' 33' ' ' THR . 2.9 t-20 -76.77 51.66 0.78 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.201 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.623 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 3.7 m -84.66 123.53 30.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.988 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -139.77 148.5 42.32 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.732 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 11' ' ' GLY . 0.7 OUTLIER -91.17 117.51 29.68 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.796 178.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.56 164.53 41.99 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.203 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -73.07 176.38 9.18 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.564 2.176 . . . . 0.0 112.253 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.6 mtm180 -71.31 -172.36 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.486 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.1 mp -122.57 33.73 5.35 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.712 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.52 142.27 43.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.28 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.443 ' N ' ' SD ' ' A' ' 43' ' ' MET . 2.1 mpt? -102.71 108.72 20.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.499 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.07 -41.62 94.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.63 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.8 10.15 0.02 OUTLIER Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 mp -89.17 -43.73 10.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.524 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.19 35.55 12.19 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.438 ' CD2' ' C ' ' A' ' 48' ' ' LEU . 0.8 OUTLIER -150.04 -40.78 0.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.793 0.33 . . . . 0.0 110.456 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.456 179.883 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -153.74 84.31 1.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.698 0.285 . . . . 0.0 110.527 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -177.56 20.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.617 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.574 ' CD ' ' N ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -111.35 -37.87 5.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.371 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.425 ' O ' ' O ' ' A' ' 4' ' ' LYS . 2.9 p -45.54 -96.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.656 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.4 pp -112.99 -174.36 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.272 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -106.63 -5.19 18.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.456 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.514 ' NZ ' ' O ' ' A' ' 12' ' ' ARG . 4.9 pttt -111.84 -119.73 0.29 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.561 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 23.9 p-10 -173.72 -42.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.45 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.469 ' CZ ' ' O ' ' A' ' 22' ' ' ARG . 69.0 m-85 -140.98 165.36 27.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.757 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 105.58 -152.58 17.2 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.244 -0.743 . . . . 0.0 111.244 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.514 ' O ' ' NZ ' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -37.42 130.31 0.96 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.848 0.356 . . . . 0.0 111.022 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.586 ' SG ' ' N ' ' A' ' 14' ' ' LYS . 0.8 OUTLIER -160.28 157.58 28.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.606 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.586 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 8.3 tttm -156.7 108.67 2.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.382 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 33.1 m95 -48.97 -27.3 3.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.623 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.12 -31.7 16.42 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.96 -104.38 2.07 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.0 p -90.22 144.02 30.48 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.597 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.1 -160.43 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.287 1.992 . . . . 0.0 111.956 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 12.8 t -160.98 90.45 0.83 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.933 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -49.81 -83.01 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.817 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.469 ' O ' ' CZ ' ' A' ' 10' ' ' TYR . 1.1 mpt_? -78.41 101.33 7.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.839 0.352 . . . . 0.0 110.431 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.493 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 112.83 116.45 3.4 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.455 ' C ' ' H ' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -110.91 4.81 20.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.782 0.325 . . . . 0.0 110.363 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.6 40.93 1.15 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 56.2 m -71.73 88.88 1.0 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.786 0.327 . . . . 0.0 110.296 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.3 tt -115.54 156.81 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.545 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.629 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.5 OUTLIER -137.45 -172.47 3.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.829 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 31' ' ' MET . 1.6 t -98.55 161.01 13.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.553 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.3 tp -42.19 -24.57 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.445 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.44 ' N ' ' O ' ' A' ' 29' ' ' SER . 2.8 mtt -81.66 -47.37 13.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.507 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.18 50.59 1.72 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.819 -0.913 . . . . 0.0 110.819 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.443 ' CG2' ' N ' ' A' ' 34' ' ' ASN . 8.9 t -131.15 -49.54 1.01 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.769 0.319 . . . . 0.0 110.659 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.443 ' N ' ' CG2' ' A' ' 33' ' ' THR . 72.0 m-80 -77.12 46.27 0.48 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.443 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.629 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 7.9 m -75.86 121.4 22.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.671 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -135.42 155.7 50.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.004 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 1.2 t -98.75 114.73 27.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.257 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -113.44 146.81 36.14 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.547 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -70.56 -162.84 0.1 Allowed 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.384 2.056 . . . . 0.0 112.147 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -101.96 170.42 8.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.5 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.9 mp -51.25 123.06 8.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.641 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -88.37 -50.69 13.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.606 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 20.7 mtm -137.82 131.21 30.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.54 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -63.04 -106.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.542 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -103.67 -18.02 15.4 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.404 HD12 ' H ' ' A' ' 46' ' ' LEU . 2.1 mp -91.67 173.1 8.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.663 0.268 . . . . 0.0 110.589 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -118.29 63.02 0.43 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.436 ' CD2' ' C ' ' A' ' 48' ' ' LEU . 1.0 OUTLIER -153.78 -41.21 0.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.856 0.36 . . . . 0.0 110.472 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.419 179.861 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.532 ' HZ3' ' NH1' ' A' ' 22' ' ' ARG . 1.5 mmmp? 53.76 15.52 0.82 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 121.089 -0.245 . . . . 0.0 110.587 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.6 mmtm -119.05 28.85 8.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.631 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.32 -28.75 38.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.371 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.72 -100.54 0.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.135 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.528 ' CD1' ' H ' ' A' ' 9' ' ' ASP . 2.4 pp -135.23 -167.65 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.376 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -127.56 -17.56 4.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.752 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.497 ' CD ' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -61.42 -42.48 98.81 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.856 -0.337 . . . . 0.0 110.289 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.528 ' H ' ' CD1' ' A' ' 6' ' ' ILE . 15.5 m-20 61.18 135.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.83 0.348 . . . . 0.0 110.108 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 9' ' ' ASP . 15.2 m-85 49.99 176.35 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.529 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.521 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 83.21 -153.52 30.7 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -42.48 143.73 0.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.816 0.341 . . . . 0.0 110.82 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 36' ' ' GLU . 28.9 p -147.33 168.91 20.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.526 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -160.72 104.88 1.39 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.287 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -53.75 -19.16 3.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.37 . . . . 0.0 110.744 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.55 -8.54 52.16 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -147.72 -112.62 0.7 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.9 p -38.84 101.88 0.24 Allowed Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 110.453 -0.202 . . . . 0.0 110.453 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -79.1 -22.88 8.19 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.195 1.93 . . . . 0.0 112.567 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' A' ' 21' ' ' CYS . 0.4 OUTLIER 66.17 91.05 0.09 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.565 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 6' ' ' ILE . 89.3 m -36.25 -73.08 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.521 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.532 ' NH1' ' HZ3' ' A' ' 2' ' ' LYS . 1.6 mpt_? -94.66 125.34 39.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.491 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.7 100.9 2.62 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -96.16 -2.22 46.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.745 0.307 . . . . 0.0 110.482 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' A' ' 38' ' ' LYS . . . -68.4 64.26 0.41 Allowed Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 47.1 t -85.39 71.23 10.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.288 0.566 . . . . 0.0 110.452 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.6 tt -86.27 145.56 7.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.754 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.572 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -126.93 166.17 18.02 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.965 -179.833 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.0 168.75 18.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.656 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -54.38 -26.86 16.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.674 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.2 mtm -85.14 -41.19 15.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.463 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 106.64 59.91 0.59 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.0 t -142.25 -30.43 0.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.336 . . . . 0.0 110.576 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -84.5 46.34 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.367 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.572 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 23.5 m -75.26 110.97 10.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.655 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.591 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 9.4 mt-10 -143.21 136.64 28.31 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.462 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' A' ' 11' ' ' GLY . 0.5 OUTLIER -74.26 120.65 20.12 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.429 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 25' ' ' GLY . 0.7 OUTLIER -101.53 146.91 33.05 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.387 -179.594 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -68.91 163.54 37.09 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.452 2.101 . . . . 0.0 112.198 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.22 -176.84 4.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.602 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.8 mp -97.83 76.04 2.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.458 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.4 tp -69.55 152.06 9.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.611 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.536 ' SD ' ' N ' ' A' ' 43' ' ' MET . 1.2 mpt? -43.38 166.24 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.573 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -48.33 -14.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.585 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 43' ' ' MET . . . 171.89 -45.6 0.18 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.408 ' O ' ' CB ' ' A' ' 43' ' ' MET . 1.6 mp -106.34 128.88 54.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.776 0.322 . . . . 0.0 110.351 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.53 59.28 1.61 Allowed Glycine 0 CA--C 1.52 0.357 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.443 ' C ' ' CD2' ' A' ' 48' ' ' LEU . 0.9 OUTLIER -121.6 -39.39 2.65 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.855 0.36 . . . . 0.0 110.491 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.459 179.854 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.6 ptpt -141.8 -89.88 0.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.766 0.317 . . . . 0.0 110.597 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -164.03 -159.57 0.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.66 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 0.1 OUTLIER -82.76 -171.03 3.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.53 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 4' ' ' LYS . 0.5 OUTLIER 77.77 171.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.473 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.426 ' O ' ' O ' ' A' ' 5' ' ' CYS . 2.6 pp -51.34 -172.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.969 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -149.26 63.45 1.03 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.628 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 39.3 pttt -169.11 -13.72 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.779 -179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.411 ' O ' ' O ' ' A' ' 10' ' ' TYR . 2.7 m-20 65.04 127.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.41 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.411 ' O ' ' O ' ' A' ' 9' ' ' ASP . 18.9 m-85 50.0 178.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.563 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.95 -109.82 2.77 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.7 ttp85 -114.76 137.97 51.29 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.811 0.339 . . . . 0.0 110.403 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.2 p -143.01 178.3 7.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.658 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -157.18 116.97 3.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.988 0.423 . . . . 0.0 110.689 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.53 ' C ' ' H ' ' A' ' 17' ' ' GLY . 0.0 OUTLIER -51.19 139.36 18.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.363 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.88 -37.17 0.62 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.53 ' H ' ' C ' ' A' ' 15' ' ' TRP . . . -93.19 -145.0 16.01 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 17' ' ' GLY . 31.2 p -36.02 95.66 0.09 OUTLIER Pre-proline 0 CA--C 1.536 0.405 0 O-C-N 123.579 0.223 . . . . 0.0 110.696 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.41 ' N ' ' O ' ' A' ' 17' ' ' GLY . 24.5 Cg_exo -61.87 156.88 46.17 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.105 1.87 . . . . 0.0 112.023 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -111.82 102.49 10.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.375 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -50.35 -71.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.544 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.9 mmp_? -104.25 107.77 18.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.273 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.47 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 133.68 77.83 0.11 Allowed Glycine 0 CA--C 1.52 0.381 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -79.39 5.37 12.78 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 120.934 0.397 . . . . 0.0 110.512 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.88 66.88 0.92 Allowed Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.497 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 19.2 m -97.26 102.78 14.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.0 0.428 . . . . 0.0 110.643 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.2 tt -109.31 157.08 9.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.802 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.52 175.92 8.89 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.681 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.2 166.81 14.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.645 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.6 tp -47.29 -27.48 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.904 0.383 . . . . 0.0 110.623 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.3 mtt -89.5 -46.07 8.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.589 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.92 68.93 1.01 Allowed Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -146.23 -12.15 0.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.714 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -118.05 40.62 3.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.378 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.522 ' SG ' ' NE1' ' A' ' 15' ' ' TRP . 3.6 m -56.14 105.82 0.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.739 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -103.67 134.88 46.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.661 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.497 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 4.3 t -84.78 97.09 9.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.215 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -97.53 148.75 34.89 Favored Pre-proline 0 C--O 1.235 0.341 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.971 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -39.56 -66.55 0.13 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 122.482 2.121 . . . . 0.0 112.407 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.6 ptp85 -135.9 -167.86 2.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.59 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.515 ' N ' ' CD1' ' A' ' 41' ' ' LEU . 8.1 mp -88.38 -173.51 4.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.552 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.6 tp -68.49 -19.45 24.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.442 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.515 ' N ' ' SD ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -52.13 143.13 14.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.581 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -75.26 38.1 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.525 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 43' ' ' MET . . . 73.51 66.64 1.96 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' A' ' 46' ' ' LEU . 6.9 mp 39.46 55.44 2.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.816 0.341 . . . . 0.0 110.735 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.53 -28.22 0.23 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.44 ' CD2' ' C ' ' A' ' 48' ' ' LEU . 1.0 OUTLIER -103.8 -39.76 6.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.711 0.291 . . . . 0.0 110.507 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.505 179.931 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt 47.56 -168.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 0.0 110.605 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.46 169.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.557 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.455 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 0.5 OUTLIER -81.2 -80.82 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.531 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 4' ' ' LYS . 7.2 p 35.87 -110.4 0.06 Allowed 'General case' 0 N--CA 1.461 0.083 0 O-C-N 123.253 0.346 . . . . 0.0 110.817 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.436 ' N ' ' SG ' ' A' ' 5' ' ' CYS . 2.2 pp -129.62 176.23 8.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.512 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.44 -19.0 10.28 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.017 0.437 . . . . 0.0 110.488 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -89.54 58.39 4.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.925 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 10' ' ' TYR . 1.1 m-20 -36.62 133.9 0.52 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.782 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 9' ' ' ASP . 88.3 m-85 56.51 158.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.512 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.05 -105.25 1.21 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -99.46 144.72 28.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.901 0.382 . . . . 0.0 110.853 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -158.35 141.97 15.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.553 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.1 tptm -147.71 120.94 8.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.485 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.93 -17.97 62.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.445 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.73 9.72 34.81 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -134.85 -113.23 1.32 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 p -88.78 151.36 47.44 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.473 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.07 -159.86 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.394 2.063 . . . . 0.0 112.017 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.6 t -160.93 81.72 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.221 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -39.45 -68.82 0.15 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.803 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.8 mtt-85 -104.7 88.0 2.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.606 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.491 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 157.4 94.95 0.1 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.61 -7.79 27.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.71 0.291 . . . . 0.0 110.554 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.89 53.55 4.26 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.567 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 91.8 m -75.98 93.72 3.3 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.1 tt -104.35 149.3 8.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.143 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.2 OUTLIER -134.52 -179.36 5.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.795 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.88 172.59 8.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.293 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.3 tp -55.2 -24.88 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.725 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 3.9 mtp -87.89 -16.81 32.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.617 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.42 64.5 3.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.6 t -140.77 -33.66 0.53 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.78 0.324 . . . . 0.0 110.533 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.422 ' ND2' ' OE1' ' A' ' 36' ' ' GLU . 3.2 t30 -95.71 47.58 1.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.331 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.623 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 59.4 m -69.79 107.91 3.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.728 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.422 ' OE1' ' ND2' ' A' ' 34' ' ' ASN . 10.9 mt-10 -111.66 146.66 37.08 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.055 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.567 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -94.44 116.41 28.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.557 179.712 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.431 ' CB ' ' CD ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -126.85 179.46 1.2 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.562 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' A' ' 38' ' ' LYS . 22.1 Cg_exo -62.16 -148.4 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.483 2.122 . . . . 0.0 112.028 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -101.61 -179.09 3.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.506 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.6 mp -49.95 -67.67 0.24 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.544 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 pt -74.15 152.3 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.567 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 10.1 mtt -66.88 139.15 57.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.55 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -65.02 -23.82 67.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.634 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 161.08 -38.29 0.42 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mp -97.67 156.02 16.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.73 0.3 . . . . 0.0 110.571 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.4 45.2 2.57 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.436 ' CD2' ' C ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -88.47 -40.2 13.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.808 0.337 . . . . 0.0 110.378 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.605 179.952 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.3 mttp 50.54 90.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.732 0.301 . . . . 0.0 110.668 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -106.66 5.6 29.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.55 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.501 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -105.39 -165.21 1.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.486 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 4' ' ' LYS . 11.5 p 37.21 -119.56 0.17 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.631 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.483 ' O ' ' CB ' ' A' ' 7' ' ' ALA . 1.1 pp -108.43 0.83 9.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.772 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 6' ' ' ILE . . . 79.27 -61.95 0.31 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.514 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -65.55 -164.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.542 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -139.53 133.33 30.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.354 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 52.38 178.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.622 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 109.14 -123.99 7.13 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.446 ' NH1' ' O ' ' A' ' 33' ' ' THR . 3.9 tpt180 -98.31 146.94 25.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.64 0.257 . . . . 0.0 110.551 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.455 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 3.7 p -145.89 175.71 10.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.478 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 17' ' ' GLY . 24.9 tttm -151.51 96.73 2.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.334 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -45.87 -21.62 0.14 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.76 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.76 36.28 4.33 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 14' ' ' LYS . . . 169.43 -124.72 1.18 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 19' ' ' PRO . 71.6 p -37.28 100.01 0.19 Allowed Pre-proline 0 N--CA 1.464 0.269 0 O-C-N 123.443 0.143 . . . . 0.0 110.84 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 18' ' ' THR . 39.6 Cg_exo -54.32 -145.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.529 2.152 . . . . 0.0 112.516 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.98 90.31 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.201 0.524 . . . . 0.0 110.709 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -45.68 -79.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.423 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 -95.04 126.73 40.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.358 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.499 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 99.88 82.02 1.64 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.415 ' H ' ' CD ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -85.76 11.88 10.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.637 0.256 . . . . 0.0 110.603 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.96 49.74 4.29 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.8 t -81.46 103.42 11.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.923 0.392 . . . . 0.0 110.913 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.7 tt -113.77 148.18 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.288 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -129.71 161.65 30.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.77 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.51 165.68 14.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.746 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 tp -52.3 -28.44 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.635 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.6 mtt -83.49 -40.64 18.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.76 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.41 62.97 0.73 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.446 ' O ' ' NH1' ' A' ' 12' ' ' ARG . 3.5 t -143.51 -24.36 0.59 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.762 0.315 . . . . 0.0 110.746 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -98.74 54.44 1.03 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.429 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.612 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 60.4 m -77.68 94.97 4.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.391 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -110.2 138.0 47.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.785 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -92.8 118.73 31.41 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.679 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -127.84 150.64 73.94 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.754 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.29 175.17 4.28 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.554 2.17 . . . . 0.0 112.106 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -90.96 -133.67 0.12 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.426 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 mp -133.93 -173.5 3.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.49 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.44 -53.91 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.559 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 11.0 mtt -46.69 151.69 0.56 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.497 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -90.21 -8.1 51.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.619 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 156.21 -42.33 0.56 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.55 174.81 6.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.786 0.327 . . . . 0.0 110.571 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.54 57.9 1.14 Allowed Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.425 ' CD2' ' C ' ' A' ' 48' ' ' LEU . 1.2 tt -129.18 -40.18 1.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.791 0.329 . . . . 0.0 110.515 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.584 179.938 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.2 tttt 54.46 39.0 30.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.824 0.345 . . . . 0.0 110.586 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -92.05 58.68 3.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.55 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 0.3 OUTLIER -132.59 -129.56 0.18 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.54 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 4' ' ' LYS . 5.7 p 37.87 -119.2 0.2 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.665 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.456 ' CG2' ' HZ3' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -101.24 -13.73 8.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.664 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 9' ' ' ASP . . . 71.4 -55.45 0.65 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.868 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.456 ' HZ3' ' CG2' ' A' ' 6' ' ' ILE . 9.3 pttt -52.86 -4.51 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.815 0.34 . . . . 0.0 111.188 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.553 ' H ' ' C ' ' A' ' 7' ' ' ALA . 26.8 t0 63.44 -75.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.503 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.534 ' CE1' ' OD1' ' A' ' 9' ' ' ASP . 82.9 m-85 -115.92 159.52 21.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.586 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 134.57 -154.94 21.68 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.428 ' O ' ' NE ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -55.57 117.18 3.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.589 0.233 . . . . 0.0 110.796 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.604 ' SG ' ' N ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -119.02 168.57 10.69 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.711 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.604 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -141.58 96.09 2.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.484 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -54.95 120.36 6.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.956 0.408 . . . . 0.0 110.443 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.83 -20.64 49.9 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -103.32 -68.81 0.79 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.2 p -89.89 144.52 31.65 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.777 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.41 -18.25 18.03 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.156 1.904 . . . . 0.0 112.342 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.2 t 47.41 90.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.341 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -39.4 -86.0 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.878 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.517 ' O ' ' CZ ' ' A' ' 10' ' ' TYR . 41.0 mtm180 -109.14 106.55 16.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.9 0.381 . . . . 0.0 110.386 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.507 ' N ' ' NH1' ' A' ' 24' ' ' ARG . . . 155.5 70.87 0.01 OUTLIER Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.507 ' NH1' ' N ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -80.67 6.09 13.76 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.537 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -103.74 55.19 0.63 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.0 t -83.13 109.29 17.04 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.06 0.457 . . . . 0.0 110.683 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.3 tt -109.84 143.93 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.409 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.9 m -125.05 167.58 14.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.745 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.41 178.7 1.48 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.58 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 tp -61.32 -28.85 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.69 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.9 mtt -84.64 -35.98 22.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.544 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.39 62.51 0.77 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.9 t -142.63 -38.59 0.36 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.776 0.322 . . . . 0.0 110.615 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -79.64 49.68 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.534 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.9 m -72.71 123.71 23.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.644 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -138.17 121.02 16.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.898 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.507 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -70.14 115.1 8.95 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.338 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -125.27 149.89 65.51 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.716 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 40' ' ' ARG . 40.5 Cg_endo -68.61 -164.93 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.599 2.2 . . . . 0.0 112.09 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.531 ' C ' ' H ' ' A' ' 42' ' ' ILE . 85.9 mtt180 -46.08 172.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.536 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.481 ' CD1' ' N ' ' A' ' 41' ' ' LEU . 9.7 mp -72.21 16.02 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.532 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.531 ' H ' ' C ' ' A' ' 40' ' ' ARG . 1.6 tp -49.66 142.62 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.575 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.495 ' C ' ' H ' ' A' ' 45' ' ' GLY . 1.7 mpt? -95.46 127.52 41.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.613 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -47.9 -13.88 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.563 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.495 ' H ' ' C ' ' A' ' 43' ' ' MET . . . -172.2 -70.45 0.04 OUTLIER Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.574 ' CD1' ' N ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -119.61 -62.56 1.48 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.736 0.303 . . . . 0.0 110.535 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.44 43.86 0.23 Allowed Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.418 ' C ' ' CD2' ' A' ' 48' ' ' LEU . 0.9 OUTLIER -94.88 -39.94 9.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.738 0.304 . . . . 0.0 110.535 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.633 179.923 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt -59.51 141.81 53.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.863 0.363 . . . . 0.0 110.626 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.82 133.6 35.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.56 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.508 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 0.4 OUTLIER -79.81 -112.16 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.212 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 4' ' ' LYS . 11.2 p 37.48 -121.61 0.21 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.633 0.254 . . . . 0.0 110.735 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.524 ' CD1' ' H ' ' A' ' 9' ' ' ASP . 1.8 pp -129.61 -170.71 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.27 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.15 -30.78 5.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.437 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.456 ' O ' ' CB ' ' A' ' 9' ' ' ASP . 8.5 mtmt -43.71 -67.06 0.31 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.6 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.552 ' OD1' ' CE1' ' A' ' 10' ' ' TYR . 6.9 t0 78.82 117.35 0.06 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.48 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.562 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 42.4 m-85 53.76 168.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.468 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.21 -127.69 9.33 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.1 ttt-85 -72.41 140.6 48.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.838 0.351 . . . . 0.0 110.615 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.617 ' SG ' ' N ' ' A' ' 14' ' ' LYS . 0.7 OUTLIER -152.08 158.93 43.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.653 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.617 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 6.9 mttt -157.65 123.83 4.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.241 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.528 ' CZ2' ' SG ' ' A' ' 28' ' ' CYS . 1.0 OUTLIER -52.47 -24.87 8.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.582 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -112.34 14.08 25.59 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.07 -117.15 2.07 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.9 p -90.2 141.19 27.51 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.762 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 20' ' ' CYS . 58.9 Cg_endo -74.0 -32.69 6.8 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.554 2.17 . . . . 0.0 112.273 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.602 ' O ' ' N ' ' A' ' 22' ' ' ARG . 1.6 t 80.73 27.39 0.24 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.6 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.1 t 34.4 -84.1 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.608 0.567 . . . . 0.0 111.431 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.602 ' N ' ' O ' ' A' ' 20' ' ' CYS . 76.2 mtt180 -99.93 122.77 43.35 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.594 ' H ' ' HE ' ' A' ' 24' ' ' ARG . . . 130.06 79.43 0.21 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.627 ' H ' ' NE ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -79.51 1.05 27.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.76 0.314 . . . . 0.0 110.421 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -75.86 35.27 1.23 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.483 ' H ' ' C ' ' A' ' 24' ' ' ARG . 20.4 m -67.17 82.78 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.775 0.321 . . . . 0.0 110.593 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.3 tt -122.21 153.55 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.535 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.528 ' SG ' ' CZ2' ' A' ' 15' ' ' TRP . 6.6 m -118.75 165.84 13.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.771 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.7 170.48 7.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.403 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.3 tp -54.12 -25.72 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.817 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.4 mtt -81.19 -37.39 28.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.646 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.68 58.48 0.94 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.5 t -148.76 -32.33 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 0.0 110.609 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -81.16 50.46 1.42 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.51 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.0 m -74.81 110.48 9.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.783 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -138.7 149.47 45.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.741 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -89.73 107.28 19.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.117 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -97.28 148.05 33.85 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.555 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 40' ' ' ARG . 52.8 Cg_endo -69.55 -91.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.251 1.967 . . . . 0.0 112.114 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.472 ' O ' ' O ' ' A' ' 39' ' ' PRO . 5.9 mtt180 47.57 103.4 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.561 0.696 . . . . 0.0 110.578 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -137.44 134.05 35.4 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.853 -179.656 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.4 tp -47.67 145.59 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.701 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.404 ' O ' ' CG ' ' A' ' 43' ' ' MET . 9.3 ptt? -75.25 130.6 39.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.615 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -89.32 -18.82 26.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.579 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 131.72 -24.51 4.09 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 mp -114.03 -2.85 13.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.786 0.327 . . . . 0.0 110.656 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.82 -64.24 1.98 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.431 ' CD2' ' C ' ' A' ' 48' ' ' LEU . 0.9 OUTLIER -130.17 -40.75 1.29 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.843 0.354 . . . . 0.0 110.354 179.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.439 -179.993 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -87.27 -176.56 5.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.85 0.357 . . . . 0.0 110.465 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.47 156.66 37.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.405 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -79.22 -65.57 0.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.465 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.444 ' SG ' ' C ' ' A' ' 4' ' ' LYS . 0.1 OUTLIER 33.68 -88.72 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 O-C-N 123.741 0.651 . . . . 0.0 111.161 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.538 ' N ' ' O ' ' A' ' 4' ' ' LYS . 2.0 pp -133.71 1.43 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 0.0 110.006 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' A' ' 6' ' ' ILE . . . 82.52 -62.41 0.14 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.067 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -60.73 -140.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.5 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 10' ' ' TYR . 11.8 m-20 -140.39 -149.97 0.3 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.533 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.432 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 9.5 m-85 -40.95 163.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.529 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.543 ' N ' ' SG ' ' A' ' 37' ' ' CYS . . . 138.51 -138.95 9.86 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -79.92 127.44 32.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.679 0.276 . . . . 0.0 110.706 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.3 p -134.81 -172.18 2.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.597 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -160.01 115.66 2.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.354 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 32.3 m95 -57.7 -12.9 3.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.507 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -134.81 31.84 2.68 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.1 -133.64 1.81 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 14' ' ' LYS . 63.4 p -39.82 104.59 0.33 Allowed Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -79.02 -163.93 0.25 Allowed 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.958 1.772 . . . . 0.0 112.429 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -153.4 105.06 2.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.867 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.8 m -38.15 -75.36 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.682 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 mtp85 -95.75 120.94 36.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.415 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.703 ' H ' HH11 ' A' ' 24' ' ' ARG . . . 122.72 92.85 1.12 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.703 HH11 ' H ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -88.39 -8.37 55.13 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.742 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.44 66.85 3.85 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.3 m -81.78 80.72 8.02 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.28 0.562 . . . . 0.0 110.229 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.2 tt -80.65 139.18 18.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.495 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.604 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -132.27 175.94 8.83 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.819 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.65 169.49 15.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.528 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.4 tp -53.45 -24.91 9.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.655 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.2 mtm -92.16 -35.61 13.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.574 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.26 56.98 0.86 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 t -131.95 -33.54 1.35 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.798 0.332 . . . . 0.0 110.524 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -86.49 42.52 1.01 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.344 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.604 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 45.6 m -69.2 120.11 14.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.585 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -142.54 129.11 20.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.882 0.373 . . . . 0.0 111.057 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' N ' ' A' ' 11' ' ' GLY . 0.8 OUTLIER -80.15 127.47 32.37 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.522 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -137.29 149.7 66.56 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.402 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.3 -168.75 0.22 Allowed 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.308 2.005 . . . . 0.0 112.211 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.4 ptt85 -162.13 130.46 4.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.567 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.9 mp -109.6 103.61 12.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.462 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.529 ' N ' ' CD1' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -144.61 -171.34 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.643 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -127.79 141.58 51.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.504 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.39 -11.75 61.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.586 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 136.49 -21.03 3.46 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.469 ' CD1' ' N ' ' A' ' 46' ' ' LEU . 7.3 mp -58.82 -113.26 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.74 0.305 . . . . 0.0 110.623 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -179.7 30.93 0.06 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.433 ' CD2' ' C ' ' A' ' 48' ' ' LEU . 0.9 OUTLIER -147.37 -41.1 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.729 0.299 . . . . 0.0 110.567 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.582 179.979 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.551 ' HZ3' ' HZ2' ' A' ' 8' ' ' LYS . 18.9 mtmm 55.6 60.43 3.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.771 0.32 . . . . 0.0 110.549 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -100.77 -2.47 32.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.673 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -91.61 -40.47 11.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.531 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.428 ' O ' ' O ' ' A' ' 6' ' ' ILE . 7.2 p -54.15 -172.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.399 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.441 HG13 ' H ' ' A' ' 21' ' ' CYS . 2.1 pp -50.02 -178.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.331 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 6' ' ' ILE . . . -35.59 -89.94 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.872 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.551 ' HZ2' ' HZ3' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -175.7 73.28 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 120.9 0.381 . . . . 0.0 110.371 179.669 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.47 ' C ' ' CD1' ' A' ' 10' ' ' TYR . 0.8 OUTLIER 162.38 -109.33 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.997 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.552 ' CZ ' ' O ' ' A' ' 22' ' ' ARG . 43.6 m-85 -142.48 -162.4 1.41 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.199 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 118.42 -119.9 4.52 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.03 151.32 21.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.717 0.294 . . . . 0.0 110.554 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.568 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 1.5 t -123.05 179.96 4.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.334 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -160.12 91.89 0.97 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.428 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.412 ' C ' ' H ' ' A' ' 17' ' ' GLY . 4.9 m0 -49.51 -81.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.451 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.77 -14.68 1.11 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 15' ' ' TRP . . . -95.07 -134.4 7.65 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.421 ' H ' ' HG1' ' A' ' 18' ' ' THR . 0.7 OUTLIER -89.18 152.75 48.36 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.592 -179.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.54 178.34 6.83 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.319 2.013 . . . . 0.0 112.364 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.568 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -102.78 127.54 49.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.388 179.635 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.441 ' H ' HG13 ' A' ' 6' ' ' ILE . 59.8 m -50.85 -97.2 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.916 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.552 ' O ' ' CZ ' ' A' ' 10' ' ' TYR . 4.7 mtt180 -83.65 24.8 0.83 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.428 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.91 151.13 17.7 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.95 -14.34 0.53 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.796 0.331 . . . . 0.0 110.701 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.26 47.75 3.89 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 95.4 m -77.19 105.86 8.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.723 0.297 . . . . 0.0 110.633 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.3 tt -119.36 145.73 25.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.293 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.9 m -131.8 -178.6 4.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.759 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.623 ' HG ' ' H ' ' A' ' 31' ' ' MET . 0.1 OUTLIER -83.83 168.75 15.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.652 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.576 ' N ' ' HG ' ' A' ' 29' ' ' SER . 8.5 tp -49.64 -25.56 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.578 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.623 ' H ' ' HG ' ' A' ' 29' ' ' SER . 1.5 mtt -86.93 -47.41 9.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.484 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.66 57.03 0.75 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.0 t -136.12 -24.78 1.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.749 0.309 . . . . 0.0 110.522 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -101.44 50.89 0.85 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.383 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 97.7 m -68.63 122.81 19.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.806 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -119.77 127.87 53.21 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.079 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.512 ' N ' ' O ' ' A' ' 11' ' ' GLY . 6.1 t -84.82 97.45 9.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.363 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.4 mtmt -107.96 147.0 34.62 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.743 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.88 -167.96 0.26 Allowed 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.371 2.047 . . . . 0.0 112.084 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -62.35 152.09 34.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.6 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.5 mp -87.5 -179.98 6.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.517 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.2 tp -76.49 145.04 10.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.511 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 27.5 mtt -81.1 104.65 11.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.523 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.45 -27.96 20.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.509 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.43 -99.27 0.71 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.51 -67.38 1.0 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.821 0.343 . . . . 0.0 110.577 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -172.6 37.94 0.15 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.433 ' CD2' ' C ' ' A' ' 48' ' ' LEU . 1.0 OUTLIER -96.64 -41.26 8.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.868 0.366 . . . . 0.0 110.513 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.52 179.836 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.6 tptm 63.41 1.95 1.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.778 0.323 . . . . 0.0 110.644 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.451 ' H ' ' C ' ' A' ' 1' ' ' GLY . 0.3 OUTLIER -96.36 -4.88 41.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.604 -179.848 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.408 ' O ' ' O ' ' A' ' 5' ' ' CYS . 6.1 ttpt -79.36 -55.71 4.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.484 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.408 ' O ' ' O ' ' A' ' 4' ' ' LYS . 4.7 p -47.09 174.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.218 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.547 ' C ' ' H ' ' A' ' 8' ' ' LYS . 2.5 pp -54.92 -25.78 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.015 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.524 ' C ' ' H ' ' A' ' 9' ' ' ASP . . . 66.82 -36.6 0.27 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.547 ' H ' ' C ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -72.57 15.74 0.17 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 122.119 0.961 . . . . 0.0 110.726 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 7' ' ' ALA . 2.9 p-10 42.95 -110.39 0.15 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.924 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.491 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 3.4 m-30 -77.4 126.65 31.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.218 -178.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 159.04 -96.55 0.15 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.9 ttt85 -110.77 146.42 36.39 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.785 0.326 . . . . 0.0 110.752 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -158.03 143.75 17.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.617 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.582 ' NZ ' ' SG ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -137.34 126.01 23.81 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.997 0.427 . . . . 0.0 110.629 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -28.13 63.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.541 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.62 -6.85 57.16 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.75 -115.61 3.22 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.3 p -90.21 142.81 28.83 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.567 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.67 167.47 27.17 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.182 1.922 . . . . 0.0 112.396 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 1.5 t -103.48 107.18 17.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.958 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.31 -72.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.529 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.8 mtm-85 -100.08 122.57 43.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.486 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 82.26 109.78 0.43 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.676 ' HE ' ' N ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -102.88 19.34 19.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.661 0.267 . . . . 0.0 110.649 -179.952 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.02 53.48 4.75 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.561 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 38.0 m -73.97 113.29 10.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.992 0.425 . . . . 0.0 110.501 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.0 tt -126.11 148.03 30.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.084 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.555 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -126.16 168.17 14.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.577 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 31' ' ' MET . 4.3 m -77.44 157.38 30.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.569 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -42.19 -24.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.847 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.431 ' N ' ' O ' ' A' ' 29' ' ' SER . 1.2 mtp -88.28 -50.92 6.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.757 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.83 63.72 0.53 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.6 t -145.04 -17.52 0.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.779 0.323 . . . . 0.0 110.302 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -107.74 51.07 0.75 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.171 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.582 ' SG ' ' NZ ' ' A' ' 14' ' ' LYS . 31.3 m -73.39 86.22 1.5 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.23 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -102.16 152.2 21.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.449 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.561 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -98.98 120.87 40.15 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.616 179.304 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -129.54 159.65 68.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.427 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 38' ' ' LYS . 50.9 Cg_exo -46.05 -178.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.352 2.035 . . . . 0.0 112.21 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.69 -176.02 4.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.461 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' A' ' 42' ' ' ILE . 2.7 mp -65.96 166.79 10.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.988 0.423 . . . . 0.0 110.43 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.517 ' CD1' ' N ' ' A' ' 42' ' ' ILE . 0.0 OUTLIER -52.09 -171.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.808 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.442 ' C ' ' H ' ' A' ' 45' ' ' GLY . 8.4 ptt? -139.71 -19.7 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.552 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -78.76 33.18 0.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.553 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.442 ' H ' ' C ' ' A' ' 43' ' ' MET . . . -145.43 -45.22 0.04 OUTLIER Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.471 ' H ' ' CD1' ' A' ' 46' ' ' LEU . 7.5 mp -56.47 -24.02 43.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.756 0.312 . . . . 0.0 110.505 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.2 25.26 9.01 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.435 ' C ' ' CD2' ' A' ' 48' ' ' LEU . 1.1 tt -88.46 -42.09 12.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.713 0.292 . . . . 0.0 110.451 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.957 -1.021 . . . . 0.0 110.566 179.945 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.553 ' HZ2' ' NH1' ' A' ' 22' ' ' ARG . 21.1 tptp -171.06 90.49 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.788 0.327 . . . . 0.0 110.611 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.488 ' NZ ' ' HZ3' ' A' ' 2' ' ' LYS . 16.1 mttp 46.09 -160.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.452 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 5' ' ' CYS . 3.6 tmtt? -106.96 -39.81 5.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.369 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.447 ' O ' ' O ' ' A' ' 4' ' ' LYS . 4.6 p -46.33 -99.43 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.003 0.43 . . . . 0.0 110.722 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.419 ' N ' ' SG ' ' A' ' 5' ' ' CYS . 1.1 pp -139.26 -172.16 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.446 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.44 -30.19 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.774 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.628 ' H ' ' CD ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -51.7 -42.33 62.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.431 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 10' ' ' TYR . 4.8 m-20 58.92 125.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.47 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 9' ' ' ASP . 66.5 m-85 55.97 160.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.854 0.359 . . . . 0.0 110.795 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.18 -152.04 21.93 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.415 ' N ' ' OE2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -42.24 125.42 3.09 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.657 -0.32 . . . . 0.0 110.944 -179.807 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 2.9 t -154.73 150.46 27.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.649 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.5 ' H ' ' HG1' ' A' ' 18' ' ' THR . 25.3 tttp -155.88 103.7 2.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.534 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.41 ' C ' ' H ' ' A' ' 17' ' ' GLY . 13.8 m95 -42.05 154.95 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.412 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.46 -47.5 0.71 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 15' ' ' TRP . . . -84.96 -90.79 0.82 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.5 ' HG1' ' H ' ' A' ' 14' ' ' LYS . 3.9 p -90.19 112.98 55.61 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-O 119.448 -0.31 . . . . 0.0 110.75 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 18' ' ' THR . 52.0 Cg_exo -51.49 -161.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.12 1.88 . . . . 0.0 112.611 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 6.3 t -171.92 61.18 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.475 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -38.22 -42.4 0.68 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.807 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.553 ' NH1' ' HZ2' ' A' ' 2' ' ' LYS . 26.4 mtt180 -120.36 99.81 6.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.44 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.499 ' O ' ' SG ' ' A' ' 20' ' ' CYS . . . 130.81 91.95 0.59 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.411 ' C ' ' H ' ' A' ' 26' ' ' CYS . 2.2 ptm180 -85.47 -12.43 51.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.85 0.357 . . . . 0.0 110.488 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.17 41.84 1.59 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.411 ' H ' ' C ' ' A' ' 24' ' ' ARG . 9.3 t -81.87 108.58 15.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.03 0.443 . . . . 0.0 110.685 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.8 tt -145.47 152.09 14.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.318 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.647 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 1.0 OUTLIER -129.84 177.1 7.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.699 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.15 165.93 21.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.417 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.1 tp -51.76 -25.9 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.64 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.9 mtt -86.34 -29.8 22.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.633 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.66 62.78 1.59 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -137.4 -36.06 0.66 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.785 0.326 . . . . 0.0 110.688 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -94.76 54.15 1.71 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.183 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.647 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 1.8 m -85.56 114.4 22.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.622 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.415 ' OE2' ' N ' ' A' ' 12' ' ' ARG . 9.2 mm-40 -137.74 154.3 49.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.803 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -98.76 111.3 23.72 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.191 179.356 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -102.06 147.04 33.36 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.643 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.31 -168.14 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.339 2.026 . . . . 0.0 112.325 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.9 mtm105 -78.1 -167.94 1.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.53 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 mp -83.57 -47.92 10.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.66 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.6 pp -117.44 156.79 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.553 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.534 ' SD ' ' N ' ' A' ' 43' ' ' MET . 2.2 mpt? -93.12 141.21 28.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.518 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -87.06 123.95 32.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.691 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 46' ' ' LEU . . . 66.83 11.13 57.26 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.535 ' CD1' ' N ' ' A' ' 46' ' ' LEU . 6.8 mp 43.59 96.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.815 0.341 . . . . 0.0 110.787 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.84 52.95 0.52 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.418 ' C ' ' CD2' ' A' ' 48' ' ' LEU . 0.8 OUTLIER -157.71 -39.7 0.07 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.665 0.269 . . . . 0.0 110.49 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.408 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.707 179.902 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.632 ' NZ ' ' HZ2' ' A' ' 3' ' ' LYS . 15.7 pttp -132.84 169.7 16.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.88 0.371 . . . . 0.0 110.48 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.632 ' HZ2' ' NZ ' ' A' ' 2' ' ' LYS . 33.6 mttt 55.09 -179.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.501 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.507 ' CG ' ' H ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER -86.18 -105.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.617 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.507 ' H ' ' CG ' ' A' ' 4' ' ' LYS . 35.2 m 38.55 -118.91 0.23 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.497 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.615 ' CD1' ' H ' ' A' ' 9' ' ' ASP . 1.5 pp -106.07 -5.07 9.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.536 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 1' ' ' GLY . . . 73.64 -56.14 0.66 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.639 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 10' ' ' TYR . 30.9 mmtm -49.17 -14.04 0.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.713 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.615 ' H ' ' CD1' ' A' ' 6' ' ' ILE . 19.4 m-20 59.1 -76.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.524 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.538 ' N ' ' O ' ' A' ' 8' ' ' LYS . 52.0 m-85 -108.95 163.68 13.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.505 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.23 -156.67 15.51 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.529 HH12 ' N ' ' A' ' 35' ' ' CYS . 0.2 OUTLIER -39.68 130.66 1.87 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.838 0.351 . . . . 0.0 110.876 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.599 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 26.6 p -157.01 179.17 9.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.587 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -160.64 115.53 2.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.467 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -56.96 -39.63 74.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.762 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -98.91 28.13 16.65 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -147.0 -78.21 0.03 OUTLIER Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.2 p -90.4 148.07 38.12 Favored Pre-proline 0 C--N 1.325 -0.478 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.197 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.64 -31.72 10.42 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.386 2.057 . . . . 0.0 112.422 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 22' ' ' ARG . 17.2 t 58.16 87.26 0.07 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.359 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -37.17 -76.47 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.711 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.402 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -99.81 175.12 5.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.545 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.479 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 50.95 74.87 0.25 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -79.79 10.75 3.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.664 0.269 . . . . 0.0 110.442 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.14 49.84 4.3 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.405 ' SG ' ' C ' ' A' ' 13' ' ' CYS . 5.2 t -68.89 90.77 0.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.949 0.404 . . . . 0.0 110.387 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.2 tt -103.97 147.45 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.405 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 11.3 m -126.79 164.3 21.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.737 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 m -73.18 167.25 21.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.458 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.5 tp -51.55 -28.35 8.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.668 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.6 mtm -80.09 -33.66 38.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.625 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.04 65.22 1.39 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.0 t -150.21 -28.88 0.23 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.768 0.318 . . . . 0.0 110.663 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.408 ' C ' HH12 ' A' ' 12' ' ' ARG . 13.9 t-20 -93.85 53.93 1.88 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.446 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.529 ' N ' HH12 ' A' ' 12' ' ' ARG . 72.5 m -75.04 120.27 20.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.681 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.453 ' C ' ' SG ' ' A' ' 13' ' ' CYS . 56.3 mt-10 -135.56 138.42 42.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.62 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.599 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -83.8 105.38 14.66 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.22 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.52 149.69 40.62 Favored Pre-proline 0 C--O 1.236 0.368 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.574 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.85 -85.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.597 2.198 . . . . 0.0 111.975 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -127.81 -120.76 0.24 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.646 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.9 mp -85.05 126.59 33.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.677 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.7 pt -82.3 -42.56 18.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.528 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 3.6 mtt -68.38 99.75 0.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.503 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -83.53 -24.53 31.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.456 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.61 -102.81 0.3 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.11 -54.15 2.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.783 0.325 . . . . 0.0 110.542 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -176.25 12.69 0.03 OUTLIER Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.438 ' CD2' ' C ' ' A' ' 48' ' ' LEU . 1.4 tt -101.85 -41.81 6.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.689 0.28 . . . . 0.0 110.593 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.589 -179.818 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.93 -76.79 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.834 0.35 . . . . 0.0 110.49 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.54 ' HZ1' HH22 ' A' ' 22' ' ' ARG . 2.1 mmmm -74.41 -163.31 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.339 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.05 -28.89 6.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.349 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.416 ' SG ' ' N ' ' A' ' 6' ' ' ILE . 14.0 p -71.87 -120.71 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.516 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.416 ' N ' ' SG ' ' A' ' 5' ' ' CYS . 1.7 pp -104.09 1.33 10.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.902 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 68.6 -64.56 0.31 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.506 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.7 mmtp -56.61 -164.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.665 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.409 ' O ' ' O ' ' A' ' 10' ' ' TYR . 3.8 p-10 -139.28 127.87 23.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.471 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.409 ' O ' ' O ' ' A' ' 9' ' ' ASP . 79.4 m-85 54.42 167.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.63 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.07 -113.48 1.75 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -108.91 136.96 47.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.667 0.27 . . . . 0.0 110.823 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 5.9 p -143.48 174.75 10.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.995 0.426 . . . . 0.0 110.935 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -160.4 108.14 1.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.385 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.544 ' C ' ' H ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -41.07 -67.41 0.25 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.849 -179.803 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.78 28.55 0.91 Allowed Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.544 ' H ' ' C ' ' A' ' 15' ' ' TRP . . . -145.34 -92.95 0.14 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.2 p -91.45 144.8 30.2 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.093 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.82 -32.7 7.1 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.128 1.885 . . . . 0.0 112.386 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.1 t 67.55 100.93 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.595 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -58.63 -83.97 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.599 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.54 HH22 ' HZ1' ' A' ' 3' ' ' LYS . 15.4 mmt-85 -84.19 117.32 23.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.597 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.508 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 115.24 89.85 1.64 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -86.37 -24.13 25.9 Favored 'General case' 0 N--CA 1.44 -0.939 0 O-C-N 122.532 -0.393 . . . . 0.0 110.268 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.01 58.46 0.79 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.8 t -87.78 113.06 23.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.871 0.367 . . . . 0.0 110.259 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.1 tt -131.15 156.53 42.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.592 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.635 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.5 OUTLIER -135.73 174.62 10.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.541 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.1 t -79.95 158.41 26.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.441 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -42.96 -32.0 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 120.906 0.384 . . . . 0.0 110.092 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 16.6 mtm -79.31 -43.35 23.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.994 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.01 62.85 0.88 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 t -139.47 -35.02 0.55 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.81 0.338 . . . . 0.0 110.64 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -95.15 50.85 1.29 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.142 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.635 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 31.3 m -75.15 102.34 4.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.533 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -109.88 141.25 42.86 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.15 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.3 OUTLIER -97.09 103.49 15.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.227 179.562 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.89 162.1 47.36 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.436 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.45 -172.95 1.01 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.514 2.143 . . . . 0.0 112.174 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.436 ' O ' ' O ' ' A' ' 41' ' ' LEU . 0.4 OUTLIER -142.21 -88.14 0.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.75 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 40' ' ' ARG . 5.4 mp 52.19 170.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.072 0.463 . . . . 0.0 110.62 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.574 ' C ' ' H ' ' A' ' 44' ' ' GLU . 1.8 tp -99.47 165.27 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.386 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 27.9 ttp 57.1 0.92 0.09 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.83 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.574 ' H ' ' C ' ' A' ' 42' ' ' ILE . 41.5 tt0 -60.27 -55.46 33.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.509 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.81 -34.61 5.91 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 48' ' ' LEU . 0.8 OUTLIER -114.22 -156.15 0.59 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.74 0.305 . . . . 0.0 110.503 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.49 -63.47 0.27 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.428 ' N ' ' O ' ' A' ' 46' ' ' LEU . 1.2 tt -159.34 -42.05 0.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.692 0.282 . . . . 0.0 110.433 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.553 179.817 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -55.5 113.23 1.35 Allowed 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 121.119 -0.233 . . . . 0.0 110.495 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 2' ' ' LYS . 10.6 pttm 31.22 -109.74 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.639 0.587 . . . . 0.0 110.944 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.719 ' HZ2' ' H ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -140.65 -45.29 0.4 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.512 179.486 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.719 ' H ' ' HZ2' ' A' ' 4' ' ' LYS . 0.5 OUTLIER 29.15 -92.36 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 O-C-N 123.812 0.695 . . . . 0.0 111.239 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.464 ' O ' ' CB ' ' A' ' 7' ' ' ALA . 2.3 pp -141.95 -0.19 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.464 ' CB ' ' O ' ' A' ' 6' ' ' ILE . . . 80.35 -64.31 0.19 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.728 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 7' ' ' ALA . 10.1 mttp -53.61 -170.28 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.155 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -126.78 -155.22 0.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.66 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.44 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 13.4 m-85 -45.01 155.4 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.485 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 144.47 -103.28 0.29 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.506 HH11 ' HZ1' ' A' ' 14' ' ' LYS . 0.9 OUTLIER -123.32 134.7 54.02 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.788 0.328 . . . . 0.0 110.871 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -148.67 179.84 7.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.661 179.463 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.602 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 2.4 tttp -143.73 110.34 5.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.511 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.555 ' C ' ' H ' ' A' ' 17' ' ' GLY . 10.1 m95 -48.19 141.56 6.19 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.552 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.29 -36.31 0.26 Allowed Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.555 ' H ' ' C ' ' A' ' 15' ' ' TRP . . . -83.08 -91.29 0.67 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 19' ' ' PRO . 13.5 p -91.73 111.56 50.12 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-O 119.312 -0.375 . . . . 0.0 110.731 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 18' ' ' THR . 42.7 Cg_exo -52.46 -156.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.169 1.912 . . . . 0.0 112.672 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -165.27 92.77 0.57 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.296 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.6 m -41.45 -77.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.657 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 36.1 mtt85 -94.74 115.71 27.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.476 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.55 85.82 1.88 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.9 ptm85 -80.3 0.56 32.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.584 0.231 . . . . 0.0 110.773 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.36 98.25 2.4 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -121.06 108.74 14.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.235 0.54 . . . . 0.0 110.323 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.6 tt -114.58 155.9 15.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.782 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.8 m -132.35 177.58 7.48 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.899 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.667 ' N ' HD22 ' A' ' 34' ' ' ASN . 11.9 t -91.29 159.59 15.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.568 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.4 tp -40.67 -24.75 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.651 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.474 ' N ' ' O ' ' A' ' 29' ' ' SER . 3.1 mtt -80.76 -42.26 22.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.752 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 29' ' ' SER . . . 87.28 63.17 1.44 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 t -150.6 -31.33 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.838 0.352 . . . . 0.0 110.466 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.667 HD22 ' N ' ' A' ' 29' ' ' SER . 0.1 OUTLIER -89.44 32.22 0.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.464 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 90.3 m -51.46 105.11 0.1 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.657 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -107.59 132.83 52.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.309 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -87.48 130.11 34.82 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.544 179.335 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.32 162.28 43.33 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.47 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -71.3 -166.12 0.22 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.668 2.245 . . . . 0.0 112.142 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -72.63 -139.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.582 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.0 mp -93.68 122.83 36.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.642 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.5 pt -46.89 142.07 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.509 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -64.1 154.25 35.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.543 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -72.51 -3.26 23.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.586 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 144.77 -39.98 1.17 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.53 ' H ' ' CD1' ' A' ' 46' ' ' LEU . 9.1 mp -40.61 -58.95 1.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.863 0.363 . . . . 0.0 110.611 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.82 27.72 9.38 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.432 ' CD2' ' C ' ' A' ' 48' ' ' LEU . 1.0 OUTLIER -141.41 -40.98 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 0.0 110.423 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.457 179.729 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.6 mmtt -61.63 151.46 33.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.819 0.342 . . . . 0.0 110.617 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.71 100.87 11.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.621 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER -97.1 -26.39 14.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.666 -179.901 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 7' ' ' ALA . 1.8 m -59.77 -145.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.313 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.3 pp -39.49 -28.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.679 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.499 ' C ' ' H ' ' A' ' 9' ' ' ASP . . . 68.05 -57.73 0.46 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.818 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.579 ' NZ ' ' CB ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -44.55 -16.57 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.944 0.402 . . . . 0.0 110.998 -179.415 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.499 ' H ' ' C ' ' A' ' 7' ' ' ALA . 0.8 OUTLIER 72.6 111.02 0.06 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.501 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 55.87 169.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.478 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.19 -105.68 1.05 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -111.19 145.05 39.35 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.813 0.339 . . . . 0.0 110.503 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.9 p -145.43 168.72 19.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.721 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.63 109.83 3.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.489 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -52.95 -40.88 64.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.943 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.55 27.37 20.6 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -168.54 -126.11 0.83 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -40.45 109.26 0.59 Allowed Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.841 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -76.1 152.45 35.78 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.96 1.773 . . . . 0.0 112.097 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.73 137.57 51.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.134 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -95.34 -79.47 0.43 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.485 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 70.7 mtt-85 -81.99 109.06 15.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.549 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.499 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 103.47 92.09 2.22 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.37 14.56 10.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.751 0.31 . . . . 0.0 110.643 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.56 56.73 4.17 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.0 t -79.94 113.49 18.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.728 0.299 . . . . 0.0 110.659 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.5 tt -126.02 148.44 30.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.315 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.1 m -126.33 174.15 8.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.605 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.12 169.44 17.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.49 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -52.36 -27.41 10.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.929 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.6 mtp -85.5 -25.58 26.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.66 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.84 66.04 1.66 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.0 t -145.18 -34.15 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.846 0.355 . . . . 0.0 110.547 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.62 53.8 2.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.324 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.7 m -72.13 98.29 2.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -105.31 140.64 38.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.819 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 0.7 OUTLIER -93.03 111.22 22.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.344 179.488 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.52 158.01 63.29 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.828 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.08 -165.05 0.15 Allowed 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.682 2.255 . . . . 0.0 112.07 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -94.26 -155.21 0.44 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.552 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.454 ' N ' ' CD1' ' A' ' 41' ' ' LEU . 10.1 mp -92.31 56.5 2.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.621 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.2 tp -82.37 -27.64 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.592 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.489 ' O ' ' N ' ' A' ' 45' ' ' GLY . 5.8 ptt? -156.63 -6.15 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.596 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -63.35 72.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.547 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 43' ' ' MET . . . 138.86 -52.03 0.74 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.591 ' CD1' ' N ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -122.95 107.03 11.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.863 0.363 . . . . 0.0 110.535 -179.752 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 140.37 -51.45 0.72 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.438 ' CD2' ' C ' ' A' ' 48' ' ' LEU . 1.2 tt -136.6 -40.44 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.693 0.282 . . . . 0.0 110.619 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.713 179.903 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.465 ' O ' ' CG ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -155.58 99.58 2.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.788 0.328 . . . . 0.0 110.496 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -60.87 -15.86 35.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.733 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.55 115.18 29.95 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.704 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.547 ' SG ' ' N ' ' A' ' 6' ' ' ILE . 31.0 p -162.28 -130.12 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.413 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.547 ' N ' ' SG ' ' A' ' 5' ' ' CYS . 2.6 pp -119.76 -174.26 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.509 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.35 -1.57 2.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.575 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.411 ' O ' ' O ' ' A' ' 9' ' ' ASP . 1.4 pttm -83.93 -12.36 55.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.593 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.434 ' H ' HD11 ' A' ' 6' ' ' ILE . 0.1 OUTLIER 60.11 133.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.549 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.432 ' O ' ' O ' ' A' ' 9' ' ' ASP . 52.5 m-85 44.29 -170.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.686 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.95 -153.96 18.69 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.2 ttt-85 -80.15 153.59 28.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.737 0.303 . . . . 0.0 110.556 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.556 ' SG ' ' N ' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -156.3 -178.74 7.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.664 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.556 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -139.47 118.21 12.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.394 179.758 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -60.01 -11.28 5.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.728 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.2 25.84 4.81 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -170.28 -144.64 4.4 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.1 p -38.32 102.59 0.25 Allowed Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 121.314 -0.154 . . . . 0.0 110.916 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -79.97 -163.03 0.2 Allowed 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.403 2.069 . . . . 0.0 112.237 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.505 ' SG ' ' O ' ' A' ' 20' ' ' CYS . 31.7 p -144.64 112.37 6.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.573 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -51.64 -81.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.636 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.03 118.4 19.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.58 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.504 ' O ' ' SG ' ' A' ' 20' ' ' CYS . . . 96.14 66.95 0.96 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -78.43 25.01 0.25 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 120.838 0.351 . . . . 0.0 110.6 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . -98.83 75.85 0.54 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -96.73 104.0 15.96 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.561 0.695 . . . . 0.0 110.784 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.6 tt -97.39 110.61 25.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.282 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.03 156.66 17.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.669 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.3 m -80.09 161.0 25.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.705 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.8 tp -44.27 -27.51 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.652 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.9 mtt -86.12 -40.46 15.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.601 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.22 65.06 0.74 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.8 t -158.74 -0.66 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.592 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -109.93 23.86 13.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.632 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.4 m -54.74 104.83 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.512 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -115.72 107.38 15.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.911 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 1.1 m -72.34 109.44 6.06 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.457 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.433 ' CB ' ' CD ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -125.48 177.5 1.87 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.877 -179.799 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' A' ' 38' ' ' LYS . 23.3 Cg_exo -63.66 -64.8 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.779 2.319 . . . . 0.0 112.231 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 39' ' ' PRO . 62.3 mtp180 54.09 166.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.489 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.644 ' CD2' ' H ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -83.23 103.32 12.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.619 -179.53 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.0 pp -136.26 132.31 49.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.417 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 8.7 mtt -132.79 138.31 47.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.55 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -89.16 -49.07 6.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.506 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.78 -6.71 0.03 OUTLIER Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 mp -104.3 47.68 0.87 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.843 0.354 . . . . 0.0 110.658 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -162.17 -53.51 0.02 OUTLIER Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.414 ' CD2' ' C ' ' A' ' 48' ' ' LEU . 1.0 OUTLIER -159.47 -41.42 0.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.692 0.282 . . . . 0.0 110.441 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.546 -179.804 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 163.79 5.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.724 0.297 . . . . 0.0 110.619 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -136.22 57.32 1.78 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.471 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -107.79 -170.3 1.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.628 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.5 m 59.72 -73.87 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.687 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.546 ' C ' ' H ' ' A' ' 8' ' ' LYS . 0.6 OUTLIER -120.95 -20.98 4.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.428 -179.522 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . 68.61 -37.82 0.36 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.039 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.546 ' H ' ' C ' ' A' ' 6' ' ' ILE . 3.5 mttm -64.34 -30.67 71.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.661 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER 56.92 126.23 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.117 -179.52 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.564 ' CD1' ' N ' ' A' ' 10' ' ' TYR . 2.4 m-30 64.11 114.56 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.433 0.635 . . . . 0.0 110.534 178.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 158.66 -144.51 10.43 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.791 -0.923 . . . . 0.0 110.791 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.516 ' O ' ' NH2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -83.52 156.34 22.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.878 0.37 . . . . 0.0 110.707 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.444 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 28.2 p -158.62 170.07 22.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.537 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.79 114.3 3.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.617 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -62.71 -11.8 19.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.707 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.33 10.28 14.84 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -139.56 -98.96 0.42 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.2 p -90.11 145.62 33.32 Favored Pre-proline 0 C--N 1.327 -0.399 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.918 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.9 -160.84 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.466 2.111 . . . . 0.0 112.155 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -165.27 103.01 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.54 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.443 ' SG ' ' C ' ' A' ' 4' ' ' LYS . 1.2 m -65.43 -89.31 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.785 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -82.65 121.49 26.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.606 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.511 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 99.11 69.18 0.91 Allowed Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -79.45 27.89 0.26 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.982 0.42 . . . . 0.0 110.529 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . -93.37 66.56 1.76 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.582 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 56.4 m -84.6 87.56 7.28 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.348 0.594 . . . . 0.0 110.697 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.7 tt -80.07 96.96 2.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.495 179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 94.4 m -92.16 154.99 18.33 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.472 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.407 ' C ' ' N ' ' A' ' 31' ' ' MET . 1.2 m -91.77 171.31 9.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.767 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 tp -51.8 -14.82 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.571 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' MET . . . . . 0.407 ' N ' ' C ' ' A' ' 29' ' ' SER . 4.7 mtm -106.98 -42.9 4.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.761 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.38 56.13 0.74 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 t -133.84 -22.44 1.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 0.0 110.446 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -94.26 13.18 24.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.576 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.6 m -49.49 91.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.681 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 34' ' ' ASN . 2.9 tt0 -107.31 123.2 47.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.582 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.582 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -77.73 99.6 5.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.361 179.892 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 23.9 mtmm -95.82 148.71 34.99 Favored Pre-proline 0 C--O 1.237 0.398 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.88 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.88 177.66 4.07 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.538 2.159 . . . . 0.0 112.146 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -166.28 160.2 15.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.48 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.619 ' N ' ' CD1' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -128.49 -169.93 2.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.742 -179.231 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.1 pt -134.77 -25.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.514 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 6.8 mtt -91.07 133.8 35.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.904 0.383 . . . . 0.0 110.668 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -43.84 -37.42 2.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.468 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 156.17 -25.6 0.54 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.8 mp -73.54 -78.77 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.755 0.312 . . . . 0.0 110.58 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.22 19.21 0.09 OUTLIER Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.415 ' CD2' ' C ' ' A' ' 48' ' ' LEU . 1.2 tt -105.72 -42.06 5.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.742 0.306 . . . . 0.0 110.602 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.396 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.676 179.864 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 41.2 tttp -88.89 -10.54 47.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.862 0.363 . . . . 0.0 110.634 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.526 ' CD ' ' N ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER 45.45 -110.64 0.24 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.388 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.98 8.97 3.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.832 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -130.31 -95.59 0.38 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.425 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.6 pp -130.96 -166.18 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.325 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' A' ' 9' ' ' ASP . . . -131.86 -24.93 2.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.758 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.623 ' H ' ' CD ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -71.76 12.52 0.37 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.79 -179.66 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.52 ' OD2' ' N ' ' A' ' 10' ' ' TYR . 6.7 p-10 36.2 -121.52 0.15 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.523 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.52 ' N ' ' OD2' ' A' ' 9' ' ' ASP . 60.5 m-85 -72.04 168.64 17.66 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.459 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.24 -145.86 17.46 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.447 ' NH1' ' NZ ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -37.74 119.26 0.73 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.853 0.358 . . . . 0.0 111.081 -179.688 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.488 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 26.9 p -151.9 171.54 17.62 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.688 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.447 ' NZ ' ' NH1' ' A' ' 12' ' ' ARG . 7.4 mttp -159.85 153.72 23.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.603 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.476 ' CZ2' ' SG ' ' A' ' 28' ' ' CYS . 0.9 OUTLIER -83.13 -52.57 6.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.783 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.48 -24.72 41.93 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.82 -119.88 0.17 Allowed Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.432 ' H ' ' HG1' ' A' ' 18' ' ' THR . 1.0 OUTLIER -88.56 151.64 48.35 Favored Pre-proline 0 C--N 1.326 -0.416 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.663 -179.677 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.52 -170.19 0.36 Allowed 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.568 2.179 . . . . 0.0 112.306 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.46 96.06 2.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.57 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 70.1 m -40.71 -84.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.582 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.515 ' O ' ' CE2' ' A' ' 10' ' ' TYR . 19.4 mtt85 -90.85 41.31 1.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.518 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.45 145.82 17.74 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.85 -25.62 0.5 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.749 0.309 . . . . 0.0 110.555 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.49 67.29 0.52 Allowed Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.426 ' O ' ' NE1' ' A' ' 15' ' ' TRP . 13.3 t -79.75 85.68 5.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.924 0.392 . . . . 0.0 110.348 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.9 tt -96.2 150.86 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.528 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.476 ' SG ' ' CZ2' ' A' ' 15' ' ' TRP . 3.7 m -130.56 177.73 7.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.769 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.92 174.7 11.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.664 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -53.79 -28.33 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.671 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.0 mtt -83.65 -46.14 12.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.721 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.9 62.38 0.82 Allowed Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.9 t -142.86 -25.73 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.796 0.332 . . . . 0.0 110.615 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -100.41 46.58 0.95 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.569 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.8 m -63.24 124.68 21.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.698 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.447 ' C ' ' SG ' ' A' ' 13' ' ' CYS . 41.3 mt-10 -130.62 138.68 50.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.52 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.488 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -87.1 122.87 31.52 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.173 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.59 148.06 63.07 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.805 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.71 179.38 2.68 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.452 2.102 . . . . 0.0 111.996 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -75.27 144.94 42.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.582 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 10.8 mp 45.42 94.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.613 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.1 tp -67.86 -29.16 44.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.624 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 8.5 mtt -43.06 156.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.547 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -87.37 -39.31 15.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.559 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 47' ' ' GLY . . . -96.19 29.28 10.34 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.569 ' CD1' ' N ' ' A' ' 46' ' ' LEU . 6.6 mp 39.51 26.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.873 0.368 . . . . 0.0 110.614 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 45' ' ' GLY . . . 149.3 61.75 0.01 OUTLIER Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.438 ' C ' ' CD2' ' A' ' 48' ' ' LEU . 1.0 OUTLIER -148.92 -40.14 0.15 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.79 0.329 . . . . 0.0 110.59 179.939 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.715 -179.902 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 6' ' ' ILE . 23.5 p . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.774 0.321 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.651 HD12 ' C ' ' A' ' 6' ' ' ILE . 2.5 pp -127.25 174.0 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.522 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.414 ' O ' ' OD1' ' A' ' 9' ' ' ASP . . . -114.3 -11.59 12.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.615 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 10' ' ' TYR . 51.1 mttt -58.14 -25.62 61.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.517 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.424 ' H ' HD13 ' A' ' 6' ' ' ILE . 1.5 m-20 68.07 -66.68 0.21 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.456 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.413 ' N ' ' O ' ' A' ' 8' ' ' LYS . 47.5 m-85 -137.22 162.31 33.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.436 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 99.1 -135.95 12.42 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.661 ' H ' ' HE ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER -39.61 111.06 0.16 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.731 0.301 . . . . 0.0 110.829 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.552 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 24.3 p -147.26 148.71 31.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.689 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -145.23 119.67 9.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.574 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -34.98 71.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.529 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.85 1.85 61.6 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -141.22 -134.07 2.99 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 19' ' ' PRO . 6.6 p -39.07 102.74 0.26 Allowed Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 110.633 -0.136 . . . . 0.0 110.633 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 18' ' ' THR . 53.1 Cg_exo -50.89 -170.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.902 1.734 . . . . 0.0 112.48 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 6.5 t -153.44 80.93 1.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.236 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -40.1 -67.97 0.2 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.654 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.08 140.59 37.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.45 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.501 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 79.76 88.81 0.5 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.48 ' O ' ' CZ ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -81.94 -7.35 59.6 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.684 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.65 67.23 0.17 Allowed Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 24' ' ' ARG . 8.6 t -96.92 101.16 12.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.873 0.368 . . . . 0.0 110.352 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.6 tt -124.43 151.08 29.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.289 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 5.4 m -120.01 161.12 21.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.813 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.6 m -64.97 -177.03 0.32 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.554 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.8 tp -62.86 -30.79 50.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.822 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.3 mtm -80.35 -26.35 38.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.767 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.53 62.1 1.9 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.2 t -147.39 -29.53 0.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 110.6 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -90.47 53.73 2.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.511 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.5 m -73.64 103.67 4.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.695 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -117.51 144.5 45.01 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.975 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.552 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -91.91 117.48 29.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.494 179.631 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.6 148.9 40.74 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.332 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo . . . . . 0 N--CA 1.494 1.519 0 C-N-CA 122.176 1.917 . . . . 0.0 111.983 179.859 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.449 ' HB2' ' H ' ' A' ' 21' ' ' CYS . 7.8 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.712 0.291 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.67 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -118.96 6.59 6.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.766 -179.182 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 6' ' ' ILE . . . 79.37 -55.57 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.303 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -80.6 -142.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.207 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 7.1 p-10 -131.9 -112.65 0.24 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.09 0.471 . . . . 0.0 111.043 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.478 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.8 m-30 -58.29 147.38 30.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.565 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.442 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 164.51 -157.61 30.04 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.318 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.41 HH21 ' HB3' ' A' ' 12' ' ' ARG . 5.0 ptm85 -71.61 125.23 26.56 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.815 0.34 . . . . 0.0 111.072 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -145.36 142.5 29.43 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.644 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.95 130.26 33.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.531 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -48.76 -34.39 12.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.568 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -112.92 24.69 12.55 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.64 -127.37 2.89 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.2 p -85.14 146.93 46.39 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.369 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.07 -159.61 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.444 2.096 . . . . 0.0 112.142 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -171.97 95.47 0.16 Allowed 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.905 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.449 ' H ' ' HB2' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -42.52 -85.07 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.294 -179.358 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.83 122.32 22.27 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.273 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.41 87.19 1.97 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -85.1 -23.58 28.42 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.885 0.374 . . . . 0.0 110.131 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.05 75.48 0.12 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 4.6 t -92.48 111.78 23.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.115 0.483 . . . . 0.0 110.25 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.469 ' CG1' ' N ' ' A' ' 28' ' ' CYS . 10.7 tt -125.76 162.5 28.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.656 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 1.7 t -144.76 -171.86 3.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.777 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.08 170.65 9.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.513 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.401 ' HA ' HD12 ' A' ' 30' ' ' ILE . 9.0 tp -52.06 -27.24 9.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.576 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.8 mtp -83.56 -38.91 21.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.608 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.26 48.0 2.7 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.644 HG23 ' N ' ' A' ' 34' ' ' ASN . 10.1 t -122.97 -50.7 1.92 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.757 0.313 . . . . 0.0 110.45 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.644 ' N ' HG23 ' A' ' 33' ' ' THR . 2.9 t-20 -76.77 51.66 0.78 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.201 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.623 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 3.7 m -84.66 123.53 30.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.988 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -139.77 148.5 42.32 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.732 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 11' ' ' GLY . 0.7 OUTLIER -91.17 117.51 29.68 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.796 178.826 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.56 164.53 41.99 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.203 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--N 1.307 -1.609 0 C-N-CA 122.564 2.176 . . . . 0.0 112.253 179.754 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.719 0.295 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.4 pp -112.99 -174.36 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.272 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -106.63 -5.19 18.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.456 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.504 ' NZ ' ' O ' ' A' ' 12' ' ' ARG . 4.9 pttt -111.84 -119.73 0.29 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.561 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 23.9 p-10 -173.72 -42.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.45 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.469 ' CZ ' ' O ' ' A' ' 22' ' ' ARG . 69.0 m-85 -140.98 165.36 27.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.757 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 105.58 -152.58 17.2 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.244 -0.743 . . . . 0.0 111.244 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.504 ' O ' ' NZ ' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -37.42 130.31 0.96 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.848 0.356 . . . . 0.0 111.022 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.586 ' SG ' ' N ' ' A' ' 14' ' ' LYS . 0.8 OUTLIER -160.28 157.58 28.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.606 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.586 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 8.3 tttm -156.7 108.67 2.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.382 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 33.1 m95 -48.97 -27.3 3.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.623 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.12 -31.7 16.42 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.96 -104.38 2.07 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.0 p -90.22 144.02 30.48 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.597 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.1 -160.43 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.287 1.992 . . . . 0.0 111.956 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 12.8 t -160.98 90.45 0.83 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.933 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -49.81 -83.01 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.817 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.469 ' O ' ' CZ ' ' A' ' 10' ' ' TYR . 1.1 mpt_? -78.41 101.33 7.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.839 0.352 . . . . 0.0 110.431 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.493 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 112.83 116.45 3.4 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.421 ' C ' ' H ' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -110.91 4.81 20.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.782 0.325 . . . . 0.0 110.363 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.6 40.93 1.15 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 56.2 m -71.73 88.88 1.0 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.786 0.327 . . . . 0.0 110.296 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.3 tt -115.54 156.81 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.545 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.629 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.5 OUTLIER -137.45 -172.47 3.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.829 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 31' ' ' MET . 1.6 t -98.55 161.01 13.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.553 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.3 tp -42.19 -24.57 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.445 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.44 ' N ' ' O ' ' A' ' 29' ' ' SER . 2.8 mtt -81.66 -47.37 13.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.507 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.18 50.59 1.72 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.819 -0.913 . . . . 0.0 110.819 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.621 HG23 ' N ' ' A' ' 34' ' ' ASN . 8.9 t -131.15 -49.54 1.01 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.769 0.319 . . . . 0.0 110.659 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.621 ' N ' HG23 ' A' ' 33' ' ' THR . 72.0 m-80 -77.12 46.27 0.48 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.443 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.629 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 7.9 m -75.86 121.4 22.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.671 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -135.42 155.7 50.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.004 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 1.2 t -98.75 114.73 27.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.257 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -113.44 146.81 36.14 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.547 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 N--CA 1.495 1.616 0 C-N-CA 122.384 2.056 . . . . 0.0 112.147 179.607 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.531 0.217 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.785 HD13 ' H ' ' A' ' 9' ' ' ASP . 2.4 pp -135.23 -167.65 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.376 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -127.56 -17.56 4.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.752 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.497 ' CD ' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -61.42 -42.48 98.81 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.856 -0.337 . . . . 0.0 110.289 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.785 ' H ' HD13 ' A' ' 6' ' ' ILE . 15.5 m-20 61.18 135.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.83 0.348 . . . . 0.0 110.108 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 9' ' ' ASP . 15.2 m-85 49.99 176.35 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.529 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.521 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 83.21 -153.52 30.7 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -42.48 143.73 0.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.816 0.341 . . . . 0.0 110.82 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 36' ' ' GLU . 28.9 p -147.33 168.91 20.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.526 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -160.72 104.88 1.39 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.287 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -53.75 -19.16 3.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.37 . . . . 0.0 110.744 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.55 -8.54 52.16 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -147.72 -112.62 0.7 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.9 p -38.84 101.88 0.24 Allowed Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 110.453 -0.202 . . . . 0.0 110.453 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -79.1 -22.88 8.19 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.195 1.93 . . . . 0.0 112.567 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' A' ' 21' ' ' CYS . 0.4 OUTLIER 66.17 91.05 0.09 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.565 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 6' ' ' ILE . 89.3 m -36.25 -73.08 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.521 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -94.66 125.34 39.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.491 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.7 100.9 2.62 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -96.16 -2.22 46.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.745 0.307 . . . . 0.0 110.482 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' A' ' 38' ' ' LYS . . . -68.4 64.26 0.41 Allowed Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 47.1 t -85.39 71.23 10.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.288 0.566 . . . . 0.0 110.452 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.6 tt -86.27 145.56 7.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.754 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.572 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -126.93 166.17 18.02 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.965 -179.833 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.0 168.75 18.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.656 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -54.38 -26.86 16.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.674 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.2 mtm -85.14 -41.19 15.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.463 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 106.64 59.91 0.59 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.0 t -142.25 -30.43 0.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.336 . . . . 0.0 110.576 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -84.5 46.34 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.367 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.572 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 23.5 m -75.26 110.97 10.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.655 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.591 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 9.4 mt-10 -143.21 136.64 28.31 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.462 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' A' ' 11' ' ' GLY . 0.5 OUTLIER -74.26 120.65 20.12 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.429 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 25' ' ' GLY . 0.7 OUTLIER -101.53 146.91 33.05 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.387 -179.594 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo . . . . . 0 N--CA 1.495 1.559 0 C-N-CA 122.452 2.101 . . . . 0.0 112.198 179.888 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 6' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.856 0.36 . . . . 0.0 110.473 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.675 HG23 ' O ' ' A' ' 19' ' ' PRO . 2.6 pp -51.34 -172.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.969 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -149.26 63.45 1.03 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.628 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.408 ' H ' ' H ' ' A' ' 9' ' ' ASP . 39.3 pttt -169.11 -13.72 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.779 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.513 ' H ' HD13 ' A' ' 6' ' ' ILE . 2.7 m-20 65.04 127.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.41 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.411 ' O ' ' O ' ' A' ' 9' ' ' ASP . 18.9 m-85 50.0 178.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.563 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.95 -109.82 2.77 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.7 ttp85 -114.76 137.97 51.29 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.811 0.339 . . . . 0.0 110.403 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.2 p -143.01 178.3 7.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.658 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -157.18 116.97 3.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.988 0.423 . . . . 0.0 110.689 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.522 ' NE1' ' SG ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -51.19 139.36 18.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.363 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.88 -37.17 0.62 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.492 ' H ' ' C ' ' A' ' 15' ' ' TRP . . . -93.19 -145.0 16.01 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 17' ' ' GLY . 31.2 p -36.02 95.66 0.09 OUTLIER Pre-proline 0 CA--C 1.536 0.405 0 O-C-N 123.579 0.223 . . . . 0.0 110.696 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.675 ' O ' HG23 ' A' ' 6' ' ' ILE . 24.5 Cg_exo -61.87 156.88 46.17 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.105 1.87 . . . . 0.0 112.023 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -111.82 102.49 10.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.375 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -50.35 -71.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.544 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.9 mmp_? -104.25 107.77 18.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.273 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.47 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 133.68 77.83 0.11 Allowed Glycine 0 CA--C 1.52 0.381 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -79.39 5.37 12.78 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 120.934 0.397 . . . . 0.0 110.512 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.88 66.88 0.92 Allowed Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.497 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 19.2 m -97.26 102.78 14.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.0 0.428 . . . . 0.0 110.643 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.2 tt -109.31 157.08 9.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.802 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.52 175.92 8.89 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.681 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.2 166.81 14.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.645 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.492 HG23 ' HG2' ' A' ' 31' ' ' MET . 4.6 tp -47.29 -27.48 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.904 0.383 . . . . 0.0 110.623 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.492 ' HG2' HG23 ' A' ' 30' ' ' ILE . 1.3 mtt -89.5 -46.07 8.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.589 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.92 68.93 1.01 Allowed Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -146.23 -12.15 0.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.714 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -118.05 40.62 3.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.378 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.522 ' SG ' ' NE1' ' A' ' 15' ' ' TRP . 3.6 m -56.14 105.82 0.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.739 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -103.67 134.88 46.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.661 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.497 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 4.3 t -84.78 97.09 9.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.215 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -97.53 148.75 34.89 Favored Pre-proline 0 C--O 1.235 0.341 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.971 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo . . . . . 0 C--N 1.317 -1.087 0 C-N-CA 122.482 2.121 . . . . 0.0 112.407 179.462 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.436 ' SG ' ' N ' ' A' ' 6' ' ' ILE . 7.2 p . . . . . 0 N--CA 1.461 0.083 0 CA-C-O 120.715 0.293 . . . . 0.0 110.817 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.436 ' N ' ' SG ' ' A' ' 5' ' ' CYS . 2.2 pp -129.62 176.23 8.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.512 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.44 -19.0 10.28 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.017 0.437 . . . . 0.0 110.488 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -89.54 58.39 4.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.925 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 10' ' ' TYR . 1.1 m-20 -36.62 133.9 0.52 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.782 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 9' ' ' ASP . 88.3 m-85 56.51 158.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.512 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.05 -105.25 1.21 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -99.46 144.72 28.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.901 0.382 . . . . 0.0 110.853 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -158.35 141.97 15.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.553 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.1 tptm -147.71 120.94 8.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.485 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.93 -17.97 62.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.445 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.73 9.72 34.81 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -134.85 -113.23 1.32 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 p -88.78 151.36 47.44 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.473 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.07 -159.86 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.394 2.063 . . . . 0.0 112.017 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.6 t -160.93 81.72 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.221 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -39.45 -68.82 0.15 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.803 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.8 mtt-85 -104.7 88.0 2.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.606 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.491 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 157.4 94.95 0.1 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.61 -7.79 27.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.71 0.291 . . . . 0.0 110.554 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.89 53.55 4.26 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.567 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 91.8 m -75.98 93.72 3.3 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.1 tt -104.35 149.3 8.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.143 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.2 OUTLIER -134.52 -179.36 5.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.795 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.88 172.59 8.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.293 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.423 HG23 ' HG2' ' A' ' 31' ' ' MET . 7.3 tp -55.2 -24.88 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.725 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.423 ' HG2' HG23 ' A' ' 30' ' ' ILE . 3.9 mtp -87.89 -16.81 32.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.617 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.42 64.5 3.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.6 t -140.77 -33.66 0.53 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.78 0.324 . . . . 0.0 110.533 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -95.71 47.58 1.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.331 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.623 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 59.4 m -69.79 107.91 3.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.728 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -111.66 146.66 37.08 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.055 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.567 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -94.44 116.41 28.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.557 179.712 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.431 ' CB ' ' CD ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -126.85 179.46 1.2 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.562 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' A' ' 38' ' ' LYS . 22.1 Cg_exo . . . . . 0 N--CA 1.495 1.592 0 C-N-CA 122.483 2.122 . . . . 0.0 112.028 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.409 ' SG ' ' N ' ' A' ' 6' ' ' ILE . 11.5 p . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.768 0.318 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.656 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 1.1 pp -108.43 0.83 9.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.772 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.656 ' HB3' ' O ' ' A' ' 6' ' ' ILE . . . 79.27 -61.95 0.31 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.514 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -65.55 -164.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.542 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -139.53 133.33 30.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.354 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 52.38 178.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.622 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 109.14 -123.99 7.13 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.446 ' NH1' ' O ' ' A' ' 33' ' ' THR . 3.9 tpt180 -98.31 146.94 25.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.64 0.257 . . . . 0.0 110.551 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.455 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 3.7 p -145.89 175.71 10.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.478 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 17' ' ' GLY . 24.9 tttm -151.51 96.73 2.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.334 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -45.87 -21.62 0.14 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.76 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.76 36.28 4.33 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 14' ' ' LYS . . . 169.43 -124.72 1.18 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 19' ' ' PRO . 71.6 p -37.28 100.01 0.19 Allowed Pre-proline 0 N--CA 1.464 0.269 0 O-C-N 123.443 0.143 . . . . 0.0 110.84 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 18' ' ' THR . 39.6 Cg_exo -54.32 -145.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.529 2.152 . . . . 0.0 112.516 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.98 90.31 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.201 0.524 . . . . 0.0 110.709 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -45.68 -79.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.423 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 -95.04 126.73 40.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.358 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.499 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 99.88 82.02 1.64 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.49 ' CD ' ' H ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -85.76 11.88 10.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.637 0.256 . . . . 0.0 110.603 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.96 49.74 4.29 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.8 t -81.46 103.42 11.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.923 0.392 . . . . 0.0 110.913 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.7 tt -113.77 148.18 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.288 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -129.71 161.65 30.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.77 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.51 165.68 14.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.746 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 tp -52.3 -28.44 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.635 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.6 mtt -83.49 -40.64 18.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.76 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.41 62.97 0.73 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.446 ' O ' ' NH1' ' A' ' 12' ' ' ARG . 3.5 t -143.51 -24.36 0.59 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.762 0.315 . . . . 0.0 110.746 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -98.74 54.44 1.03 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.429 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.612 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 60.4 m -77.68 94.97 4.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.391 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -110.2 138.0 47.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.785 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -92.8 118.73 31.41 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.679 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -127.84 150.64 73.94 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.754 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo . . . . . 0 N--CA 1.495 1.581 0 C-N-CA 122.554 2.17 . . . . 0.0 112.106 179.608 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 120.767 0.317 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.662 HD12 ' N ' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -101.24 -13.73 8.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.664 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.662 ' N ' HD12 ' A' ' 6' ' ' ILE . . . 71.4 -55.45 0.65 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.868 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 10' ' ' TYR . 9.3 pttt -52.86 -4.51 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.815 0.34 . . . . 0.0 111.188 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.543 ' H ' ' C ' ' A' ' 7' ' ' ALA . 26.8 t0 63.44 -75.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.503 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.534 ' CE1' ' OD1' ' A' ' 9' ' ' ASP . 82.9 m-85 -115.92 159.52 21.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.586 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 134.57 -154.94 21.68 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.484 ' NH1' HG21 ' A' ' 18' ' ' THR . 0.0 OUTLIER -55.57 117.18 3.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.589 0.233 . . . . 0.0 110.796 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.604 ' SG ' ' N ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -119.02 168.57 10.69 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.711 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.604 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -141.58 96.09 2.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.484 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -54.95 120.36 6.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.956 0.408 . . . . 0.0 110.443 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.83 -20.64 49.9 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -103.32 -68.81 0.79 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.484 HG21 ' NH1' ' A' ' 12' ' ' ARG . 44.2 p -89.89 144.52 31.65 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.777 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.41 -18.25 18.03 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.156 1.904 . . . . 0.0 112.342 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.2 t 47.41 90.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.341 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -39.4 -86.0 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.878 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.517 ' O ' ' CZ ' ' A' ' 10' ' ' TYR . 41.0 mtm180 -109.14 106.55 16.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.9 0.381 . . . . 0.0 110.386 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.509 ' H ' ' NH1' ' A' ' 24' ' ' ARG . . . 155.5 70.87 0.01 OUTLIER Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.514 ' CZ ' ' H ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -80.67 6.09 13.76 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.537 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -103.74 55.19 0.63 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.0 t -83.13 109.29 17.04 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.06 0.457 . . . . 0.0 110.683 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.3 tt -109.84 143.93 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.409 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.9 m -125.05 167.58 14.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.745 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.41 178.7 1.48 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.58 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 tp -61.32 -28.85 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.69 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.9 mtt -84.64 -35.98 22.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.544 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.39 62.51 0.77 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.447 HG23 ' N ' ' A' ' 34' ' ' ASN . 8.9 t -142.63 -38.59 0.36 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.776 0.322 . . . . 0.0 110.615 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.447 ' N ' HG23 ' A' ' 33' ' ' THR . 4.1 t-20 -79.64 49.68 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.534 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.9 m -72.71 123.71 23.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.644 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -138.17 121.02 16.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.898 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.507 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -70.14 115.1 8.95 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.338 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -125.27 149.89 65.51 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.716 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo . . . . . 0 N--CA 1.494 1.536 0 C-N-CA 122.599 2.2 . . . . 0.0 112.09 179.869 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.462 0.16 0 CA-C-O 120.633 0.254 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.574 ' CD1' ' H ' ' A' ' 9' ' ' ASP . 1.8 pp -129.61 -170.71 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.27 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.15 -30.78 5.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.437 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.456 ' O ' ' CB ' ' A' ' 9' ' ' ASP . 8.5 mtmt -43.71 -67.06 0.31 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.6 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.574 ' H ' ' CD1' ' A' ' 6' ' ' ILE . 6.9 t0 78.82 117.35 0.06 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.48 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.562 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 42.4 m-85 53.76 168.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.468 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 100.21 -127.69 9.33 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.1 ttt-85 -72.41 140.6 48.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.838 0.351 . . . . 0.0 110.615 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.617 ' SG ' ' N ' ' A' ' 14' ' ' LYS . 0.7 OUTLIER -152.08 158.93 43.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.653 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.617 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 6.9 mttt -157.65 123.83 4.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.241 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.528 ' CZ2' ' SG ' ' A' ' 28' ' ' CYS . 1.0 OUTLIER -52.47 -24.87 8.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.582 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -112.34 14.08 25.59 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.07 -117.15 2.07 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.9 p -90.2 141.19 27.51 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.762 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 20' ' ' CYS . 58.9 Cg_endo -74.0 -32.69 6.8 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.554 2.17 . . . . 0.0 112.273 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.602 ' O ' ' N ' ' A' ' 22' ' ' ARG . 1.6 t 80.73 27.39 0.24 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.6 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.1 t 34.4 -84.1 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.608 0.567 . . . . 0.0 111.431 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.602 ' N ' ' O ' ' A' ' 20' ' ' CYS . 76.2 mtt180 -99.93 122.77 43.35 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.698 ' H ' ' HE ' ' A' ' 24' ' ' ARG . . . 130.06 79.43 0.21 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.698 ' HE ' ' H ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -79.51 1.05 27.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.76 0.314 . . . . 0.0 110.421 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -75.86 35.27 1.23 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.446 ' H ' ' C ' ' A' ' 24' ' ' ARG . 20.4 m -67.17 82.78 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.775 0.321 . . . . 0.0 110.593 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.3 tt -122.21 153.55 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.535 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.528 ' SG ' ' CZ2' ' A' ' 15' ' ' TRP . 6.6 m -118.75 165.84 13.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.771 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.7 170.48 7.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.403 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 30' ' ' ILE . 10.3 tp -54.12 -25.72 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.817 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.4 mtt -81.19 -37.39 28.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.646 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.68 58.48 0.94 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.5 t -148.76 -32.33 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 0.0 110.609 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -81.16 50.46 1.42 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.51 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.0 m -74.81 110.48 9.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.783 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -138.7 149.47 45.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.741 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.415 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.7 OUTLIER -89.73 107.28 19.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.117 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -97.28 148.05 33.85 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.555 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 N--CA 1.493 1.458 0 C-N-CA 122.251 1.967 . . . . 0.0 112.114 179.869 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.162 0 CA-C-O 120.371 0.129 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.642 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 2.0 pp -133.71 1.43 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 0.0 110.006 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 6' ' ' ILE . . . 82.52 -62.41 0.14 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.067 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -60.73 -140.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.5 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 10' ' ' TYR . 11.8 m-20 -140.39 -149.97 0.3 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.533 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.423 ' O ' ' O ' ' A' ' 9' ' ' ASP . 9.5 m-85 -40.95 163.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.529 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.543 ' N ' ' SG ' ' A' ' 37' ' ' CYS . . . 138.51 -138.95 9.86 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -79.92 127.44 32.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.679 0.276 . . . . 0.0 110.706 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.3 p -134.81 -172.18 2.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.597 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -160.01 115.66 2.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.354 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 32.3 m95 -57.7 -12.9 3.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.507 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -134.81 31.84 2.68 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.1 -133.64 1.81 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 14' ' ' LYS . 63.4 p -39.82 104.59 0.33 Allowed Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -79.02 -163.93 0.25 Allowed 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.958 1.772 . . . . 0.0 112.429 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -153.4 105.06 2.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.867 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.8 m -38.15 -75.36 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.682 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 mtp85 -95.75 120.94 36.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.415 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.703 ' H ' HH11 ' A' ' 24' ' ' ARG . . . 122.72 92.85 1.12 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.703 HH11 ' H ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -88.39 -8.37 55.13 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.742 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.44 66.85 3.85 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.3 m -81.78 80.72 8.02 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.28 0.562 . . . . 0.0 110.229 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.2 tt -80.65 139.18 18.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.495 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.604 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -132.27 175.94 8.83 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.819 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.65 169.49 15.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.528 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.4 tp -53.45 -24.91 9.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.655 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.2 mtm -92.16 -35.61 13.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.574 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.26 56.98 0.86 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 t -131.95 -33.54 1.35 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.798 0.332 . . . . 0.0 110.524 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -86.49 42.52 1.01 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.344 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.604 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 45.6 m -69.2 120.11 14.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.585 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -142.54 129.11 20.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.882 0.373 . . . . 0.0 111.057 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' N ' ' A' ' 11' ' ' GLY . 0.8 OUTLIER -80.15 127.47 32.37 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.522 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -137.29 149.7 66.56 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.402 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo . . . . . 0 N--CA 1.494 1.552 0 C-N-CA 122.308 2.005 . . . . 0.0 112.211 179.869 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.428 ' O ' ' O ' ' A' ' 6' ' ' ILE . 7.2 p . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.822 0.344 . . . . 0.0 110.399 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.478 HG13 ' H ' ' A' ' 21' ' ' CYS . 2.1 pp -50.02 -178.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.331 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 6' ' ' ILE . . . -35.59 -89.94 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.872 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.445 ' O ' ' CB ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -175.7 73.28 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 120.9 0.381 . . . . 0.0 110.371 179.669 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.47 ' C ' ' CD1' ' A' ' 10' ' ' TYR . 0.8 OUTLIER 162.38 -109.33 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.997 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.552 ' CZ ' ' O ' ' A' ' 22' ' ' ARG . 43.6 m-85 -142.48 -162.4 1.41 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.199 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 118.42 -119.9 4.52 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.03 151.32 21.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.717 0.294 . . . . 0.0 110.554 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.568 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 1.5 t -123.05 179.96 4.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.334 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -160.12 91.89 0.97 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.428 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.402 ' C ' ' N ' ' A' ' 17' ' ' GLY . 4.9 m0 -49.51 -81.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.451 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.77 -14.68 1.11 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.402 ' N ' ' C ' ' A' ' 15' ' ' TRP . . . -95.07 -134.4 7.65 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.18 152.75 48.36 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.592 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.54 178.34 6.83 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.319 2.013 . . . . 0.0 112.364 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.568 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -102.78 127.54 49.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.388 179.635 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.478 ' H ' HG13 ' A' ' 6' ' ' ILE . 59.8 m -50.85 -97.2 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.916 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.552 ' O ' ' CZ ' ' A' ' 10' ' ' TYR . 4.7 mtt180 -83.65 24.8 0.83 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.428 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.91 151.13 17.7 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.95 -14.34 0.53 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.796 0.331 . . . . 0.0 110.701 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.26 47.75 3.89 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 95.4 m -77.19 105.86 8.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.723 0.297 . . . . 0.0 110.633 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.3 tt -119.36 145.73 25.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.293 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.9 m -131.8 -178.6 4.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.759 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.83 168.75 15.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.652 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.5 tp -49.64 -25.56 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.578 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.5 mtt -86.93 -47.41 9.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.484 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.66 57.03 0.75 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.0 t -136.12 -24.78 1.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.749 0.309 . . . . 0.0 110.522 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -101.44 50.89 0.85 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.383 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 97.7 m -68.63 122.81 19.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.806 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -119.77 127.87 53.21 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.079 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.512 ' N ' ' O ' ' A' ' 11' ' ' GLY . 6.1 t -84.82 97.45 9.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.363 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.4 mtmt -107.96 147.0 34.62 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.743 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo . . . . . 0 N--CA 1.495 1.577 0 C-N-CA 122.371 2.047 . . . . 0.0 112.084 179.607 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.7 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.939 0.399 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.838 HD12 ' N ' ' A' ' 7' ' ' ALA . 2.5 pp -54.92 -25.78 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.015 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.838 ' N ' HD12 ' A' ' 6' ' ' ILE . . . 66.82 -36.6 0.27 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.52 ' H ' ' C ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -72.57 15.74 0.17 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 122.119 0.961 . . . . 0.0 110.726 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.508 ' H ' ' C ' ' A' ' 7' ' ' ALA . 2.9 p-10 42.95 -110.39 0.15 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.924 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.491 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.4 m-30 -77.4 126.65 31.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.218 -178.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 159.04 -96.55 0.15 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.9 ttt85 -110.77 146.42 36.39 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.785 0.326 . . . . 0.0 110.752 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -158.03 143.75 17.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.617 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.579 ' NZ ' ' SG ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -137.34 126.01 23.81 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.997 0.427 . . . . 0.0 110.629 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.427 ' HE1' ' HB2' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -71.94 -28.13 63.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.541 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.62 -6.85 57.16 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.75 -115.61 3.22 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.3 p -90.21 142.81 28.83 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.567 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.67 167.47 27.17 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.182 1.922 . . . . 0.0 112.396 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 1.5 t -103.48 107.18 17.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.958 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.31 -72.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.529 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.402 ' HE ' ' HB3' ' A' ' 9' ' ' ASP . 7.8 mtm-85 -100.08 122.57 43.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.486 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 82.26 109.78 0.43 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.705 ' HE ' ' N ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -102.88 19.34 19.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.661 0.267 . . . . 0.0 110.649 -179.952 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.02 53.48 4.75 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.561 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 38.0 m -73.97 113.29 10.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.992 0.425 . . . . 0.0 110.501 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.0 tt -126.11 148.03 30.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.084 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.555 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -126.16 168.17 14.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.577 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 31' ' ' MET . 4.3 m -77.44 157.38 30.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.569 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -42.19 -24.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.847 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.431 ' N ' ' O ' ' A' ' 29' ' ' SER . 1.2 mtp -88.28 -50.92 6.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.757 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.83 63.72 0.53 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.6 t -145.04 -17.52 0.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.779 0.323 . . . . 0.0 110.302 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -107.74 51.07 0.75 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.171 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.579 ' SG ' ' NZ ' ' A' ' 14' ' ' LYS . 31.3 m -73.39 86.22 1.5 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.23 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -102.16 152.2 21.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.449 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.561 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -98.98 120.87 40.15 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.616 179.304 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -129.54 159.65 68.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.427 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 38' ' ' LYS . 50.9 Cg_exo . . . . . 0 N--CA 1.493 1.46 0 C-N-CA 122.352 2.035 . . . . 0.0 112.21 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 6' ' ' ILE . 4.6 p . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 121.003 0.43 . . . . 0.0 110.722 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.419 ' N ' ' SG ' ' A' ' 5' ' ' CYS . 1.1 pp -139.26 -172.16 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.446 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.44 -30.19 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.774 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.717 ' H ' ' CD ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -51.7 -42.33 62.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.431 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 10' ' ' TYR . 4.8 m-20 58.92 125.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.47 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 9' ' ' ASP . 66.5 m-85 55.97 160.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.854 0.359 . . . . 0.0 110.795 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.18 -152.04 21.93 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.415 ' N ' ' OE2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -42.24 125.42 3.09 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.657 -0.32 . . . . 0.0 110.944 -179.807 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 2.9 t -154.73 150.46 27.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.649 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.467 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 25.3 tttp -155.88 103.7 2.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.534 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 13.8 m95 -42.05 154.95 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.412 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.46 -47.5 0.71 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.96 -90.79 0.82 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 19' ' ' PRO . 3.9 p -90.19 112.98 55.61 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-O 119.448 -0.31 . . . . 0.0 110.75 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 18' ' ' THR . 52.0 Cg_exo -51.49 -161.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.12 1.88 . . . . 0.0 112.611 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 6.3 t -171.92 61.18 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.475 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -38.22 -42.4 0.68 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.807 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.4 mtt180 -120.36 99.81 6.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.44 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.499 ' O ' ' SG ' ' A' ' 20' ' ' CYS . . . 130.81 91.95 0.59 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -85.47 -12.43 51.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.85 0.357 . . . . 0.0 110.488 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.17 41.84 1.59 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.3 t -81.87 108.58 15.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.03 0.443 . . . . 0.0 110.685 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.8 tt -145.47 152.09 14.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.318 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.647 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 1.0 OUTLIER -129.84 177.1 7.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.699 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.15 165.93 21.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.417 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.437 HG23 ' HG2' ' A' ' 31' ' ' MET . 6.1 tp -51.76 -25.9 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.64 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.437 ' HG2' HG23 ' A' ' 30' ' ' ILE . 4.9 mtt -86.34 -29.8 22.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.633 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.66 62.78 1.59 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -137.4 -36.06 0.66 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.785 0.326 . . . . 0.0 110.688 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -94.76 54.15 1.71 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.183 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.647 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 1.8 m -85.56 114.4 22.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.622 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.415 ' OE2' ' N ' ' A' ' 12' ' ' ARG . 9.2 mm-40 -137.74 154.3 49.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.803 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -98.76 111.3 23.72 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.191 179.356 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -102.06 147.04 33.36 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.643 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo . . . . . 0 N--CA 1.494 1.547 0 C-N-CA 122.339 2.026 . . . . 0.0 112.325 179.604 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 120.714 0.292 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.661 ' CD1' ' H ' ' A' ' 9' ' ' ASP . 1.5 pp -106.07 -5.07 9.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.536 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.64 ' N ' HD12 ' A' ' 6' ' ' ILE . . . 73.64 -56.14 0.66 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.639 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 10' ' ' TYR . 30.9 mmtm -49.17 -14.04 0.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.713 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.661 ' H ' ' CD1' ' A' ' 6' ' ' ILE . 19.4 m-20 59.1 -76.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.524 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.538 ' N ' ' O ' ' A' ' 8' ' ' LYS . 52.0 m-85 -108.95 163.68 13.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.505 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.23 -156.67 15.51 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.546 HH12 ' N ' ' A' ' 35' ' ' CYS . 0.2 OUTLIER -39.68 130.66 1.87 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.838 0.351 . . . . 0.0 110.876 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.599 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 26.6 p -157.01 179.17 9.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.587 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -160.64 115.53 2.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.467 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -56.96 -39.63 74.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.762 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -98.91 28.13 16.65 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -147.0 -78.21 0.03 OUTLIER Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.2 p -90.4 148.07 38.12 Favored Pre-proline 0 C--N 1.325 -0.478 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.197 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.64 -31.72 10.42 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.386 2.057 . . . . 0.0 112.422 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 22' ' ' ARG . 17.2 t 58.16 87.26 0.07 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.359 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -37.17 -76.47 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.711 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.402 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -99.81 175.12 5.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.545 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.479 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 50.95 74.87 0.25 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -79.79 10.75 3.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.664 0.269 . . . . 0.0 110.442 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.14 49.84 4.3 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.405 ' SG ' ' C ' ' A' ' 13' ' ' CYS . 5.2 t -68.89 90.77 0.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.949 0.404 . . . . 0.0 110.387 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.2 tt -103.97 147.45 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.405 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 11.3 m -126.79 164.3 21.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.737 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 m -73.18 167.25 21.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.458 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.5 tp -51.55 -28.35 8.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.668 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.6 mtm -80.09 -33.66 38.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.625 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.04 65.22 1.39 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.0 t -150.21 -28.88 0.23 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.768 0.318 . . . . 0.0 110.663 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.426 ' C ' HH12 ' A' ' 12' ' ' ARG . 0.5 OUTLIER -93.85 53.93 1.88 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.446 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.546 ' N ' HH12 ' A' ' 12' ' ' ARG . 72.5 m -75.04 120.27 20.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.681 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.453 ' C ' ' SG ' ' A' ' 13' ' ' CYS . 56.3 mt-10 -135.56 138.42 42.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.62 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.599 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -83.8 105.38 14.66 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.22 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.52 149.69 40.62 Favored Pre-proline 0 C--O 1.236 0.368 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.574 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo . . . . . 0 N--CA 1.495 1.565 0 C-N-CA 122.597 2.198 . . . . 0.0 111.975 179.412 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.416 ' SG ' ' N ' ' A' ' 6' ' ' ILE . 14.0 p . . . . . 0 CA--C 1.523 -0.089 0 CA-C-O 120.865 0.364 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.537 HD12 ' N ' ' A' ' 7' ' ' ALA . 1.7 pp -104.09 1.33 10.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.902 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.537 ' N ' HD12 ' A' ' 6' ' ' ILE . . . 68.6 -64.56 0.31 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.506 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 6' ' ' ILE . 7.7 mmtp -56.61 -164.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.665 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.409 ' O ' ' O ' ' A' ' 10' ' ' TYR . 3.8 p-10 -139.28 127.87 23.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.471 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.409 ' O ' ' O ' ' A' ' 9' ' ' ASP . 79.4 m-85 54.42 167.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.63 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.07 -113.48 1.75 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.42 ' NH1' HG21 ' A' ' 18' ' ' THR . 1.3 ptm180 -108.91 136.96 47.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.667 0.27 . . . . 0.0 110.823 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 5.9 p -143.48 174.75 10.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.995 0.426 . . . . 0.0 110.935 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -160.4 108.14 1.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.385 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.505 ' C ' ' H ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -41.07 -67.41 0.25 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.849 -179.803 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.78 28.55 0.91 Allowed Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 15' ' ' TRP . . . -145.34 -92.95 0.14 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.42 HG21 ' NH1' ' A' ' 12' ' ' ARG . 3.2 p -91.45 144.8 30.2 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.093 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.82 -32.7 7.1 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.128 1.885 . . . . 0.0 112.386 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.1 t 67.55 100.93 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.595 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -58.63 -83.97 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.599 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.4 mmt-85 -84.19 117.32 23.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.597 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.508 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 115.24 89.85 1.64 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -86.37 -24.13 25.9 Favored 'General case' 0 N--CA 1.44 -0.939 0 O-C-N 122.532 -0.393 . . . . 0.0 110.268 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.01 58.46 0.79 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.8 t -87.78 113.06 23.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.871 0.367 . . . . 0.0 110.259 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.1 tt -131.15 156.53 42.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.592 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.635 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.5 OUTLIER -135.73 174.62 10.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.541 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.1 t -79.95 158.41 26.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.441 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -42.96 -32.0 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 120.906 0.384 . . . . 0.0 110.092 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 16.6 mtm -79.31 -43.35 23.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.994 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.01 62.85 0.88 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 t -139.47 -35.02 0.55 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.81 0.338 . . . . 0.0 110.64 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -95.15 50.85 1.29 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.142 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.635 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 31.3 m -75.15 102.34 4.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.533 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -109.88 141.25 42.86 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.15 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.3 OUTLIER -97.09 103.49 15.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.227 179.562 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.89 162.1 47.36 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.436 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 C--N 1.31 -1.494 0 C-N-CA 122.514 2.143 . . . . 0.0 112.174 179.985 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.529 0.16 0 CA-C-O 120.726 0.298 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.653 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 2.3 pp -141.95 -0.19 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 6' ' ' ILE . . . 80.35 -64.31 0.19 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.728 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 7' ' ' ALA . 10.1 mttp -53.61 -170.28 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.155 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -126.78 -155.22 0.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.66 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -45.01 155.4 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.485 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 144.47 -103.28 0.29 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.466 HH11 ' NZ ' ' A' ' 14' ' ' LYS . 0.9 OUTLIER -123.32 134.7 54.02 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.788 0.328 . . . . 0.0 110.871 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -148.67 179.84 7.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.661 179.463 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.602 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 2.4 tttp -143.73 110.34 5.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.511 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.516 ' C ' ' H ' ' A' ' 17' ' ' GLY . 10.1 m95 -48.19 141.56 6.19 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.552 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.29 -36.31 0.26 Allowed Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 15' ' ' TRP . . . -83.08 -91.29 0.67 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 19' ' ' PRO . 13.5 p -91.73 111.56 50.12 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-O 119.312 -0.375 . . . . 0.0 110.731 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 18' ' ' THR . 42.7 Cg_exo -52.46 -156.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.169 1.912 . . . . 0.0 112.672 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -165.27 92.77 0.57 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.296 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.6 m -41.45 -77.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.657 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 36.1 mtt85 -94.74 115.71 27.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.476 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.55 85.82 1.88 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.9 ptm85 -80.3 0.56 32.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.584 0.231 . . . . 0.0 110.773 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.36 98.25 2.4 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -121.06 108.74 14.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.235 0.54 . . . . 0.0 110.323 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.6 tt -114.58 155.9 15.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.782 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.8 m -132.35 177.58 7.48 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.899 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 31' ' ' MET . 11.9 t -91.29 159.59 15.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.568 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.4 tp -40.67 -24.75 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.651 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.474 ' N ' ' O ' ' A' ' 29' ' ' SER . 3.1 mtt -80.76 -42.26 22.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.752 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 29' ' ' SER . . . 87.28 63.17 1.44 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 t -150.6 -31.33 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.838 0.352 . . . . 0.0 110.466 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.422 ' OD1' ' N ' ' A' ' 29' ' ' SER . 9.3 p-10 -89.44 32.22 0.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.464 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 90.3 m -51.46 105.11 0.1 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.657 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -107.59 132.83 52.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.309 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -87.48 130.11 34.82 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.544 179.335 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.32 162.28 43.33 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.47 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo . . . . . 0 N--CA 1.493 1.469 0 C-N-CA 122.668 2.245 . . . . 0.0 112.142 179.692 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 7' ' ' ALA . 1.8 m . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 120.641 0.257 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 19' ' ' PRO . 1.3 pp -39.49 -28.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.679 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 9' ' ' ASP . . . 68.05 -57.73 0.46 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.818 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.579 ' NZ ' ' CB ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -44.55 -16.57 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.944 0.402 . . . . 0.0 110.998 -179.415 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.504 ' H ' HD12 ' A' ' 6' ' ' ILE . 0.8 OUTLIER 72.6 111.02 0.06 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.501 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 55.87 169.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.478 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.19 -105.68 1.05 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -111.19 145.05 39.35 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.813 0.339 . . . . 0.0 110.503 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.9 p -145.43 168.72 19.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.721 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.63 109.83 3.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.489 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -52.95 -40.88 64.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.943 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.55 27.37 20.6 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -168.54 -126.11 0.83 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -40.45 109.26 0.59 Allowed Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.841 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.558 ' O ' HG23 ' A' ' 6' ' ' ILE . 54.3 Cg_endo -76.1 152.45 35.78 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.96 1.773 . . . . 0.0 112.097 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.73 137.57 51.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.134 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -95.34 -79.47 0.43 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.485 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 70.7 mtt-85 -81.99 109.06 15.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.549 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.499 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 103.47 92.09 2.22 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.37 14.56 10.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.751 0.31 . . . . 0.0 110.643 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.56 56.73 4.17 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.0 t -79.94 113.49 18.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.728 0.299 . . . . 0.0 110.659 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.5 tt -126.02 148.44 30.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.315 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.1 m -126.33 174.15 8.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.605 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.12 169.44 17.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.49 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.415 HG23 ' HG2' ' A' ' 31' ' ' MET . 0.6 OUTLIER -52.36 -27.41 10.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.929 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.415 ' HG2' HG23 ' A' ' 30' ' ' ILE . 1.6 mtp -85.5 -25.58 26.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.66 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.84 66.04 1.66 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.0 t -145.18 -34.15 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.846 0.355 . . . . 0.0 110.547 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -90.62 53.8 2.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.324 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.7 m -72.13 98.29 2.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -105.31 140.64 38.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.819 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 0.7 OUTLIER -93.03 111.22 22.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.344 179.488 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.52 158.01 63.29 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.828 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo . . . . . 0 N--CA 1.494 1.555 0 C-N-CA 122.682 2.255 . . . . 0.0 112.07 179.72 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.547 ' SG ' ' N ' ' A' ' 6' ' ' ILE . 31.0 p . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 120.759 0.314 . . . . 0.0 110.413 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.663 HD13 ' H ' ' A' ' 9' ' ' ASP . 2.6 pp -119.76 -174.26 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.509 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.35 -1.57 2.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.575 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.429 ' HZ2' HG12 ' A' ' 6' ' ' ILE . 1.4 pttm -83.93 -12.36 55.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.593 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.663 ' H ' HD13 ' A' ' 6' ' ' ILE . 0.1 OUTLIER 60.11 133.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.549 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.432 ' O ' ' O ' ' A' ' 9' ' ' ASP . 52.5 m-85 44.29 -170.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.686 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.95 -153.96 18.69 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.2 ttt-85 -80.15 153.59 28.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.737 0.303 . . . . 0.0 110.556 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.556 ' SG ' ' N ' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -156.3 -178.74 7.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.664 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.556 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -139.47 118.21 12.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.394 179.758 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -60.01 -11.28 5.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.728 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.419 ' H ' ' HD3' ' A' ' 14' ' ' LYS . . . -128.2 25.84 4.81 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -170.28 -144.64 4.4 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.1 p -38.32 102.59 0.25 Allowed Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 121.314 -0.154 . . . . 0.0 110.916 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -79.97 -163.03 0.2 Allowed 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.403 2.069 . . . . 0.0 112.237 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.505 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 31.7 p -144.64 112.37 6.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.573 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -51.64 -81.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.636 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.419 ' H ' ' HD2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -77.03 118.4 19.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.58 -179.901 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.504 ' O ' ' SG ' ' A' ' 20' ' ' CYS . . . 96.14 66.95 0.96 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -78.43 25.01 0.25 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 120.838 0.351 . . . . 0.0 110.6 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . -98.83 75.85 0.54 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -96.73 104.0 15.96 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.561 0.695 . . . . 0.0 110.784 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.615 ' O ' HG23 ' A' ' 27' ' ' ILE . 10.6 tt -97.39 110.61 25.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.282 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.03 156.66 17.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.669 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.3 m -80.09 161.0 25.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.705 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.8 tp -44.27 -27.51 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.652 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.9 mtt -86.12 -40.46 15.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.601 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.22 65.06 0.74 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.8 t -158.74 -0.66 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.592 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.93 23.86 13.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.632 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.4 m -54.74 104.83 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.512 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -115.72 107.38 15.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.911 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 1.1 m -72.34 109.44 6.06 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.457 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.433 ' CB ' ' CD ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -125.48 177.5 1.87 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.877 -179.799 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' A' ' 38' ' ' LYS . 23.3 Cg_exo . . . . . 0 N--CA 1.496 1.631 0 C-N-CA 122.779 2.319 . . . . 0.0 112.231 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.5 m . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 121.006 0.431 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.54 HD13 ' H ' ' A' ' 9' ' ' ASP . 0.6 OUTLIER -120.95 -20.98 4.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.428 -179.522 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 6' ' ' ILE . . . 68.61 -37.82 0.36 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.039 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.513 ' H ' ' C ' ' A' ' 6' ' ' ILE . 3.5 mttm -64.34 -30.67 71.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.661 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.54 ' H ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER 56.92 126.23 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.117 -179.52 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.564 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 2.4 m-30 64.11 114.56 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.433 0.635 . . . . 0.0 110.534 178.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 158.66 -144.51 10.43 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.791 -0.923 . . . . 0.0 110.791 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.516 ' O ' ' NH2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -83.52 156.34 22.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.878 0.37 . . . . 0.0 110.707 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.444 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 28.2 p -158.62 170.07 22.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.537 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.79 114.3 3.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.617 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -62.71 -11.8 19.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.707 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.33 10.28 14.84 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -139.56 -98.96 0.42 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.2 p -90.11 145.62 33.32 Favored Pre-proline 0 C--N 1.327 -0.399 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.918 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.9 -160.84 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.466 2.111 . . . . 0.0 112.155 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -165.27 103.01 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.54 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.43 -89.31 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.785 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -82.65 121.49 26.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.606 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.511 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 99.11 69.18 0.91 Allowed Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -79.45 27.89 0.26 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.982 0.42 . . . . 0.0 110.529 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 36' ' ' GLU . . . -93.37 66.56 1.76 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.582 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 56.4 m -84.6 87.56 7.28 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.348 0.594 . . . . 0.0 110.697 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.648 ' O ' HG23 ' A' ' 27' ' ' ILE . 1.7 tt -80.07 96.96 2.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.495 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 94.4 m -92.16 154.99 18.33 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.472 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.407 ' C ' ' N ' ' A' ' 31' ' ' MET . 1.2 m -91.77 171.31 9.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.767 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 tp -51.8 -14.82 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.571 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' MET . . . . . 0.407 ' N ' ' C ' ' A' ' 29' ' ' SER . 4.7 mtm -106.98 -42.9 4.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.761 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.38 56.13 0.74 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 t -133.84 -22.44 1.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 0.0 110.446 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -94.26 13.18 24.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.576 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.6 m -49.49 91.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.681 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 34' ' ' ASN . 2.9 tt0 -107.31 123.2 47.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.582 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.582 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -77.73 99.6 5.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.361 179.892 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.413 ' HZ3' ' HB2' ' A' ' 38' ' ' LYS . 23.9 mtmm -95.82 148.71 34.99 Favored Pre-proline 0 C--O 1.237 0.398 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.88 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 0 N--CA 1.493 1.479 0 C-N-CA 122.538 2.159 . . . . 0.0 112.146 179.653 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.234 0.237 0 CA-C-O 120.846 0.355 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.426 HD12 ' C ' ' A' ' 6' ' ' ILE . 2.6 pp -130.96 -166.18 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.325 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.448 ' C ' ' H ' ' A' ' 9' ' ' ASP . . . -131.86 -24.93 2.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.758 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.696 ' H ' ' CD ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -71.76 12.52 0.37 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.79 -179.66 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.52 ' OD2' ' N ' ' A' ' 10' ' ' TYR . 6.7 p-10 36.2 -121.52 0.15 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.523 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.52 ' N ' ' OD2' ' A' ' 9' ' ' ASP . 60.5 m-85 -72.04 168.64 17.66 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.459 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.24 -145.86 17.46 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.447 ' NH1' ' NZ ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -37.74 119.26 0.73 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.853 0.358 . . . . 0.0 111.081 -179.688 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.488 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 26.9 p -151.9 171.54 17.62 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.688 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.447 ' NZ ' ' NH1' ' A' ' 12' ' ' ARG . 7.4 mttp -159.85 153.72 23.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.603 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.476 ' CZ2' ' SG ' ' A' ' 28' ' ' CYS . 0.9 OUTLIER -83.13 -52.57 6.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.783 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.48 -24.72 41.93 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.82 -119.88 0.17 Allowed Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.56 151.64 48.35 Favored Pre-proline 0 C--N 1.326 -0.416 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.663 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.52 -170.19 0.36 Allowed 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.568 2.179 . . . . 0.0 112.306 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.46 96.06 2.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.57 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 70.1 m -40.71 -84.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.582 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.515 ' O ' ' CE2' ' A' ' 10' ' ' TYR . 19.4 mtt85 -90.85 41.31 1.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.518 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.45 145.82 17.74 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.85 -25.62 0.5 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.749 0.309 . . . . 0.0 110.555 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.49 67.29 0.52 Allowed Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.426 ' O ' ' NE1' ' A' ' 15' ' ' TRP . 13.3 t -79.75 85.68 5.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.924 0.392 . . . . 0.0 110.348 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.9 tt -96.2 150.86 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.528 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.476 ' SG ' ' CZ2' ' A' ' 15' ' ' TRP . 3.7 m -130.56 177.73 7.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.769 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.92 174.7 11.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.664 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -53.79 -28.33 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.671 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.0 mtt -83.65 -46.14 12.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.721 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.9 62.38 0.82 Allowed Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.9 t -142.86 -25.73 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.796 0.332 . . . . 0.0 110.615 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -100.41 46.58 0.95 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.569 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.8 m -63.24 124.68 21.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.698 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.447 ' C ' ' SG ' ' A' ' 13' ' ' CYS . 41.3 mt-10 -130.62 138.68 50.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.52 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.488 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -87.1 122.87 31.52 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.173 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.59 148.06 63.07 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.805 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 N--CA 1.495 1.586 0 C-N-CA 122.452 2.102 . . . . 0.0 111.996 179.49 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.475 ' C ' ' H ' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.511 ' NZ ' ' NH2' ' A' ' 22' ' ' ARG . 10.4 mmtm 55.7 5.4 0.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.696 0.284 . . . . 0.0 110.647 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.475 ' H ' ' C ' ' A' ' 1' ' ' GLY . 4.7 mttp -76.09 10.38 1.97 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.616 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.03 -9.51 8.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.673 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 6' ' ' ILE . 23.5 p -135.05 -118.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.625 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.651 ' C ' HD12 ' A' ' 6' ' ' ILE . 2.5 pp -127.25 174.0 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.522 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.414 ' O ' ' OD1' ' A' ' 9' ' ' ASP . . . -114.3 -11.59 12.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.615 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 10' ' ' TYR . 51.1 mttt -58.14 -25.62 61.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.517 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.424 ' H ' HD13 ' A' ' 6' ' ' ILE . 1.5 m-20 68.07 -66.68 0.21 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.456 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.413 ' N ' ' O ' ' A' ' 8' ' ' LYS . 47.5 m-85 -137.22 162.31 33.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.436 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 99.1 -135.95 12.42 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.661 ' HE ' ' H ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER -39.61 111.06 0.16 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.731 0.301 . . . . 0.0 110.829 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.552 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 24.3 p -147.26 148.71 31.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.689 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -145.23 119.67 9.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.574 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -34.98 71.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.529 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.85 1.85 61.6 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -141.22 -134.07 2.99 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 19' ' ' PRO . 6.6 p -39.07 102.74 0.26 Allowed Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 110.633 -0.136 . . . . 0.0 110.633 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 18' ' ' THR . 53.1 Cg_exo -50.89 -170.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.902 1.734 . . . . 0.0 112.48 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 6.5 t -153.44 80.93 1.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.236 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -40.1 -67.97 0.2 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.654 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.511 ' NH2' ' NZ ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -104.08 140.59 37.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.45 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.501 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 79.76 88.81 0.5 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.48 ' CZ ' ' O ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -81.94 -7.35 59.6 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.684 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.65 67.23 0.17 Allowed Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 24' ' ' ARG . 8.6 t -96.92 101.16 12.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.873 0.368 . . . . 0.0 110.352 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.6 tt -124.43 151.08 29.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.289 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 5.4 m -120.01 161.12 21.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.813 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.6 m -64.97 -177.03 0.32 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.554 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.8 tp -62.86 -30.79 50.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.822 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.3 mtm -80.35 -26.35 38.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.767 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.53 62.1 1.9 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.2 t -147.39 -29.53 0.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 110.6 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -90.47 53.73 2.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.511 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.5 m -73.64 103.67 4.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.695 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -117.51 144.5 45.01 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.975 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.552 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -91.91 117.48 29.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.494 179.631 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.6 148.9 40.74 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.332 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.77 -28.41 25.24 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.176 1.917 . . . . 0.0 111.983 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.4 mtp85 -64.8 141.83 58.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.666 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.998 ' H ' HD22 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -81.44 -160.56 0.35 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.558 -179.647 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.11 -36.87 39.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.499 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -61.01 109.07 0.98 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.622 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -80.71 23.99 0.5 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.708 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.19 -91.07 0.08 OUTLIER Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.828 ' H ' HD12 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -129.39 -62.26 0.99 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.828 0.347 . . . . 0.0 110.66 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -165.92 49.6 0.27 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.0 tt -93.25 -45.3 7.91 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.483 179.845 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 69.48 149.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.904 0.383 . . . . 0.0 110.601 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.0 ttpp 66.09 62.95 0.58 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.525 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.408 ' NZ ' ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -134.62 -24.56 1.53 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.706 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.449 ' HB2' ' H ' ' A' ' 21' ' ' CYS . 7.8 m -55.89 -78.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.694 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.67 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -118.96 6.59 6.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.766 -179.182 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 6' ' ' ILE . . . 79.37 -55.57 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.303 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -80.6 -142.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.207 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 7.1 p-10 -131.9 -112.65 0.24 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.09 0.471 . . . . 0.0 111.043 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.478 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.8 m-30 -58.29 147.38 30.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.565 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.442 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 164.51 -157.61 30.04 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.318 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.41 HH21 ' HB3' ' A' ' 12' ' ' ARG . 5.0 ptm85 -71.61 125.23 26.56 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.815 0.34 . . . . 0.0 111.072 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -145.36 142.5 29.43 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.644 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.95 130.26 33.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.531 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -48.76 -34.39 12.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.568 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -112.92 24.69 12.55 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.64 -127.37 2.89 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.2 p -85.14 146.93 46.39 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.369 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.07 -159.61 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.444 2.096 . . . . 0.0 112.142 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -171.97 95.47 0.16 Allowed 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.905 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.449 ' H ' ' HB2' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -42.52 -85.07 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.294 -179.358 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.83 122.32 22.27 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.273 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.41 87.19 1.97 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -85.1 -23.58 28.42 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.885 0.374 . . . . 0.0 110.131 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.05 75.48 0.12 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 4.6 t -92.48 111.78 23.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.115 0.483 . . . . 0.0 110.25 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.469 ' CG1' ' N ' ' A' ' 28' ' ' CYS . 10.7 tt -125.76 162.5 28.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.656 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 1.7 t -144.76 -171.86 3.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.777 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.08 170.65 9.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.513 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.401 ' HA ' HD12 ' A' ' 30' ' ' ILE . 9.0 tp -52.06 -27.24 9.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.576 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.8 mtp -83.56 -38.91 21.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.608 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.26 48.0 2.7 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.644 HG23 ' N ' ' A' ' 34' ' ' ASN . 10.1 t -122.97 -50.7 1.92 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.757 0.313 . . . . 0.0 110.45 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.644 ' N ' HG23 ' A' ' 33' ' ' THR . 2.9 t-20 -76.77 51.66 0.78 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.201 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.623 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 3.7 m -84.66 123.53 30.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.988 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -139.77 148.5 42.32 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.732 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 11' ' ' GLY . 0.7 OUTLIER -91.17 117.51 29.68 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.796 178.826 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.56 164.53 41.99 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.203 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -73.07 176.38 9.18 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.564 2.176 . . . . 0.0 112.253 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.6 mtm180 -71.31 -172.36 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.486 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.1 mp -122.57 33.73 5.35 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.712 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.52 142.27 43.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.28 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.443 ' SD ' ' N ' ' A' ' 43' ' ' MET . 2.1 mpt? -102.71 108.72 20.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.499 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.07 -41.62 94.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.63 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.439 ' H ' ' H ' ' A' ' 46' ' ' LEU . . . 178.8 10.15 0.02 OUTLIER Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.439 ' H ' ' H ' ' A' ' 45' ' ' GLY . 1.6 mp -89.17 -43.73 10.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.524 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.19 35.55 12.19 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.657 HD23 ' N ' ' A' ' 49' ' ' ALA . 0.8 OUTLIER -150.04 -40.78 0.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.793 0.33 . . . . 0.0 110.456 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.657 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.456 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -153.74 84.31 1.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.698 0.285 . . . . 0.0 110.527 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -177.56 20.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.617 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.574 ' N ' ' CD ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -111.35 -37.87 5.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.371 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.425 ' O ' ' O ' ' A' ' 4' ' ' LYS . 2.9 p -45.54 -96.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.656 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.4 pp -112.99 -174.36 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.272 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -106.63 -5.19 18.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.456 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.504 ' NZ ' ' O ' ' A' ' 12' ' ' ARG . 4.9 pttt -111.84 -119.73 0.29 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.561 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 23.9 p-10 -173.72 -42.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.45 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.469 ' CZ ' ' O ' ' A' ' 22' ' ' ARG . 69.0 m-85 -140.98 165.36 27.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.757 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 105.58 -152.58 17.2 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.244 -0.743 . . . . 0.0 111.244 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.504 ' O ' ' NZ ' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -37.42 130.31 0.96 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.848 0.356 . . . . 0.0 111.022 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.586 ' SG ' ' N ' ' A' ' 14' ' ' LYS . 0.8 OUTLIER -160.28 157.58 28.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.606 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.586 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 8.3 tttm -156.7 108.67 2.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.382 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 33.1 m95 -48.97 -27.3 3.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.623 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.12 -31.7 16.42 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.96 -104.38 2.07 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.0 p -90.22 144.02 30.48 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.597 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.1 -160.43 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.287 1.992 . . . . 0.0 111.956 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 12.8 t -160.98 90.45 0.83 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.933 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -49.81 -83.01 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.817 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.469 ' O ' ' CZ ' ' A' ' 10' ' ' TYR . 1.1 mpt_? -78.41 101.33 7.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.839 0.352 . . . . 0.0 110.431 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.493 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 112.83 116.45 3.4 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.421 ' C ' ' H ' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -110.91 4.81 20.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.782 0.325 . . . . 0.0 110.363 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.6 40.93 1.15 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 56.2 m -71.73 88.88 1.0 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.786 0.327 . . . . 0.0 110.296 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.3 tt -115.54 156.81 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.545 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.629 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.5 OUTLIER -137.45 -172.47 3.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.829 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 31' ' ' MET . 1.6 t -98.55 161.01 13.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.553 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.3 tp -42.19 -24.57 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.445 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.44 ' N ' ' O ' ' A' ' 29' ' ' SER . 2.8 mtt -81.66 -47.37 13.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.507 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.18 50.59 1.72 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.819 -0.913 . . . . 0.0 110.819 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.621 HG23 ' N ' ' A' ' 34' ' ' ASN . 8.9 t -131.15 -49.54 1.01 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.769 0.319 . . . . 0.0 110.659 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.621 ' N ' HG23 ' A' ' 33' ' ' THR . 72.0 m-80 -77.12 46.27 0.48 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.443 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.629 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 7.9 m -75.86 121.4 22.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.671 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -135.42 155.7 50.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.004 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 1.2 t -98.75 114.73 27.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.257 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -113.44 146.81 36.14 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.547 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -70.56 -162.84 0.1 Allowed 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.384 2.056 . . . . 0.0 112.147 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -101.96 170.42 8.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.5 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.9 mp -51.25 123.06 8.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.641 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -88.37 -50.69 13.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.606 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 20.7 mtm -137.82 131.21 30.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.54 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -63.04 -106.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.542 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -103.67 -18.02 15.4 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.463 ' H ' HD12 ' A' ' 46' ' ' LEU . 2.1 mp -91.67 173.1 8.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.663 0.268 . . . . 0.0 110.589 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -118.29 63.02 0.43 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -153.78 -41.21 0.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.856 0.36 . . . . 0.0 110.472 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.655 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.419 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.475 ' NZ ' ' NH1' ' A' ' 22' ' ' ARG . 1.5 mmmp? 53.76 15.52 0.82 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 121.089 -0.245 . . . . 0.0 110.587 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.6 mmtm -119.05 28.85 8.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.631 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.32 -28.75 38.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.371 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.72 -100.54 0.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.135 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.785 HD13 ' H ' ' A' ' 9' ' ' ASP . 2.4 pp -135.23 -167.65 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.376 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -127.56 -17.56 4.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.752 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.497 ' CD ' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -61.42 -42.48 98.81 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.856 -0.337 . . . . 0.0 110.289 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.785 ' H ' HD13 ' A' ' 6' ' ' ILE . 15.5 m-20 61.18 135.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.83 0.348 . . . . 0.0 110.108 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 9' ' ' ASP . 15.2 m-85 49.99 176.35 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.529 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.521 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 83.21 -153.52 30.7 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -42.48 143.73 0.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.816 0.341 . . . . 0.0 110.82 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 36' ' ' GLU . 28.9 p -147.33 168.91 20.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.526 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -160.72 104.88 1.39 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.287 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -53.75 -19.16 3.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.37 . . . . 0.0 110.744 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.55 -8.54 52.16 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -147.72 -112.62 0.7 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.9 p -38.84 101.88 0.24 Allowed Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 110.453 -0.202 . . . . 0.0 110.453 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -79.1 -22.88 8.19 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.195 1.93 . . . . 0.0 112.567 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' A' ' 21' ' ' CYS . 0.4 OUTLIER 66.17 91.05 0.09 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.565 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 6' ' ' ILE . 89.3 m -36.25 -73.08 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.521 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.475 ' NH1' ' NZ ' ' A' ' 2' ' ' LYS . 1.6 mpt_? -94.66 125.34 39.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.491 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.7 100.9 2.62 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -96.16 -2.22 46.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.745 0.307 . . . . 0.0 110.482 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' A' ' 38' ' ' LYS . . . -68.4 64.26 0.41 Allowed Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 47.1 t -85.39 71.23 10.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.288 0.566 . . . . 0.0 110.452 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.6 tt -86.27 145.56 7.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.754 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.572 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -126.93 166.17 18.02 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.965 -179.833 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.0 168.75 18.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.656 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -54.38 -26.86 16.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.674 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.2 mtm -85.14 -41.19 15.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.463 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 106.64 59.91 0.59 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.0 t -142.25 -30.43 0.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.336 . . . . 0.0 110.576 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -84.5 46.34 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.367 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.572 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 23.5 m -75.26 110.97 10.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.655 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.591 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 9.4 mt-10 -143.21 136.64 28.31 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.462 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' A' ' 11' ' ' GLY . 0.5 OUTLIER -74.26 120.65 20.12 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.429 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 25' ' ' GLY . 0.7 OUTLIER -101.53 146.91 33.05 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.387 -179.594 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -68.91 163.54 37.09 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.452 2.101 . . . . 0.0 112.198 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.547 ' HE ' HD13 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -140.22 -176.84 4.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.602 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 41' ' ' LEU . 10.8 mp -97.83 76.04 2.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.458 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.547 HD13 ' HE ' ' A' ' 40' ' ' ARG . 1.4 tp -69.55 152.06 9.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.611 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.536 ' N ' ' SD ' ' A' ' 43' ' ' MET . 1.2 mpt? -43.38 166.24 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.573 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -48.33 -14.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.585 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.451 ' N ' ' C ' ' A' ' 43' ' ' MET . . . 171.89 -45.6 0.18 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.408 ' O ' ' CB ' ' A' ' 43' ' ' MET . 1.6 mp -106.34 128.88 54.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.776 0.322 . . . . 0.0 110.351 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.53 59.28 1.61 Allowed Glycine 0 CA--C 1.52 0.357 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.642 ' C ' HD23 ' A' ' 48' ' ' LEU . 0.9 OUTLIER -121.6 -39.39 2.65 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.855 0.36 . . . . 0.0 110.491 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.64 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.459 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.6 ptpt -141.8 -89.88 0.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.766 0.317 . . . . 0.0 110.597 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -164.03 -159.57 0.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.66 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 0.1 OUTLIER -82.76 -171.03 3.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.53 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 4' ' ' LYS . 0.5 OUTLIER 77.77 171.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.473 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.675 HG23 ' O ' ' A' ' 19' ' ' PRO . 2.6 pp -51.34 -172.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.969 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -149.26 63.45 1.03 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.628 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.408 ' H ' ' H ' ' A' ' 9' ' ' ASP . 39.3 pttt -169.11 -13.72 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.779 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.513 ' H ' HD13 ' A' ' 6' ' ' ILE . 2.7 m-20 65.04 127.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.41 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.411 ' O ' ' O ' ' A' ' 9' ' ' ASP . 18.9 m-85 50.0 178.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.563 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.95 -109.82 2.77 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.7 ttp85 -114.76 137.97 51.29 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.811 0.339 . . . . 0.0 110.403 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.2 p -143.01 178.3 7.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.658 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -157.18 116.97 3.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.988 0.423 . . . . 0.0 110.689 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.522 ' NE1' ' SG ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -51.19 139.36 18.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.363 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.88 -37.17 0.62 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.492 ' H ' ' C ' ' A' ' 15' ' ' TRP . . . -93.19 -145.0 16.01 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 17' ' ' GLY . 31.2 p -36.02 95.66 0.09 OUTLIER Pre-proline 0 CA--C 1.536 0.405 0 O-C-N 123.579 0.223 . . . . 0.0 110.696 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.675 ' O ' HG23 ' A' ' 6' ' ' ILE . 24.5 Cg_exo -61.87 156.88 46.17 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.105 1.87 . . . . 0.0 112.023 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -111.82 102.49 10.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.375 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -50.35 -71.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.544 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.9 mmp_? -104.25 107.77 18.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.273 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.47 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 133.68 77.83 0.11 Allowed Glycine 0 CA--C 1.52 0.381 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -79.39 5.37 12.78 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 120.934 0.397 . . . . 0.0 110.512 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.88 66.88 0.92 Allowed Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.497 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 19.2 m -97.26 102.78 14.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.0 0.428 . . . . 0.0 110.643 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.2 tt -109.31 157.08 9.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.802 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.52 175.92 8.89 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.681 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.2 166.81 14.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.645 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.492 HG23 ' HG2' ' A' ' 31' ' ' MET . 4.6 tp -47.29 -27.48 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.904 0.383 . . . . 0.0 110.623 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.492 ' HG2' HG23 ' A' ' 30' ' ' ILE . 1.3 mtt -89.5 -46.07 8.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.589 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.92 68.93 1.01 Allowed Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -146.23 -12.15 0.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.714 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -118.05 40.62 3.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.378 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.522 ' SG ' ' NE1' ' A' ' 15' ' ' TRP . 3.6 m -56.14 105.82 0.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.739 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -103.67 134.88 46.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.661 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.497 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 4.3 t -84.78 97.09 9.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.215 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -97.53 148.75 34.89 Favored Pre-proline 0 C--O 1.235 0.341 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.971 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -39.56 -66.55 0.13 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 122.482 2.121 . . . . 0.0 112.407 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.6 ptp85 -135.9 -167.86 2.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.59 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.685 ' N ' HD12 ' A' ' 41' ' ' LEU . 8.1 mp -88.38 -173.51 4.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.552 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.6 tp -68.49 -19.45 24.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.442 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.51 ' N ' ' SD ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -52.13 143.13 14.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.581 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -75.26 38.1 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.525 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 43' ' ' MET . . . 73.51 66.64 1.96 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.726 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.9 mp 39.46 55.44 2.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.816 0.341 . . . . 0.0 110.735 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.53 -28.22 0.23 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.643 ' C ' HD23 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -103.8 -39.76 6.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.711 0.291 . . . . 0.0 110.507 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.618 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.505 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt 47.56 -168.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 0.0 110.605 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.46 169.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.557 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.455 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 0.5 OUTLIER -81.2 -80.82 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.531 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 4' ' ' LYS . 7.2 p 35.87 -110.4 0.06 Allowed 'General case' 0 N--CA 1.461 0.083 0 O-C-N 123.253 0.346 . . . . 0.0 110.817 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.436 ' N ' ' SG ' ' A' ' 5' ' ' CYS . 2.2 pp -129.62 176.23 8.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.512 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.44 -19.0 10.28 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.017 0.437 . . . . 0.0 110.488 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -89.54 58.39 4.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.925 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 10' ' ' TYR . 1.1 m-20 -36.62 133.9 0.52 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.782 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 9' ' ' ASP . 88.3 m-85 56.51 158.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.512 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.05 -105.25 1.21 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -99.46 144.72 28.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.901 0.382 . . . . 0.0 110.853 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -158.35 141.97 15.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.553 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.1 tptm -147.71 120.94 8.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.485 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.93 -17.97 62.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.445 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.73 9.72 34.81 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -134.85 -113.23 1.32 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 p -88.78 151.36 47.44 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.473 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.07 -159.86 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.394 2.063 . . . . 0.0 112.017 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.6 t -160.93 81.72 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.221 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -39.45 -68.82 0.15 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.803 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.8 mtt-85 -104.7 88.0 2.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.606 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.491 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 157.4 94.95 0.1 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.61 -7.79 27.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.71 0.291 . . . . 0.0 110.554 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.89 53.55 4.26 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.567 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 91.8 m -75.98 93.72 3.3 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.1 tt -104.35 149.3 8.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.143 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.2 OUTLIER -134.52 -179.36 5.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.795 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.88 172.59 8.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.293 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.423 HG23 ' HG2' ' A' ' 31' ' ' MET . 7.3 tp -55.2 -24.88 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.725 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.423 ' HG2' HG23 ' A' ' 30' ' ' ILE . 3.9 mtp -87.89 -16.81 32.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.617 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.42 64.5 3.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.6 t -140.77 -33.66 0.53 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.78 0.324 . . . . 0.0 110.533 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -95.71 47.58 1.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.331 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.623 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 59.4 m -69.79 107.91 3.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.728 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -111.66 146.66 37.08 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.055 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.567 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -94.44 116.41 28.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.557 179.712 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.431 ' CB ' ' CD ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -126.85 179.46 1.2 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.562 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' A' ' 38' ' ' LYS . 22.1 Cg_exo -62.16 -148.4 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.483 2.122 . . . . 0.0 112.028 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -101.61 -179.09 3.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.506 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.6 mp -49.95 -67.67 0.24 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.544 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 pt -74.15 152.3 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.567 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 10.1 mtt -66.88 139.15 57.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.55 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -65.02 -23.82 67.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.634 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 161.08 -38.29 0.42 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mp -97.67 156.02 16.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.73 0.3 . . . . 0.0 110.571 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.4 45.2 2.57 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.663 HD23 ' N ' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -88.47 -40.2 13.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.808 0.337 . . . . 0.0 110.378 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.663 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.605 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.3 mttp 50.54 90.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.732 0.301 . . . . 0.0 110.668 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -106.66 5.6 29.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.55 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.501 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -105.39 -165.21 1.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.486 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 4' ' ' LYS . 11.5 p 37.21 -119.56 0.17 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.631 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.656 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 1.1 pp -108.43 0.83 9.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.772 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.656 ' HB3' ' O ' ' A' ' 6' ' ' ILE . . . 79.27 -61.95 0.31 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.514 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -65.55 -164.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.542 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -139.53 133.33 30.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.354 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 52.38 178.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.622 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 109.14 -123.99 7.13 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.446 ' NH1' ' O ' ' A' ' 33' ' ' THR . 3.9 tpt180 -98.31 146.94 25.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.64 0.257 . . . . 0.0 110.551 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.455 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 3.7 p -145.89 175.71 10.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.478 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 17' ' ' GLY . 24.9 tttm -151.51 96.73 2.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.334 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -45.87 -21.62 0.14 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.76 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.76 36.28 4.33 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 14' ' ' LYS . . . 169.43 -124.72 1.18 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 19' ' ' PRO . 71.6 p -37.28 100.01 0.19 Allowed Pre-proline 0 N--CA 1.464 0.269 0 O-C-N 123.443 0.143 . . . . 0.0 110.84 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 18' ' ' THR . 39.6 Cg_exo -54.32 -145.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.529 2.152 . . . . 0.0 112.516 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.98 90.31 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.201 0.524 . . . . 0.0 110.709 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -45.68 -79.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.423 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 -95.04 126.73 40.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.358 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.499 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 99.88 82.02 1.64 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.49 ' CD ' ' H ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -85.76 11.88 10.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.637 0.256 . . . . 0.0 110.603 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.96 49.74 4.29 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.8 t -81.46 103.42 11.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.923 0.392 . . . . 0.0 110.913 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.7 tt -113.77 148.18 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.288 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -129.71 161.65 30.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.77 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.51 165.68 14.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.746 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 tp -52.3 -28.44 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.635 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.6 mtt -83.49 -40.64 18.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.76 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.41 62.97 0.73 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.446 ' O ' ' NH1' ' A' ' 12' ' ' ARG . 3.5 t -143.51 -24.36 0.59 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.762 0.315 . . . . 0.0 110.746 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -98.74 54.44 1.03 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.429 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.612 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 60.4 m -77.68 94.97 4.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.391 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -110.2 138.0 47.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.785 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -92.8 118.73 31.41 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.679 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -127.84 150.64 73.94 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.754 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.29 175.17 4.28 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.554 2.17 . . . . 0.0 112.106 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -90.96 -133.67 0.12 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.426 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 mp -133.93 -173.5 3.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.49 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.44 -53.91 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.559 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 11.0 mtt -46.69 151.69 0.56 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.497 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -90.21 -8.1 51.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.619 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 156.21 -42.33 0.56 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.459 ' H ' HD12 ' A' ' 46' ' ' LEU . 0.8 OUTLIER -99.55 174.81 6.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.786 0.327 . . . . 0.0 110.571 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.54 57.9 1.14 Allowed Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.628 ' C ' HD23 ' A' ' 48' ' ' LEU . 1.2 tt -129.18 -40.18 1.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.791 0.329 . . . . 0.0 110.515 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.593 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.584 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.2 tttt 54.46 39.0 30.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.824 0.345 . . . . 0.0 110.586 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -92.05 58.68 3.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.55 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 0.3 OUTLIER -132.59 -129.56 0.18 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.54 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 4' ' ' LYS . 5.7 p 37.87 -119.2 0.2 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.665 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.662 HD12 ' N ' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -101.24 -13.73 8.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.664 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.662 ' N ' HD12 ' A' ' 6' ' ' ILE . . . 71.4 -55.45 0.65 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.868 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 10' ' ' TYR . 9.3 pttt -52.86 -4.51 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.815 0.34 . . . . 0.0 111.188 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.543 ' H ' ' C ' ' A' ' 7' ' ' ALA . 26.8 t0 63.44 -75.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.503 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.534 ' CE1' ' OD1' ' A' ' 9' ' ' ASP . 82.9 m-85 -115.92 159.52 21.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.586 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 134.57 -154.94 21.68 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.484 ' NH1' HG21 ' A' ' 18' ' ' THR . 0.0 OUTLIER -55.57 117.18 3.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.589 0.233 . . . . 0.0 110.796 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.604 ' SG ' ' N ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -119.02 168.57 10.69 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.711 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.604 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -141.58 96.09 2.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.484 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -54.95 120.36 6.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.956 0.408 . . . . 0.0 110.443 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.83 -20.64 49.9 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -103.32 -68.81 0.79 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.484 HG21 ' NH1' ' A' ' 12' ' ' ARG . 44.2 p -89.89 144.52 31.65 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.777 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.41 -18.25 18.03 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.156 1.904 . . . . 0.0 112.342 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.2 t 47.41 90.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.341 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -39.4 -86.0 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.878 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.517 ' O ' ' CZ ' ' A' ' 10' ' ' TYR . 41.0 mtm180 -109.14 106.55 16.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.9 0.381 . . . . 0.0 110.386 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.509 ' H ' ' NH1' ' A' ' 24' ' ' ARG . . . 155.5 70.87 0.01 OUTLIER Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.514 ' CZ ' ' H ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -80.67 6.09 13.76 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.537 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -103.74 55.19 0.63 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.0 t -83.13 109.29 17.04 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.06 0.457 . . . . 0.0 110.683 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.3 tt -109.84 143.93 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.409 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.9 m -125.05 167.58 14.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.745 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.41 178.7 1.48 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.58 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 tp -61.32 -28.85 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.69 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.9 mtt -84.64 -35.98 22.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.544 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.39 62.51 0.77 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.447 HG23 ' N ' ' A' ' 34' ' ' ASN . 8.9 t -142.63 -38.59 0.36 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.776 0.322 . . . . 0.0 110.615 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.447 ' N ' HG23 ' A' ' 33' ' ' THR . 4.1 t-20 -79.64 49.68 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.534 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.9 m -72.71 123.71 23.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.644 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -138.17 121.02 16.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.898 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.507 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -70.14 115.1 8.95 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.338 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -125.27 149.89 65.51 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.716 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 40' ' ' ARG . 40.5 Cg_endo -68.61 -164.93 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.599 2.2 . . . . 0.0 112.09 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.484 ' C ' ' H ' ' A' ' 42' ' ' ILE . 85.9 mtt180 -46.08 172.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.536 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.593 ' N ' HD12 ' A' ' 41' ' ' LEU . 9.7 mp -72.21 16.02 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.532 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.484 ' H ' ' C ' ' A' ' 40' ' ' ARG . 1.6 tp -49.66 142.62 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.575 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.466 ' C ' ' N ' ' A' ' 45' ' ' GLY . 1.7 mpt? -95.46 127.52 41.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.613 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -47.9 -13.88 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.563 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.466 ' N ' ' C ' ' A' ' 43' ' ' MET . . . -172.2 -70.45 0.04 OUTLIER Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.967 ' H ' HD12 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -119.61 -62.56 1.48 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.736 0.303 . . . . 0.0 110.535 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.44 43.86 0.23 Allowed Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.623 ' C ' HD23 ' A' ' 48' ' ' LEU . 0.9 OUTLIER -94.88 -39.94 9.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.738 0.304 . . . . 0.0 110.535 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.623 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.633 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt -59.51 141.81 53.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.863 0.363 . . . . 0.0 110.626 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.4 ' H ' ' HG2' ' A' ' 3' ' ' LYS . 0.5 OUTLIER -82.82 133.6 35.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.56 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.508 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 0.4 OUTLIER -79.81 -112.16 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.212 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 4' ' ' LYS . 11.2 p 37.48 -121.61 0.21 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.633 0.254 . . . . 0.0 110.735 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.574 ' CD1' ' H ' ' A' ' 9' ' ' ASP . 1.8 pp -129.61 -170.71 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.27 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.15 -30.78 5.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.437 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.456 ' O ' ' CB ' ' A' ' 9' ' ' ASP . 8.5 mtmt -43.71 -67.06 0.31 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.6 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.574 ' H ' ' CD1' ' A' ' 6' ' ' ILE . 6.9 t0 78.82 117.35 0.06 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.48 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.562 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 42.4 m-85 53.76 168.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.468 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 100.21 -127.69 9.33 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.1 ttt-85 -72.41 140.6 48.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.838 0.351 . . . . 0.0 110.615 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.617 ' SG ' ' N ' ' A' ' 14' ' ' LYS . 0.7 OUTLIER -152.08 158.93 43.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.653 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.617 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 6.9 mttt -157.65 123.83 4.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.241 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.528 ' CZ2' ' SG ' ' A' ' 28' ' ' CYS . 1.0 OUTLIER -52.47 -24.87 8.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.582 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -112.34 14.08 25.59 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.07 -117.15 2.07 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.9 p -90.2 141.19 27.51 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.762 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 20' ' ' CYS . 58.9 Cg_endo -74.0 -32.69 6.8 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.554 2.17 . . . . 0.0 112.273 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.602 ' O ' ' N ' ' A' ' 22' ' ' ARG . 1.6 t 80.73 27.39 0.24 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.6 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.1 t 34.4 -84.1 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.608 0.567 . . . . 0.0 111.431 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.602 ' N ' ' O ' ' A' ' 20' ' ' CYS . 76.2 mtt180 -99.93 122.77 43.35 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.698 ' H ' ' HE ' ' A' ' 24' ' ' ARG . . . 130.06 79.43 0.21 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.698 ' HE ' ' H ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -79.51 1.05 27.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.76 0.314 . . . . 0.0 110.421 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -75.86 35.27 1.23 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.446 ' H ' ' C ' ' A' ' 24' ' ' ARG . 20.4 m -67.17 82.78 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.775 0.321 . . . . 0.0 110.593 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.3 tt -122.21 153.55 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.535 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.528 ' SG ' ' CZ2' ' A' ' 15' ' ' TRP . 6.6 m -118.75 165.84 13.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.771 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.7 170.48 7.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.403 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 30' ' ' ILE . 10.3 tp -54.12 -25.72 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.817 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.4 mtt -81.19 -37.39 28.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.646 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.68 58.48 0.94 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.5 t -148.76 -32.33 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 0.0 110.609 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -81.16 50.46 1.42 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.51 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.0 m -74.81 110.48 9.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.783 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -138.7 149.47 45.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.741 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.415 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.7 OUTLIER -89.73 107.28 19.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.117 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -97.28 148.05 33.85 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.555 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 40' ' ' ARG . 52.8 Cg_endo -69.55 -91.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.251 1.967 . . . . 0.0 112.114 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.472 ' O ' ' O ' ' A' ' 39' ' ' PRO . 5.9 mtt180 47.57 103.4 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.561 0.696 . . . . 0.0 110.578 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.911 ' H ' HD12 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -137.44 134.05 35.4 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.853 -179.656 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.4 tp -47.67 145.59 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.701 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.459 ' SD ' ' HB2' ' A' ' 49' ' ' ALA . 9.3 ptt? -75.25 130.6 39.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.615 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -89.32 -18.82 26.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.579 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 131.72 -24.51 4.09 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 mp -114.03 -2.85 13.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.786 0.327 . . . . 0.0 110.656 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.82 -64.24 1.98 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.654 HD23 ' N ' ' A' ' 49' ' ' ALA . 0.9 OUTLIER -130.17 -40.75 1.29 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.843 0.354 . . . . 0.0 110.354 179.771 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.654 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.439 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -87.27 -176.56 5.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.85 0.357 . . . . 0.0 110.465 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.47 156.66 37.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.405 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -79.22 -65.57 0.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.465 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.444 ' SG ' ' C ' ' A' ' 4' ' ' LYS . 0.1 OUTLIER 33.68 -88.72 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 O-C-N 123.741 0.651 . . . . 0.0 111.161 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.642 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 2.0 pp -133.71 1.43 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 0.0 110.006 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 6' ' ' ILE . . . 82.52 -62.41 0.14 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.067 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -60.73 -140.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.5 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 10' ' ' TYR . 11.8 m-20 -140.39 -149.97 0.3 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.533 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.423 ' O ' ' O ' ' A' ' 9' ' ' ASP . 9.5 m-85 -40.95 163.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.529 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.543 ' N ' ' SG ' ' A' ' 37' ' ' CYS . . . 138.51 -138.95 9.86 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -79.92 127.44 32.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.679 0.276 . . . . 0.0 110.706 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.3 p -134.81 -172.18 2.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.597 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -160.01 115.66 2.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.354 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 32.3 m95 -57.7 -12.9 3.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.507 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -134.81 31.84 2.68 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.1 -133.64 1.81 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 14' ' ' LYS . 63.4 p -39.82 104.59 0.33 Allowed Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -79.02 -163.93 0.25 Allowed 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.958 1.772 . . . . 0.0 112.429 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -153.4 105.06 2.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.867 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.8 m -38.15 -75.36 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.682 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 mtp85 -95.75 120.94 36.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.415 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.703 ' H ' HH11 ' A' ' 24' ' ' ARG . . . 122.72 92.85 1.12 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.703 HH11 ' H ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -88.39 -8.37 55.13 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.742 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.44 66.85 3.85 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.3 m -81.78 80.72 8.02 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.28 0.562 . . . . 0.0 110.229 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.2 tt -80.65 139.18 18.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.495 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.604 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -132.27 175.94 8.83 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.819 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.65 169.49 15.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.528 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.4 tp -53.45 -24.91 9.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.655 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.2 mtm -92.16 -35.61 13.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.574 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.26 56.98 0.86 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 t -131.95 -33.54 1.35 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.798 0.332 . . . . 0.0 110.524 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -86.49 42.52 1.01 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.344 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.604 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 45.6 m -69.2 120.11 14.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.585 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -142.54 129.11 20.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.882 0.373 . . . . 0.0 111.057 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' N ' ' A' ' 11' ' ' GLY . 0.8 OUTLIER -80.15 127.47 32.37 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.522 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -137.29 149.7 66.56 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.402 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.3 -168.75 0.22 Allowed 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.308 2.005 . . . . 0.0 112.211 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.559 ' C ' HD12 ' A' ' 41' ' ' LEU . 33.4 ptt85 -162.13 130.46 4.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.567 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.559 HD12 ' C ' ' A' ' 40' ' ' ARG . 10.9 mp -109.6 103.61 12.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.462 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.735 ' H ' HD13 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -144.61 -171.34 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.643 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -127.79 141.58 51.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.504 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.39 -11.75 61.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.586 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 136.49 -21.03 3.46 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.677 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.3 mp -58.82 -113.26 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.74 0.305 . . . . 0.0 110.623 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -179.7 30.93 0.06 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.657 HD23 ' N ' ' A' ' 49' ' ' ALA . 0.9 OUTLIER -147.37 -41.1 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.729 0.299 . . . . 0.0 110.567 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.657 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.582 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.9 mtmm 55.6 60.43 3.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.771 0.32 . . . . 0.0 110.549 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -100.77 -2.47 32.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.673 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -91.61 -40.47 11.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.531 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.428 ' O ' ' O ' ' A' ' 6' ' ' ILE . 7.2 p -54.15 -172.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.399 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.478 HG13 ' H ' ' A' ' 21' ' ' CYS . 2.1 pp -50.02 -178.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.331 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 6' ' ' ILE . . . -35.59 -89.94 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.872 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.445 ' O ' ' CB ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -175.7 73.28 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 120.9 0.381 . . . . 0.0 110.371 179.669 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.47 ' C ' ' CD1' ' A' ' 10' ' ' TYR . 0.8 OUTLIER 162.38 -109.33 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.997 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.552 ' CZ ' ' O ' ' A' ' 22' ' ' ARG . 43.6 m-85 -142.48 -162.4 1.41 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.199 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 118.42 -119.9 4.52 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.03 151.32 21.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.717 0.294 . . . . 0.0 110.554 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.568 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 1.5 t -123.05 179.96 4.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.334 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -160.12 91.89 0.97 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.428 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.402 ' C ' ' N ' ' A' ' 17' ' ' GLY . 4.9 m0 -49.51 -81.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.451 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.77 -14.68 1.11 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.402 ' N ' ' C ' ' A' ' 15' ' ' TRP . . . -95.07 -134.4 7.65 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.18 152.75 48.36 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.592 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.54 178.34 6.83 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.319 2.013 . . . . 0.0 112.364 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.568 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -102.78 127.54 49.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.388 179.635 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.478 ' H ' HG13 ' A' ' 6' ' ' ILE . 59.8 m -50.85 -97.2 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.916 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.552 ' O ' ' CZ ' ' A' ' 10' ' ' TYR . 4.7 mtt180 -83.65 24.8 0.83 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.428 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.91 151.13 17.7 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.95 -14.34 0.53 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.796 0.331 . . . . 0.0 110.701 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.26 47.75 3.89 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 95.4 m -77.19 105.86 8.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.723 0.297 . . . . 0.0 110.633 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.3 tt -119.36 145.73 25.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.293 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.9 m -131.8 -178.6 4.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.759 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.83 168.75 15.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.652 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.5 tp -49.64 -25.56 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.578 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.5 mtt -86.93 -47.41 9.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.484 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.66 57.03 0.75 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.0 t -136.12 -24.78 1.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.749 0.309 . . . . 0.0 110.522 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -101.44 50.89 0.85 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.383 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 97.7 m -68.63 122.81 19.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.806 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -119.77 127.87 53.21 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.079 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.512 ' N ' ' O ' ' A' ' 11' ' ' GLY . 6.1 t -84.82 97.45 9.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.363 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.4 mtmt -107.96 147.0 34.62 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.743 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.88 -167.96 0.26 Allowed 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.371 2.047 . . . . 0.0 112.084 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -62.35 152.09 34.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.6 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.5 mp -87.5 -179.98 6.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.517 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.2 tp -76.49 145.04 10.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.511 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 27.5 mtt -81.1 104.65 11.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.523 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.45 -27.96 20.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.509 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.43 -99.27 0.71 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.409 HD12 ' H ' ' A' ' 46' ' ' LEU . 1.0 OUTLIER -115.51 -67.38 1.0 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.821 0.343 . . . . 0.0 110.577 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -172.6 37.94 0.15 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.64 HD23 ' N ' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -96.64 -41.26 8.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.868 0.366 . . . . 0.0 110.513 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.64 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.52 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.6 tptm 63.41 1.95 1.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.778 0.323 . . . . 0.0 110.644 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.36 -4.88 41.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.604 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.408 ' O ' ' O ' ' A' ' 5' ' ' CYS . 6.1 ttpt -79.36 -55.71 4.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.484 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.408 ' O ' ' O ' ' A' ' 4' ' ' LYS . 4.7 p -47.09 174.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.218 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.838 HD12 ' N ' ' A' ' 7' ' ' ALA . 2.5 pp -54.92 -25.78 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.015 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.838 ' N ' HD12 ' A' ' 6' ' ' ILE . . . 66.82 -36.6 0.27 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.52 ' H ' ' C ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -72.57 15.74 0.17 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 122.119 0.961 . . . . 0.0 110.726 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.508 ' H ' ' C ' ' A' ' 7' ' ' ALA . 2.9 p-10 42.95 -110.39 0.15 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.924 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.491 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.4 m-30 -77.4 126.65 31.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.218 -178.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 159.04 -96.55 0.15 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.9 ttt85 -110.77 146.42 36.39 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.785 0.326 . . . . 0.0 110.752 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -158.03 143.75 17.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.617 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.579 ' NZ ' ' SG ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -137.34 126.01 23.81 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.997 0.427 . . . . 0.0 110.629 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.427 ' HE1' ' HB2' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -71.94 -28.13 63.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.541 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.62 -6.85 57.16 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.75 -115.61 3.22 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.3 p -90.21 142.81 28.83 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.567 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.67 167.47 27.17 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.182 1.922 . . . . 0.0 112.396 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 1.5 t -103.48 107.18 17.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.958 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.31 -72.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.529 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.402 ' HE ' ' HB3' ' A' ' 9' ' ' ASP . 7.8 mtm-85 -100.08 122.57 43.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.486 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 82.26 109.78 0.43 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.705 ' HE ' ' N ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -102.88 19.34 19.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.661 0.267 . . . . 0.0 110.649 -179.952 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.02 53.48 4.75 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.561 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 38.0 m -73.97 113.29 10.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.992 0.425 . . . . 0.0 110.501 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.0 tt -126.11 148.03 30.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.084 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.555 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -126.16 168.17 14.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.577 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 31' ' ' MET . 4.3 m -77.44 157.38 30.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.569 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -42.19 -24.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.847 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.431 ' N ' ' O ' ' A' ' 29' ' ' SER . 1.2 mtp -88.28 -50.92 6.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.757 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.83 63.72 0.53 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.6 t -145.04 -17.52 0.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.779 0.323 . . . . 0.0 110.302 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -107.74 51.07 0.75 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.171 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.579 ' SG ' ' NZ ' ' A' ' 14' ' ' LYS . 31.3 m -73.39 86.22 1.5 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.23 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -102.16 152.2 21.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.449 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.561 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -98.98 120.87 40.15 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.616 179.304 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -129.54 159.65 68.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.427 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 38' ' ' LYS . 50.9 Cg_exo -46.05 -178.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.352 2.035 . . . . 0.0 112.21 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.69 -176.02 4.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.461 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.436 ' H ' HD12 ' A' ' 41' ' ' LEU . 2.7 mp -65.96 166.79 10.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.988 0.423 . . . . 0.0 110.43 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.554 ' N ' HD13 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -52.09 -171.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.808 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.409 ' C ' ' H ' ' A' ' 45' ' ' GLY . 8.4 ptt? -139.71 -19.7 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.552 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -78.76 33.18 0.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.553 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 43' ' ' MET . . . -145.43 -45.22 0.04 OUTLIER Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.654 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.5 mp -56.47 -24.02 43.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.756 0.312 . . . . 0.0 110.505 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.2 25.26 9.01 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.659 HD23 ' N ' ' A' ' 49' ' ' ALA . 1.1 tt -88.46 -42.09 12.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.713 0.292 . . . . 0.0 110.451 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.659 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.957 -1.021 . . . . 0.0 110.566 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.803 ' HZ3' HH11 ' A' ' 22' ' ' ARG . 21.1 tptp -171.06 90.49 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.788 0.327 . . . . 0.0 110.611 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.1 mttp 46.09 -160.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.452 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 5' ' ' CYS . 3.6 tmtt? -106.96 -39.81 5.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.369 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.447 ' O ' ' O ' ' A' ' 4' ' ' LYS . 4.6 p -46.33 -99.43 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.003 0.43 . . . . 0.0 110.722 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.419 ' N ' ' SG ' ' A' ' 5' ' ' CYS . 1.1 pp -139.26 -172.16 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.446 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.44 -30.19 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.774 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.717 ' H ' ' CD ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -51.7 -42.33 62.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.431 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 10' ' ' TYR . 4.8 m-20 58.92 125.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.47 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 9' ' ' ASP . 66.5 m-85 55.97 160.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.854 0.359 . . . . 0.0 110.795 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.18 -152.04 21.93 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.415 ' N ' ' OE2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -42.24 125.42 3.09 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.657 -0.32 . . . . 0.0 110.944 -179.807 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 2.9 t -154.73 150.46 27.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.649 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.467 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 25.3 tttp -155.88 103.7 2.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.534 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 13.8 m95 -42.05 154.95 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.412 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.46 -47.5 0.71 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.96 -90.79 0.82 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 19' ' ' PRO . 3.9 p -90.19 112.98 55.61 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-O 119.448 -0.31 . . . . 0.0 110.75 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 18' ' ' THR . 52.0 Cg_exo -51.49 -161.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.12 1.88 . . . . 0.0 112.611 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 6.3 t -171.92 61.18 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.475 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -38.22 -42.4 0.68 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.807 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.803 HH11 ' HZ3' ' A' ' 2' ' ' LYS . 26.4 mtt180 -120.36 99.81 6.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.44 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.499 ' O ' ' SG ' ' A' ' 20' ' ' CYS . . . 130.81 91.95 0.59 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -85.47 -12.43 51.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.85 0.357 . . . . 0.0 110.488 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.17 41.84 1.59 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.3 t -81.87 108.58 15.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.03 0.443 . . . . 0.0 110.685 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.8 tt -145.47 152.09 14.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.318 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.647 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 1.0 OUTLIER -129.84 177.1 7.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.699 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.15 165.93 21.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.417 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.437 HG23 ' HG2' ' A' ' 31' ' ' MET . 6.1 tp -51.76 -25.9 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.64 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.437 ' HG2' HG23 ' A' ' 30' ' ' ILE . 4.9 mtt -86.34 -29.8 22.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.633 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.66 62.78 1.59 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -137.4 -36.06 0.66 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.785 0.326 . . . . 0.0 110.688 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -94.76 54.15 1.71 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.183 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.647 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 1.8 m -85.56 114.4 22.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.622 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.415 ' OE2' ' N ' ' A' ' 12' ' ' ARG . 9.2 mm-40 -137.74 154.3 49.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.803 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -98.76 111.3 23.72 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.191 179.356 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -102.06 147.04 33.36 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.643 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.31 -168.14 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.339 2.026 . . . . 0.0 112.325 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.412 HH21 ' HB3' ' A' ' 40' ' ' ARG . 28.9 mtm105 -78.1 -167.94 1.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.53 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 mp -83.57 -47.92 10.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.66 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.6 pp -117.44 156.79 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.553 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.534 ' N ' ' SD ' ' A' ' 43' ' ' MET . 2.2 mpt? -93.12 141.21 28.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.518 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -87.06 123.95 32.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.691 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 46' ' ' LEU . . . 66.83 11.13 57.26 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.736 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.8 mp 43.59 96.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.815 0.341 . . . . 0.0 110.787 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.84 52.95 0.52 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.626 HD23 ' N ' ' A' ' 49' ' ' ALA . 0.8 OUTLIER -157.71 -39.7 0.07 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.665 0.269 . . . . 0.0 110.49 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.626 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--N 1.327 -0.408 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.707 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -132.84 169.7 16.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.88 0.371 . . . . 0.0 110.48 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.6 mttt 55.09 -179.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.501 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.467 ' CG ' ' H ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER -86.18 -105.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.617 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.467 ' H ' ' CG ' ' A' ' 4' ' ' LYS . 35.2 m 38.55 -118.91 0.23 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.497 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.661 ' CD1' ' H ' ' A' ' 9' ' ' ASP . 1.5 pp -106.07 -5.07 9.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.536 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.64 ' N ' HD12 ' A' ' 6' ' ' ILE . . . 73.64 -56.14 0.66 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.639 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 10' ' ' TYR . 30.9 mmtm -49.17 -14.04 0.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.713 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.661 ' H ' ' CD1' ' A' ' 6' ' ' ILE . 19.4 m-20 59.1 -76.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.524 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.538 ' N ' ' O ' ' A' ' 8' ' ' LYS . 52.0 m-85 -108.95 163.68 13.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.505 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.23 -156.67 15.51 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.546 HH12 ' N ' ' A' ' 35' ' ' CYS . 0.2 OUTLIER -39.68 130.66 1.87 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.838 0.351 . . . . 0.0 110.876 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.599 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 26.6 p -157.01 179.17 9.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.587 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -160.64 115.53 2.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.467 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -56.96 -39.63 74.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.762 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -98.91 28.13 16.65 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -147.0 -78.21 0.03 OUTLIER Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.2 p -90.4 148.07 38.12 Favored Pre-proline 0 C--N 1.325 -0.478 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.197 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.64 -31.72 10.42 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.386 2.057 . . . . 0.0 112.422 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 22' ' ' ARG . 17.2 t 58.16 87.26 0.07 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.359 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -37.17 -76.47 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.711 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.402 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -99.81 175.12 5.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.545 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.479 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 50.95 74.87 0.25 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -79.79 10.75 3.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.664 0.269 . . . . 0.0 110.442 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.14 49.84 4.3 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.405 ' SG ' ' C ' ' A' ' 13' ' ' CYS . 5.2 t -68.89 90.77 0.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.949 0.404 . . . . 0.0 110.387 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.2 tt -103.97 147.45 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.405 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 11.3 m -126.79 164.3 21.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.737 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 m -73.18 167.25 21.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.458 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.5 tp -51.55 -28.35 8.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.668 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.6 mtm -80.09 -33.66 38.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.625 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.04 65.22 1.39 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.0 t -150.21 -28.88 0.23 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.768 0.318 . . . . 0.0 110.663 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.426 ' C ' HH12 ' A' ' 12' ' ' ARG . 0.5 OUTLIER -93.85 53.93 1.88 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.446 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.546 ' N ' HH12 ' A' ' 12' ' ' ARG . 72.5 m -75.04 120.27 20.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.681 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.453 ' C ' ' SG ' ' A' ' 13' ' ' CYS . 56.3 mt-10 -135.56 138.42 42.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.62 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.599 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -83.8 105.38 14.66 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.22 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.52 149.69 40.62 Favored Pre-proline 0 C--O 1.236 0.368 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.574 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.85 -85.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.597 2.198 . . . . 0.0 111.975 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -127.81 -120.76 0.24 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.646 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.404 ' N ' HD12 ' A' ' 41' ' ' LEU . 10.9 mp -85.05 126.59 33.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.677 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.7 pt -82.3 -42.56 18.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.528 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 3.6 mtt -68.38 99.75 0.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.503 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -83.53 -24.53 31.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.456 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.61 -102.81 0.3 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.11 -54.15 2.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.783 0.325 . . . . 0.0 110.542 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -176.25 12.69 0.03 OUTLIER Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.638 ' C ' HD23 ' A' ' 48' ' ' LEU . 1.4 tt -101.85 -41.81 6.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.689 0.28 . . . . 0.0 110.593 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.623 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.589 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.93 -76.79 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.834 0.35 . . . . 0.0 110.49 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.1 mmmm -74.41 -163.31 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.339 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.05 -28.89 6.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.349 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.416 ' SG ' ' N ' ' A' ' 6' ' ' ILE . 14.0 p -71.87 -120.71 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.516 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.537 HD12 ' N ' ' A' ' 7' ' ' ALA . 1.7 pp -104.09 1.33 10.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.902 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.537 ' N ' HD12 ' A' ' 6' ' ' ILE . . . 68.6 -64.56 0.31 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.506 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 6' ' ' ILE . 7.7 mmtp -56.61 -164.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.665 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.409 ' O ' ' O ' ' A' ' 10' ' ' TYR . 3.8 p-10 -139.28 127.87 23.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.471 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.409 ' O ' ' O ' ' A' ' 9' ' ' ASP . 79.4 m-85 54.42 167.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.63 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.07 -113.48 1.75 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.42 ' NH1' HG21 ' A' ' 18' ' ' THR . 1.3 ptm180 -108.91 136.96 47.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.667 0.27 . . . . 0.0 110.823 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 5.9 p -143.48 174.75 10.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.995 0.426 . . . . 0.0 110.935 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -160.4 108.14 1.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.385 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.505 ' C ' ' H ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -41.07 -67.41 0.25 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.849 -179.803 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.78 28.55 0.91 Allowed Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 15' ' ' TRP . . . -145.34 -92.95 0.14 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.42 HG21 ' NH1' ' A' ' 12' ' ' ARG . 3.2 p -91.45 144.8 30.2 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.093 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.82 -32.7 7.1 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.128 1.885 . . . . 0.0 112.386 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.1 t 67.55 100.93 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.595 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -58.63 -83.97 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.599 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.4 mmt-85 -84.19 117.32 23.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.597 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.508 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 115.24 89.85 1.64 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -86.37 -24.13 25.9 Favored 'General case' 0 N--CA 1.44 -0.939 0 O-C-N 122.532 -0.393 . . . . 0.0 110.268 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.01 58.46 0.79 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.8 t -87.78 113.06 23.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.871 0.367 . . . . 0.0 110.259 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.1 tt -131.15 156.53 42.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.592 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.635 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.5 OUTLIER -135.73 174.62 10.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.541 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.1 t -79.95 158.41 26.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.441 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -42.96 -32.0 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 120.906 0.384 . . . . 0.0 110.092 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 16.6 mtm -79.31 -43.35 23.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.994 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.01 62.85 0.88 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 t -139.47 -35.02 0.55 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.81 0.338 . . . . 0.0 110.64 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -95.15 50.85 1.29 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.142 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.635 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 31.3 m -75.15 102.34 4.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.533 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -109.88 141.25 42.86 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.15 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.3 OUTLIER -97.09 103.49 15.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.227 179.562 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.89 162.1 47.36 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.436 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.45 -172.95 1.01 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.514 2.143 . . . . 0.0 112.174 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.527 ' H ' HD12 ' A' ' 41' ' ' LEU . 0.4 OUTLIER -142.21 -88.14 0.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.75 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.527 HD12 ' H ' ' A' ' 40' ' ' ARG . 5.4 mp 52.19 170.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.072 0.463 . . . . 0.0 110.62 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.54 ' C ' ' H ' ' A' ' 44' ' ' GLU . 1.8 tp -99.47 165.27 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.386 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.512 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 27.9 ttp 57.1 0.92 0.09 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.83 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.54 ' H ' ' C ' ' A' ' 42' ' ' ILE . 41.5 tt0 -60.27 -55.46 33.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.509 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.81 -34.61 5.91 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 48' ' ' LEU . 0.8 OUTLIER -114.22 -156.15 0.59 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.74 0.305 . . . . 0.0 110.503 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.49 -63.47 0.27 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.641 HD23 ' N ' ' A' ' 49' ' ' ALA . 1.2 tt -159.34 -42.05 0.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.692 0.282 . . . . 0.0 110.433 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.641 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.553 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -55.5 113.23 1.35 Allowed 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 121.119 -0.233 . . . . 0.0 110.495 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 2' ' ' LYS . 10.6 pttm 31.22 -109.74 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.639 0.587 . . . . 0.0 110.944 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.799 ' HZ2' ' H ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -140.65 -45.29 0.4 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.512 179.486 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.799 ' H ' ' HZ2' ' A' ' 4' ' ' LYS . 0.5 OUTLIER 29.15 -92.36 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 O-C-N 123.812 0.695 . . . . 0.0 111.239 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.653 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 2.3 pp -141.95 -0.19 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 6' ' ' ILE . . . 80.35 -64.31 0.19 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.728 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 7' ' ' ALA . 10.1 mttp -53.61 -170.28 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.155 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -126.78 -155.22 0.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.66 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -45.01 155.4 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.485 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 144.47 -103.28 0.29 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.466 HH11 ' NZ ' ' A' ' 14' ' ' LYS . 0.9 OUTLIER -123.32 134.7 54.02 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.788 0.328 . . . . 0.0 110.871 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -148.67 179.84 7.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.661 179.463 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.602 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 2.4 tttp -143.73 110.34 5.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.511 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.516 ' C ' ' H ' ' A' ' 17' ' ' GLY . 10.1 m95 -48.19 141.56 6.19 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.552 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.29 -36.31 0.26 Allowed Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 15' ' ' TRP . . . -83.08 -91.29 0.67 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 19' ' ' PRO . 13.5 p -91.73 111.56 50.12 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-O 119.312 -0.375 . . . . 0.0 110.731 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 18' ' ' THR . 42.7 Cg_exo -52.46 -156.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.169 1.912 . . . . 0.0 112.672 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -165.27 92.77 0.57 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.296 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.6 m -41.45 -77.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.657 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 36.1 mtt85 -94.74 115.71 27.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.476 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.55 85.82 1.88 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.9 ptm85 -80.3 0.56 32.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.584 0.231 . . . . 0.0 110.773 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.36 98.25 2.4 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -121.06 108.74 14.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.235 0.54 . . . . 0.0 110.323 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.6 tt -114.58 155.9 15.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.782 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.8 m -132.35 177.58 7.48 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.899 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 31' ' ' MET . 11.9 t -91.29 159.59 15.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.568 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.4 tp -40.67 -24.75 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.651 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.474 ' N ' ' O ' ' A' ' 29' ' ' SER . 3.1 mtt -80.76 -42.26 22.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.752 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 29' ' ' SER . . . 87.28 63.17 1.44 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 t -150.6 -31.33 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.838 0.352 . . . . 0.0 110.466 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.422 ' OD1' ' N ' ' A' ' 29' ' ' SER . 9.3 p-10 -89.44 32.22 0.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.464 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 90.3 m -51.46 105.11 0.1 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.657 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -107.59 132.83 52.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.309 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -87.48 130.11 34.82 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.544 179.335 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.32 162.28 43.33 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.47 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -71.3 -166.12 0.22 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.668 2.245 . . . . 0.0 112.142 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -72.63 -139.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.582 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.0 mp -93.68 122.83 36.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.642 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.5 pt -46.89 142.07 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.509 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -64.1 154.25 35.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.543 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -72.51 -3.26 23.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.586 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 144.77 -39.98 1.17 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.632 ' H ' HD12 ' A' ' 46' ' ' LEU . 9.1 mp -40.61 -58.95 1.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.863 0.363 . . . . 0.0 110.611 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.82 27.72 9.38 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.641 HD23 ' N ' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -141.41 -40.98 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 0.0 110.423 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.641 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.457 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.6 mmtt -61.63 151.46 33.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.819 0.342 . . . . 0.0 110.617 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.71 100.87 11.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.621 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER -97.1 -26.39 14.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.666 -179.901 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 7' ' ' ALA . 1.8 m -59.77 -145.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.313 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 19' ' ' PRO . 1.3 pp -39.49 -28.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.679 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 9' ' ' ASP . . . 68.05 -57.73 0.46 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.818 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.579 ' CB ' ' NZ ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -44.55 -16.57 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.944 0.402 . . . . 0.0 110.998 -179.415 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.504 ' H ' HD12 ' A' ' 6' ' ' ILE . 0.8 OUTLIER 72.6 111.02 0.06 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.501 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 55.87 169.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.478 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.19 -105.68 1.05 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -111.19 145.05 39.35 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.813 0.339 . . . . 0.0 110.503 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.9 p -145.43 168.72 19.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.721 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.63 109.83 3.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.489 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -52.95 -40.88 64.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.943 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.55 27.37 20.6 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -168.54 -126.11 0.83 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -40.45 109.26 0.59 Allowed Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.841 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.558 ' O ' HG23 ' A' ' 6' ' ' ILE . 54.3 Cg_endo -76.1 152.45 35.78 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.96 1.773 . . . . 0.0 112.097 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.73 137.57 51.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.134 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -95.34 -79.47 0.43 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.485 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 70.7 mtt-85 -81.99 109.06 15.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.549 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.499 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 103.47 92.09 2.22 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.37 14.56 10.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.751 0.31 . . . . 0.0 110.643 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.56 56.73 4.17 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.0 t -79.94 113.49 18.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.728 0.299 . . . . 0.0 110.659 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.5 tt -126.02 148.44 30.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.315 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.1 m -126.33 174.15 8.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.605 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.12 169.44 17.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.49 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.415 HG23 ' HG2' ' A' ' 31' ' ' MET . 0.6 OUTLIER -52.36 -27.41 10.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.929 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.415 ' HG2' HG23 ' A' ' 30' ' ' ILE . 1.6 mtp -85.5 -25.58 26.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.66 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.84 66.04 1.66 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.0 t -145.18 -34.15 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.846 0.355 . . . . 0.0 110.547 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -90.62 53.8 2.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.324 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.7 m -72.13 98.29 2.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -105.31 140.64 38.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.819 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 0.7 OUTLIER -93.03 111.22 22.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.344 179.488 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.52 158.01 63.29 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.828 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.08 -165.05 0.15 Allowed 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.682 2.255 . . . . 0.0 112.07 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -94.26 -155.21 0.44 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.552 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 41' ' ' LEU . 10.1 mp -92.31 56.5 2.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.621 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.2 tp -82.37 -27.64 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.592 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.489 ' O ' ' N ' ' A' ' 45' ' ' GLY . 5.8 ptt? -156.63 -6.15 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.596 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.401 ' H ' ' H ' ' A' ' 43' ' ' MET . 3.8 mt-10 -63.35 72.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.547 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.616 ' H ' ' HB3' ' A' ' 49' ' ' ALA . . . 138.86 -52.03 0.74 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.969 ' H ' HD12 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -122.95 107.03 11.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.863 0.363 . . . . 0.0 110.535 -179.752 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 140.37 -51.45 0.72 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.648 ' C ' HD23 ' A' ' 48' ' ' LEU . 1.2 tt -136.6 -40.44 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.693 0.282 . . . . 0.0 110.619 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.616 ' HB3' ' H ' ' A' ' 45' ' ' GLY . . . . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.713 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.465 ' CG ' ' O ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -155.58 99.58 2.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.788 0.328 . . . . 0.0 110.496 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -60.87 -15.86 35.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.733 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.55 115.18 29.95 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.704 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.547 ' SG ' ' N ' ' A' ' 6' ' ' ILE . 31.0 p -162.28 -130.12 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.413 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.663 HD13 ' H ' ' A' ' 9' ' ' ASP . 2.6 pp -119.76 -174.26 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.509 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.35 -1.57 2.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.575 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.429 ' HZ2' HG12 ' A' ' 6' ' ' ILE . 1.4 pttm -83.93 -12.36 55.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.593 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.663 ' H ' HD13 ' A' ' 6' ' ' ILE . 0.1 OUTLIER 60.11 133.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.549 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.432 ' O ' ' O ' ' A' ' 9' ' ' ASP . 52.5 m-85 44.29 -170.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.686 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.95 -153.96 18.69 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.2 ttt-85 -80.15 153.59 28.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.737 0.303 . . . . 0.0 110.556 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.556 ' SG ' ' N ' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -156.3 -178.74 7.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.664 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.556 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -139.47 118.21 12.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.394 179.758 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -60.01 -11.28 5.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.728 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.419 ' H ' ' HD3' ' A' ' 14' ' ' LYS . . . -128.2 25.84 4.81 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -170.28 -144.64 4.4 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.1 p -38.32 102.59 0.25 Allowed Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 121.314 -0.154 . . . . 0.0 110.916 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -79.97 -163.03 0.2 Allowed 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.403 2.069 . . . . 0.0 112.237 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.505 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 31.7 p -144.64 112.37 6.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.573 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -51.64 -81.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.636 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.419 ' HD2' ' H ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -77.03 118.4 19.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.58 -179.901 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.504 ' O ' ' SG ' ' A' ' 20' ' ' CYS . . . 96.14 66.95 0.96 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -78.43 25.01 0.25 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 120.838 0.351 . . . . 0.0 110.6 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . -98.83 75.85 0.54 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -96.73 104.0 15.96 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.561 0.695 . . . . 0.0 110.784 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.615 ' O ' HG23 ' A' ' 27' ' ' ILE . 10.6 tt -97.39 110.61 25.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.282 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.03 156.66 17.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.669 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.3 m -80.09 161.0 25.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.705 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.8 tp -44.27 -27.51 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.652 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.9 mtt -86.12 -40.46 15.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.601 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.22 65.06 0.74 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.8 t -158.74 -0.66 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.592 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.93 23.86 13.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.632 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.4 m -54.74 104.83 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.512 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -115.72 107.38 15.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.911 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 1.1 m -72.34 109.44 6.06 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.457 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.433 ' CB ' ' CD ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -125.48 177.5 1.87 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.877 -179.799 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' A' ' 38' ' ' LYS . 23.3 Cg_exo -63.66 -64.8 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.779 2.319 . . . . 0.0 112.231 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 39' ' ' PRO . 62.3 mtp180 54.09 166.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.489 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.998 ' H ' HD22 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -83.23 103.32 12.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.619 -179.53 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.0 pp -136.26 132.31 49.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.417 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 8.7 mtt -132.79 138.31 47.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.55 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -89.16 -49.07 6.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.506 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.438 ' H ' ' H ' ' A' ' 46' ' ' LEU . . . 175.78 -6.71 0.03 OUTLIER Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.438 ' H ' ' H ' ' A' ' 45' ' ' GLY . 2.4 mp -104.3 47.68 0.87 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.843 0.354 . . . . 0.0 110.658 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -162.17 -53.51 0.02 OUTLIER Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.644 HD23 ' N ' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -159.47 -41.42 0.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.692 0.282 . . . . 0.0 110.441 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.644 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.546 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 163.79 5.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.724 0.297 . . . . 0.0 110.619 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -136.22 57.32 1.78 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.471 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -107.79 -170.3 1.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.628 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.5 m 59.72 -73.87 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.687 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' A' ' 4' ' ' LYS . 0.6 OUTLIER -120.95 -20.98 4.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.428 -179.522 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 6' ' ' ILE . . . 68.61 -37.82 0.36 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.039 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.513 ' H ' ' C ' ' A' ' 6' ' ' ILE . 3.5 mttm -64.34 -30.67 71.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.661 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.54 ' H ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER 56.92 126.23 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.117 -179.52 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.564 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 2.4 m-30 64.11 114.56 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.433 0.635 . . . . 0.0 110.534 178.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 158.66 -144.51 10.43 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.791 -0.923 . . . . 0.0 110.791 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.516 ' NH2' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -83.52 156.34 22.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.878 0.37 . . . . 0.0 110.707 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.444 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 28.2 p -158.62 170.07 22.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.537 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.79 114.3 3.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.617 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -62.71 -11.8 19.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.707 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.33 10.28 14.84 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -139.56 -98.96 0.42 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.2 p -90.11 145.62 33.32 Favored Pre-proline 0 C--N 1.327 -0.399 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.918 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.9 -160.84 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.466 2.111 . . . . 0.0 112.155 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -165.27 103.01 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.54 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.443 ' SG ' ' C ' ' A' ' 4' ' ' LYS . 1.2 m -65.43 -89.31 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.785 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -82.65 121.49 26.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.606 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.511 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 99.11 69.18 0.91 Allowed Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -79.45 27.89 0.26 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.982 0.42 . . . . 0.0 110.529 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 36' ' ' GLU . . . -93.37 66.56 1.76 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.582 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 56.4 m -84.6 87.56 7.28 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.348 0.594 . . . . 0.0 110.697 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.648 ' O ' HG23 ' A' ' 27' ' ' ILE . 1.7 tt -80.07 96.96 2.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.495 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 94.4 m -92.16 154.99 18.33 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.472 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.407 ' C ' ' N ' ' A' ' 31' ' ' MET . 1.2 m -91.77 171.31 9.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.767 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 tp -51.8 -14.82 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.571 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' MET . . . . . 0.407 ' N ' ' C ' ' A' ' 29' ' ' SER . 4.7 mtm -106.98 -42.9 4.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.761 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.38 56.13 0.74 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 t -133.84 -22.44 1.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 0.0 110.446 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -94.26 13.18 24.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.576 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.6 m -49.49 91.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.681 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 34' ' ' ASN . 2.9 tt0 -107.31 123.2 47.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.582 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.582 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -77.73 99.6 5.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.361 179.892 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.413 ' HZ3' ' HB2' ' A' ' 38' ' ' LYS . 23.9 mtmm -95.82 148.71 34.99 Favored Pre-proline 0 C--O 1.237 0.398 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.88 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.88 177.66 4.07 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.538 2.159 . . . . 0.0 112.146 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -166.28 160.2 15.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.48 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.88 HD13 ' N ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -128.49 -169.93 2.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.742 -179.231 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.1 pt -134.77 -25.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.514 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 6.8 mtt -91.07 133.8 35.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.904 0.383 . . . . 0.0 110.668 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -43.84 -37.42 2.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.468 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 156.17 -25.6 0.54 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.408 HD12 ' H ' ' A' ' 46' ' ' LEU . 2.8 mp -73.54 -78.77 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.755 0.312 . . . . 0.0 110.58 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.22 19.21 0.09 OUTLIER Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 49' ' ' ALA . 1.2 tt -105.72 -42.06 5.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.742 0.306 . . . . 0.0 110.602 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.624 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.221 -0.396 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.676 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 41.2 tttp -88.89 -10.54 47.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.862 0.363 . . . . 0.0 110.634 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.526 ' CD ' ' N ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER 45.45 -110.64 0.24 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.388 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.98 8.97 3.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.832 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -130.31 -95.59 0.38 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.425 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.426 ' C ' HD12 ' A' ' 6' ' ' ILE . 2.6 pp -130.96 -166.18 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.325 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.448 ' C ' ' H ' ' A' ' 9' ' ' ASP . . . -131.86 -24.93 2.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.758 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.696 ' H ' ' CD ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -71.76 12.52 0.37 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.79 -179.66 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.52 ' OD2' ' N ' ' A' ' 10' ' ' TYR . 6.7 p-10 36.2 -121.52 0.15 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.523 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.52 ' N ' ' OD2' ' A' ' 9' ' ' ASP . 60.5 m-85 -72.04 168.64 17.66 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.459 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.24 -145.86 17.46 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.447 ' NH1' ' NZ ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -37.74 119.26 0.73 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.853 0.358 . . . . 0.0 111.081 -179.688 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.488 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 26.9 p -151.9 171.54 17.62 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.688 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.447 ' NZ ' ' NH1' ' A' ' 12' ' ' ARG . 7.4 mttp -159.85 153.72 23.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.603 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.476 ' CZ2' ' SG ' ' A' ' 28' ' ' CYS . 0.9 OUTLIER -83.13 -52.57 6.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.783 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.48 -24.72 41.93 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.82 -119.88 0.17 Allowed Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.56 151.64 48.35 Favored Pre-proline 0 C--N 1.326 -0.416 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.663 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.52 -170.19 0.36 Allowed 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.568 2.179 . . . . 0.0 112.306 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.46 96.06 2.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.57 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 70.1 m -40.71 -84.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.582 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.515 ' O ' ' CE2' ' A' ' 10' ' ' TYR . 19.4 mtt85 -90.85 41.31 1.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.518 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.45 145.82 17.74 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.85 -25.62 0.5 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.749 0.309 . . . . 0.0 110.555 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.49 67.29 0.52 Allowed Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.426 ' O ' ' NE1' ' A' ' 15' ' ' TRP . 13.3 t -79.75 85.68 5.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.924 0.392 . . . . 0.0 110.348 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.9 tt -96.2 150.86 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.528 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.476 ' SG ' ' CZ2' ' A' ' 15' ' ' TRP . 3.7 m -130.56 177.73 7.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.769 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.92 174.7 11.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.664 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -53.79 -28.33 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.671 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.0 mtt -83.65 -46.14 12.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.721 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.9 62.38 0.82 Allowed Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.9 t -142.86 -25.73 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.796 0.332 . . . . 0.0 110.615 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -100.41 46.58 0.95 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.569 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.8 m -63.24 124.68 21.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.698 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.447 ' C ' ' SG ' ' A' ' 13' ' ' CYS . 41.3 mt-10 -130.62 138.68 50.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.52 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.488 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -87.1 122.87 31.52 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.173 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.59 148.06 63.07 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.805 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.71 179.38 2.68 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.452 2.102 . . . . 0.0 111.996 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -75.27 144.94 42.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.582 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 41' ' ' LEU . 10.8 mp 45.42 94.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.613 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.1 tp -67.86 -29.16 44.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.624 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 8.5 mtt -43.06 156.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.547 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -87.37 -39.31 15.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.559 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 47' ' ' GLY . . . -96.19 29.28 10.34 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.738 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.6 mp 39.51 26.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.873 0.368 . . . . 0.0 110.614 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 45' ' ' GLY . . . 149.3 61.75 0.01 OUTLIER Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.638 ' C ' HD23 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -148.92 -40.14 0.15 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.79 0.329 . . . . 0.0 110.59 179.939 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.637 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.715 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 6' ' ' ILE . 23.5 p . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.774 0.321 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.651 HD12 ' C ' ' A' ' 6' ' ' ILE . 2.5 pp -127.25 174.0 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.522 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.414 ' O ' ' OD1' ' A' ' 9' ' ' ASP . . . -114.3 -11.59 12.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.615 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 10' ' ' TYR . 51.1 mttt -58.14 -25.62 61.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.517 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.424 ' H ' HD13 ' A' ' 6' ' ' ILE . 1.5 m-20 68.07 -66.68 0.21 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.456 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.413 ' N ' ' O ' ' A' ' 8' ' ' LYS . 47.5 m-85 -137.22 162.31 33.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.436 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 99.1 -135.95 12.42 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.661 ' H ' ' HE ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER -39.61 111.06 0.16 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.731 0.301 . . . . 0.0 110.829 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.552 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 24.3 p -147.26 148.71 31.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.689 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -145.23 119.67 9.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.574 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -34.98 71.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.529 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.85 1.85 61.6 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -141.22 -134.07 2.99 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 19' ' ' PRO . 6.6 p -39.07 102.74 0.26 Allowed Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 110.633 -0.136 . . . . 0.0 110.633 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 18' ' ' THR . 53.1 Cg_exo -50.89 -170.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.902 1.734 . . . . 0.0 112.48 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 6.5 t -153.44 80.93 1.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.236 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -40.1 -67.97 0.2 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.654 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.08 140.59 37.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.45 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.501 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 79.76 88.81 0.5 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.48 ' O ' ' CZ ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -81.94 -7.35 59.6 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.684 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.65 67.23 0.17 Allowed Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 24' ' ' ARG . 8.6 t -96.92 101.16 12.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.873 0.368 . . . . 0.0 110.352 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.6 tt -124.43 151.08 29.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.289 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 5.4 m -120.01 161.12 21.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.813 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.6 m -64.97 -177.03 0.32 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.554 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.8 tp -62.86 -30.79 50.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.822 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.3 mtm -80.35 -26.35 38.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.767 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.53 62.1 1.9 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.2 t -147.39 -29.53 0.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 110.6 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -90.47 53.73 2.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.511 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.5 m -73.64 103.67 4.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.695 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -117.51 144.5 45.01 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.975 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.552 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -91.91 117.48 29.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.494 179.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.6 148.9 40.74 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.332 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo . . . . . 0 N--CA 1.494 1.519 0 C-N-CA 122.176 1.917 . . . . 0.0 111.983 179.859 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.449 ' HB2' ' H ' ' A' ' 21' ' ' CYS . 7.8 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.712 0.291 . . . . 0.0 110.694 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.67 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -118.96 6.59 6.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.766 -179.182 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 6' ' ' ILE . . . 79.37 -55.57 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.303 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -80.6 -142.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.207 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 7.1 p-10 -131.9 -112.65 0.24 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.09 0.471 . . . . 0.0 111.043 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.478 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.8 m-30 -58.29 147.38 30.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.565 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.442 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 164.51 -157.61 30.04 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.318 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.41 HH21 ' HB3' ' A' ' 12' ' ' ARG . 5.0 ptm85 -71.61 125.23 26.56 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.815 0.34 . . . . 0.0 111.072 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -145.36 142.5 29.43 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.644 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.95 130.26 33.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.531 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -48.76 -34.39 12.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.568 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -112.92 24.69 12.55 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.64 -127.37 2.89 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.2 p -85.14 146.93 46.39 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.369 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.07 -159.61 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.444 2.096 . . . . 0.0 112.142 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -171.97 95.47 0.16 Allowed 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.905 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.449 ' H ' ' HB2' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -42.52 -85.07 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.294 -179.358 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.83 122.32 22.27 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.273 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.41 87.19 1.97 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -85.1 -23.58 28.42 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.885 0.374 . . . . 0.0 110.131 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.05 75.48 0.12 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 4.6 t -92.48 111.78 23.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.115 0.483 . . . . 0.0 110.25 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.469 ' CG1' ' N ' ' A' ' 28' ' ' CYS . 10.7 tt -125.76 162.5 28.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.656 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 1.7 t -144.76 -171.86 3.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.777 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.08 170.65 9.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.513 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.401 ' HA ' HD12 ' A' ' 30' ' ' ILE . 9.0 tp -52.06 -27.24 9.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.576 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.8 mtp -83.56 -38.91 21.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.608 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.26 48.0 2.7 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.644 HG23 ' N ' ' A' ' 34' ' ' ASN . 10.1 t -122.97 -50.7 1.92 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.757 0.313 . . . . 0.0 110.45 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.644 ' N ' HG23 ' A' ' 33' ' ' THR . 2.9 t-20 -76.77 51.66 0.78 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.201 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.623 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 3.7 m -84.66 123.53 30.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.988 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -139.77 148.5 42.32 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.732 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 11' ' ' GLY . 0.7 OUTLIER -91.17 117.51 29.68 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.796 178.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.56 164.53 41.99 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.203 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--N 1.307 -1.609 0 C-N-CA 122.564 2.176 . . . . 0.0 112.253 179.754 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.9 p . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.719 0.295 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.4 pp -112.99 -174.36 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.272 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -106.63 -5.19 18.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.456 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.504 ' NZ ' ' O ' ' A' ' 12' ' ' ARG . 4.9 pttt -111.84 -119.73 0.29 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.561 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 23.9 p-10 -173.72 -42.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.45 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.469 ' CZ ' ' O ' ' A' ' 22' ' ' ARG . 69.0 m-85 -140.98 165.36 27.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.757 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 105.58 -152.58 17.2 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.244 -0.743 . . . . 0.0 111.244 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.504 ' O ' ' NZ ' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -37.42 130.31 0.96 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.848 0.356 . . . . 0.0 111.022 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.586 ' SG ' ' N ' ' A' ' 14' ' ' LYS . 0.8 OUTLIER -160.28 157.58 28.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.606 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.586 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 8.3 tttm -156.7 108.67 2.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.382 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 33.1 m95 -48.97 -27.3 3.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.623 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.12 -31.7 16.42 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.96 -104.38 2.07 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.0 p -90.22 144.02 30.48 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.597 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.1 -160.43 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.287 1.992 . . . . 0.0 111.956 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 12.8 t -160.98 90.45 0.83 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.933 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -49.81 -83.01 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.817 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.469 ' O ' ' CZ ' ' A' ' 10' ' ' TYR . 1.1 mpt_? -78.41 101.33 7.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.839 0.352 . . . . 0.0 110.431 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.493 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 112.83 116.45 3.4 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.421 ' C ' ' H ' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -110.91 4.81 20.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.782 0.325 . . . . 0.0 110.363 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.6 40.93 1.15 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 56.2 m -71.73 88.88 1.0 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.786 0.327 . . . . 0.0 110.296 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.3 tt -115.54 156.81 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.545 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.629 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.5 OUTLIER -137.45 -172.47 3.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.829 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 31' ' ' MET . 1.6 t -98.55 161.01 13.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.553 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.3 tp -42.19 -24.57 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.445 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.44 ' N ' ' O ' ' A' ' 29' ' ' SER . 2.8 mtt -81.66 -47.37 13.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.507 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.18 50.59 1.72 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.819 -0.913 . . . . 0.0 110.819 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.621 HG23 ' N ' ' A' ' 34' ' ' ASN . 8.9 t -131.15 -49.54 1.01 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.769 0.319 . . . . 0.0 110.659 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.621 ' N ' HG23 ' A' ' 33' ' ' THR . 72.0 m-80 -77.12 46.27 0.48 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.443 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.629 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 7.9 m -75.86 121.4 22.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.671 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -135.42 155.7 50.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.004 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 1.2 t -98.75 114.73 27.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.257 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -113.44 146.81 36.14 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.547 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 N--CA 1.495 1.616 0 C-N-CA 122.384 2.056 . . . . 0.0 112.147 179.607 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.531 0.217 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.785 HD13 ' H ' ' A' ' 9' ' ' ASP . 2.4 pp -135.23 -167.65 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.376 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -127.56 -17.56 4.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.752 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.497 ' CD ' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -61.42 -42.48 98.81 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.856 -0.337 . . . . 0.0 110.289 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.785 ' H ' HD13 ' A' ' 6' ' ' ILE . 15.5 m-20 61.18 135.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.83 0.348 . . . . 0.0 110.108 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 9' ' ' ASP . 15.2 m-85 49.99 176.35 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.529 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.521 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 83.21 -153.52 30.7 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -42.48 143.73 0.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.816 0.341 . . . . 0.0 110.82 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 36' ' ' GLU . 28.9 p -147.33 168.91 20.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.526 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -160.72 104.88 1.39 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.287 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -53.75 -19.16 3.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.37 . . . . 0.0 110.744 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.55 -8.54 52.16 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -147.72 -112.62 0.7 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.9 p -38.84 101.88 0.24 Allowed Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 110.453 -0.202 . . . . 0.0 110.453 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -79.1 -22.88 8.19 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.195 1.93 . . . . 0.0 112.567 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' A' ' 21' ' ' CYS . 0.4 OUTLIER 66.17 91.05 0.09 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.565 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 6' ' ' ILE . 89.3 m -36.25 -73.08 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.521 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -94.66 125.34 39.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.491 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.7 100.9 2.62 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -96.16 -2.22 46.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.745 0.307 . . . . 0.0 110.482 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' A' ' 38' ' ' LYS . . . -68.4 64.26 0.41 Allowed Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 47.1 t -85.39 71.23 10.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.288 0.566 . . . . 0.0 110.452 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.6 tt -86.27 145.56 7.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.754 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.572 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -126.93 166.17 18.02 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.965 -179.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.0 168.75 18.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.656 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -54.38 -26.86 16.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.674 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.2 mtm -85.14 -41.19 15.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.463 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 106.64 59.91 0.59 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.0 t -142.25 -30.43 0.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.336 . . . . 0.0 110.576 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -84.5 46.34 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.367 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.572 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 23.5 m -75.26 110.97 10.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.655 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.591 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 9.4 mt-10 -143.21 136.64 28.31 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.462 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' A' ' 11' ' ' GLY . 0.5 OUTLIER -74.26 120.65 20.12 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.429 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 25' ' ' GLY . 0.7 OUTLIER -101.53 146.91 33.05 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.387 -179.594 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo . . . . . 0 N--CA 1.495 1.559 0 C-N-CA 122.452 2.101 . . . . 0.0 112.198 179.888 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.426 ' O ' ' O ' ' A' ' 6' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.856 0.36 . . . . 0.0 110.473 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.675 HG23 ' O ' ' A' ' 19' ' ' PRO . 2.6 pp -51.34 -172.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.969 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -149.26 63.45 1.03 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.628 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.408 ' H ' ' H ' ' A' ' 9' ' ' ASP . 39.3 pttt -169.11 -13.72 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.779 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.513 ' H ' HD13 ' A' ' 6' ' ' ILE . 2.7 m-20 65.04 127.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.41 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.411 ' O ' ' O ' ' A' ' 9' ' ' ASP . 18.9 m-85 50.0 178.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.563 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.95 -109.82 2.77 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.7 ttp85 -114.76 137.97 51.29 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.811 0.339 . . . . 0.0 110.403 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.2 p -143.01 178.3 7.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.658 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -157.18 116.97 3.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.988 0.423 . . . . 0.0 110.689 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.522 ' NE1' ' SG ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -51.19 139.36 18.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.363 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.88 -37.17 0.62 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.492 ' H ' ' C ' ' A' ' 15' ' ' TRP . . . -93.19 -145.0 16.01 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 17' ' ' GLY . 31.2 p -36.02 95.66 0.09 OUTLIER Pre-proline 0 CA--C 1.536 0.405 0 O-C-N 123.579 0.223 . . . . 0.0 110.696 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.675 ' O ' HG23 ' A' ' 6' ' ' ILE . 24.5 Cg_exo -61.87 156.88 46.17 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.105 1.87 . . . . 0.0 112.023 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -111.82 102.49 10.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.375 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -50.35 -71.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.544 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.9 mmp_? -104.25 107.77 18.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.273 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.47 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 133.68 77.83 0.11 Allowed Glycine 0 CA--C 1.52 0.381 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -79.39 5.37 12.78 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 120.934 0.397 . . . . 0.0 110.512 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.88 66.88 0.92 Allowed Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.497 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 19.2 m -97.26 102.78 14.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.0 0.428 . . . . 0.0 110.643 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.2 tt -109.31 157.08 9.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.802 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.52 175.92 8.89 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.681 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.2 166.81 14.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.645 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.492 HG23 ' HG2' ' A' ' 31' ' ' MET . 4.6 tp -47.29 -27.48 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.904 0.383 . . . . 0.0 110.623 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.492 ' HG2' HG23 ' A' ' 30' ' ' ILE . 1.3 mtt -89.5 -46.07 8.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.589 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.92 68.93 1.01 Allowed Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -146.23 -12.15 0.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.714 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -118.05 40.62 3.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.378 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.522 ' SG ' ' NE1' ' A' ' 15' ' ' TRP . 3.6 m -56.14 105.82 0.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.739 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -103.67 134.88 46.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.661 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.497 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 4.3 t -84.78 97.09 9.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.215 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -97.53 148.75 34.89 Favored Pre-proline 0 C--O 1.235 0.341 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.971 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo . . . . . 0 C--N 1.317 -1.087 0 C-N-CA 122.482 2.121 . . . . 0.0 112.407 179.462 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.436 ' SG ' ' N ' ' A' ' 6' ' ' ILE . 7.2 p . . . . . 0 N--CA 1.461 0.083 0 CA-C-O 120.715 0.293 . . . . 0.0 110.817 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.436 ' N ' ' SG ' ' A' ' 5' ' ' CYS . 2.2 pp -129.62 176.23 8.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.512 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.44 -19.0 10.28 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.017 0.437 . . . . 0.0 110.488 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -89.54 58.39 4.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.925 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 10' ' ' TYR . 1.1 m-20 -36.62 133.9 0.52 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.782 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 9' ' ' ASP . 88.3 m-85 56.51 158.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.512 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.05 -105.25 1.21 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -99.46 144.72 28.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.901 0.382 . . . . 0.0 110.853 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -158.35 141.97 15.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.553 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.1 tptm -147.71 120.94 8.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.485 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.93 -17.97 62.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.445 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.73 9.72 34.81 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -134.85 -113.23 1.32 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 p -88.78 151.36 47.44 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.473 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.07 -159.86 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.394 2.063 . . . . 0.0 112.017 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.6 t -160.93 81.72 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.221 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -39.45 -68.82 0.15 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.803 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.8 mtt-85 -104.7 88.0 2.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.606 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.491 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 157.4 94.95 0.1 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.61 -7.79 27.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.71 0.291 . . . . 0.0 110.554 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.89 53.55 4.26 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.567 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 91.8 m -75.98 93.72 3.3 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.1 tt -104.35 149.3 8.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.143 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.2 OUTLIER -134.52 -179.36 5.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.795 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.88 172.59 8.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.293 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.423 HG23 ' HG2' ' A' ' 31' ' ' MET . 7.3 tp -55.2 -24.88 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.725 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.423 ' HG2' HG23 ' A' ' 30' ' ' ILE . 3.9 mtp -87.89 -16.81 32.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.617 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.42 64.5 3.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.6 t -140.77 -33.66 0.53 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.78 0.324 . . . . 0.0 110.533 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.422 ' ND2' ' OE1' ' A' ' 36' ' ' GLU . 3.2 t30 -95.71 47.58 1.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.331 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.623 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 59.4 m -69.79 107.91 3.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.728 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.422 ' OE1' ' ND2' ' A' ' 34' ' ' ASN . 10.9 mt-10 -111.66 146.66 37.08 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.055 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.567 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -94.44 116.41 28.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.557 179.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.431 ' CB ' ' CD ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -126.85 179.46 1.2 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.562 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' A' ' 38' ' ' LYS . 22.1 Cg_exo . . . . . 0 N--CA 1.495 1.592 0 C-N-CA 122.483 2.122 . . . . 0.0 112.028 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.409 ' SG ' ' N ' ' A' ' 6' ' ' ILE . 11.5 p . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.768 0.318 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.656 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 1.1 pp -108.43 0.83 9.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.772 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.656 ' HB3' ' O ' ' A' ' 6' ' ' ILE . . . 79.27 -61.95 0.31 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.514 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -65.55 -164.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.542 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -139.53 133.33 30.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.354 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 52.38 178.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.622 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 109.14 -123.99 7.13 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.446 ' NH1' ' O ' ' A' ' 33' ' ' THR . 3.9 tpt180 -98.31 146.94 25.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.64 0.257 . . . . 0.0 110.551 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.455 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 3.7 p -145.89 175.71 10.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.478 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 17' ' ' GLY . 24.9 tttm -151.51 96.73 2.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.334 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -45.87 -21.62 0.14 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.76 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.76 36.28 4.33 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 14' ' ' LYS . . . 169.43 -124.72 1.18 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 19' ' ' PRO . 71.6 p -37.28 100.01 0.19 Allowed Pre-proline 0 N--CA 1.464 0.269 0 O-C-N 123.443 0.143 . . . . 0.0 110.84 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 18' ' ' THR . 39.6 Cg_exo -54.32 -145.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.529 2.152 . . . . 0.0 112.516 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.98 90.31 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.201 0.524 . . . . 0.0 110.709 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -45.68 -79.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.423 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 -95.04 126.73 40.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.358 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.499 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 99.88 82.02 1.64 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.49 ' CD ' ' H ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -85.76 11.88 10.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.637 0.256 . . . . 0.0 110.603 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.96 49.74 4.29 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.8 t -81.46 103.42 11.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.923 0.392 . . . . 0.0 110.913 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.7 tt -113.77 148.18 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.288 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -129.71 161.65 30.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.77 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.51 165.68 14.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.746 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 tp -52.3 -28.44 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.635 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.6 mtt -83.49 -40.64 18.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.76 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.41 62.97 0.73 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.446 ' O ' ' NH1' ' A' ' 12' ' ' ARG . 3.5 t -143.51 -24.36 0.59 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.762 0.315 . . . . 0.0 110.746 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -98.74 54.44 1.03 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.429 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.612 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 60.4 m -77.68 94.97 4.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.391 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -110.2 138.0 47.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.785 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -92.8 118.73 31.41 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.679 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -127.84 150.64 73.94 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.754 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo . . . . . 0 N--CA 1.495 1.581 0 C-N-CA 122.554 2.17 . . . . 0.0 112.106 179.608 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 120.767 0.317 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.662 HD12 ' N ' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -101.24 -13.73 8.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.664 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.662 ' N ' HD12 ' A' ' 6' ' ' ILE . . . 71.4 -55.45 0.65 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.868 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 10' ' ' TYR . 9.3 pttt -52.86 -4.51 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.815 0.34 . . . . 0.0 111.188 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.543 ' H ' ' C ' ' A' ' 7' ' ' ALA . 26.8 t0 63.44 -75.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.503 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.534 ' CE1' ' OD1' ' A' ' 9' ' ' ASP . 82.9 m-85 -115.92 159.52 21.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.586 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 134.57 -154.94 21.68 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.484 ' NH1' HG21 ' A' ' 18' ' ' THR . 0.0 OUTLIER -55.57 117.18 3.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.589 0.233 . . . . 0.0 110.796 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.604 ' SG ' ' N ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -119.02 168.57 10.69 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.711 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.604 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -141.58 96.09 2.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.484 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -54.95 120.36 6.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.956 0.408 . . . . 0.0 110.443 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.83 -20.64 49.9 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -103.32 -68.81 0.79 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.484 HG21 ' NH1' ' A' ' 12' ' ' ARG . 44.2 p -89.89 144.52 31.65 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.777 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.41 -18.25 18.03 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.156 1.904 . . . . 0.0 112.342 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.2 t 47.41 90.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.341 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -39.4 -86.0 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.878 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.517 ' O ' ' CZ ' ' A' ' 10' ' ' TYR . 41.0 mtm180 -109.14 106.55 16.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.9 0.381 . . . . 0.0 110.386 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.509 ' H ' ' NH1' ' A' ' 24' ' ' ARG . . . 155.5 70.87 0.01 OUTLIER Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.514 ' CZ ' ' H ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -80.67 6.09 13.76 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.537 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -103.74 55.19 0.63 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.0 t -83.13 109.29 17.04 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.06 0.457 . . . . 0.0 110.683 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.3 tt -109.84 143.93 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.409 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.9 m -125.05 167.58 14.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.745 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.41 178.7 1.48 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.58 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 tp -61.32 -28.85 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.69 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.9 mtt -84.64 -35.98 22.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.544 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.39 62.51 0.77 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.447 HG23 ' N ' ' A' ' 34' ' ' ASN . 8.9 t -142.63 -38.59 0.36 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.776 0.322 . . . . 0.0 110.615 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.447 ' N ' HG23 ' A' ' 33' ' ' THR . 4.1 t-20 -79.64 49.68 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.534 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.9 m -72.71 123.71 23.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.644 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -138.17 121.02 16.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.898 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.507 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -70.14 115.1 8.95 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.338 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -125.27 149.89 65.51 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.716 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo . . . . . 0 N--CA 1.494 1.536 0 C-N-CA 122.599 2.2 . . . . 0.0 112.09 179.869 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 11.2 p . . . . . 0 N--CA 1.462 0.16 0 CA-C-O 120.633 0.254 . . . . 0.0 110.735 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.574 ' CD1' ' H ' ' A' ' 9' ' ' ASP . 1.8 pp -129.61 -170.71 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.27 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.15 -30.78 5.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.437 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.456 ' O ' ' CB ' ' A' ' 9' ' ' ASP . 8.5 mtmt -43.71 -67.06 0.31 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.6 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.574 ' H ' ' CD1' ' A' ' 6' ' ' ILE . 6.9 t0 78.82 117.35 0.06 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.48 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.562 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 42.4 m-85 53.76 168.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.468 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 100.21 -127.69 9.33 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.1 ttt-85 -72.41 140.6 48.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.838 0.351 . . . . 0.0 110.615 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.617 ' SG ' ' N ' ' A' ' 14' ' ' LYS . 0.7 OUTLIER -152.08 158.93 43.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.653 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.617 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 6.9 mttt -157.65 123.83 4.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.241 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.528 ' CZ2' ' SG ' ' A' ' 28' ' ' CYS . 1.0 OUTLIER -52.47 -24.87 8.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.582 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -112.34 14.08 25.59 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.07 -117.15 2.07 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.9 p -90.2 141.19 27.51 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.762 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 20' ' ' CYS . 58.9 Cg_endo -74.0 -32.69 6.8 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.554 2.17 . . . . 0.0 112.273 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.602 ' O ' ' N ' ' A' ' 22' ' ' ARG . 1.6 t 80.73 27.39 0.24 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.6 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.1 t 34.4 -84.1 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.608 0.567 . . . . 0.0 111.431 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.602 ' N ' ' O ' ' A' ' 20' ' ' CYS . 76.2 mtt180 -99.93 122.77 43.35 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.698 ' H ' ' HE ' ' A' ' 24' ' ' ARG . . . 130.06 79.43 0.21 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.698 ' HE ' ' H ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -79.51 1.05 27.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.76 0.314 . . . . 0.0 110.421 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -75.86 35.27 1.23 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.446 ' H ' ' C ' ' A' ' 24' ' ' ARG . 20.4 m -67.17 82.78 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.775 0.321 . . . . 0.0 110.593 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.3 tt -122.21 153.55 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.535 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.528 ' SG ' ' CZ2' ' A' ' 15' ' ' TRP . 6.6 m -118.75 165.84 13.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.771 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.7 170.48 7.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.403 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 30' ' ' ILE . 10.3 tp -54.12 -25.72 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.817 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.4 mtt -81.19 -37.39 28.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.646 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.68 58.48 0.94 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.5 t -148.76 -32.33 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 0.0 110.609 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -81.16 50.46 1.42 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.51 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.0 m -74.81 110.48 9.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.783 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -138.7 149.47 45.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.741 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.415 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.7 OUTLIER -89.73 107.28 19.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.117 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -97.28 148.05 33.85 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.555 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 N--CA 1.493 1.458 0 C-N-CA 122.251 1.967 . . . . 0.0 112.114 179.869 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.162 0 CA-C-O 120.371 0.129 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.642 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 2.0 pp -133.71 1.43 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 0.0 110.006 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 6' ' ' ILE . . . 82.52 -62.41 0.14 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.067 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -60.73 -140.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.5 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 10' ' ' TYR . 11.8 m-20 -140.39 -149.97 0.3 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.533 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.423 ' O ' ' O ' ' A' ' 9' ' ' ASP . 9.5 m-85 -40.95 163.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.529 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.543 ' N ' ' SG ' ' A' ' 37' ' ' CYS . . . 138.51 -138.95 9.86 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -79.92 127.44 32.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.679 0.276 . . . . 0.0 110.706 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.3 p -134.81 -172.18 2.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.597 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -160.01 115.66 2.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.354 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 32.3 m95 -57.7 -12.9 3.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.507 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -134.81 31.84 2.68 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.1 -133.64 1.81 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 14' ' ' LYS . 63.4 p -39.82 104.59 0.33 Allowed Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -79.02 -163.93 0.25 Allowed 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.958 1.772 . . . . 0.0 112.429 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -153.4 105.06 2.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.867 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.8 m -38.15 -75.36 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.682 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 mtp85 -95.75 120.94 36.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.415 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.703 ' H ' HH11 ' A' ' 24' ' ' ARG . . . 122.72 92.85 1.12 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.703 HH11 ' H ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -88.39 -8.37 55.13 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.742 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.44 66.85 3.85 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.3 m -81.78 80.72 8.02 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.28 0.562 . . . . 0.0 110.229 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.2 tt -80.65 139.18 18.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.495 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.604 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -132.27 175.94 8.83 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.819 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.65 169.49 15.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.528 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.4 tp -53.45 -24.91 9.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.655 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.2 mtm -92.16 -35.61 13.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.574 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.26 56.98 0.86 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 t -131.95 -33.54 1.35 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.798 0.332 . . . . 0.0 110.524 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -86.49 42.52 1.01 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.344 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.604 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 45.6 m -69.2 120.11 14.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.585 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -142.54 129.11 20.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.882 0.373 . . . . 0.0 111.057 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' N ' ' A' ' 11' ' ' GLY . 0.8 OUTLIER -80.15 127.47 32.37 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.522 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -137.29 149.7 66.56 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.402 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo . . . . . 0 N--CA 1.494 1.552 0 C-N-CA 122.308 2.005 . . . . 0.0 112.211 179.869 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.428 ' O ' ' O ' ' A' ' 6' ' ' ILE . 7.2 p . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.822 0.344 . . . . 0.0 110.399 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.478 HG13 ' H ' ' A' ' 21' ' ' CYS . 2.1 pp -50.02 -178.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.331 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 6' ' ' ILE . . . -35.59 -89.94 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.872 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.445 ' O ' ' CB ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -175.7 73.28 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 120.9 0.381 . . . . 0.0 110.371 179.669 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.47 ' C ' ' CD1' ' A' ' 10' ' ' TYR . 0.8 OUTLIER 162.38 -109.33 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.997 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.552 ' CZ ' ' O ' ' A' ' 22' ' ' ARG . 43.6 m-85 -142.48 -162.4 1.41 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.199 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 118.42 -119.9 4.52 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.03 151.32 21.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.717 0.294 . . . . 0.0 110.554 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.568 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 1.5 t -123.05 179.96 4.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.334 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -160.12 91.89 0.97 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.428 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.402 ' C ' ' N ' ' A' ' 17' ' ' GLY . 4.9 m0 -49.51 -81.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.451 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.77 -14.68 1.11 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.402 ' N ' ' C ' ' A' ' 15' ' ' TRP . . . -95.07 -134.4 7.65 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.18 152.75 48.36 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.592 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.54 178.34 6.83 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.319 2.013 . . . . 0.0 112.364 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.568 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -102.78 127.54 49.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.388 179.635 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.478 ' H ' HG13 ' A' ' 6' ' ' ILE . 59.8 m -50.85 -97.2 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.916 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.552 ' O ' ' CZ ' ' A' ' 10' ' ' TYR . 4.7 mtt180 -83.65 24.8 0.83 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.428 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.91 151.13 17.7 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.95 -14.34 0.53 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.796 0.331 . . . . 0.0 110.701 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.26 47.75 3.89 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 95.4 m -77.19 105.86 8.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.723 0.297 . . . . 0.0 110.633 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.3 tt -119.36 145.73 25.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.293 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.9 m -131.8 -178.6 4.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.759 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.83 168.75 15.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.652 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.5 tp -49.64 -25.56 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.578 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.5 mtt -86.93 -47.41 9.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.484 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.66 57.03 0.75 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.0 t -136.12 -24.78 1.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.749 0.309 . . . . 0.0 110.522 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -101.44 50.89 0.85 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.383 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 97.7 m -68.63 122.81 19.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.806 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -119.77 127.87 53.21 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.079 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.512 ' N ' ' O ' ' A' ' 11' ' ' GLY . 6.1 t -84.82 97.45 9.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.363 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.4 mtmt -107.96 147.0 34.62 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.743 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo . . . . . 0 N--CA 1.495 1.577 0 C-N-CA 122.371 2.047 . . . . 0.0 112.084 179.607 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 4.7 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.939 0.399 . . . . 0.0 110.218 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.838 HD12 ' N ' ' A' ' 7' ' ' ALA . 2.5 pp -54.92 -25.78 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.015 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.838 ' N ' HD12 ' A' ' 6' ' ' ILE . . . 66.82 -36.6 0.27 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.52 ' H ' ' C ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -72.57 15.74 0.17 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 122.119 0.961 . . . . 0.0 110.726 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.508 ' H ' ' C ' ' A' ' 7' ' ' ALA . 2.9 p-10 42.95 -110.39 0.15 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.924 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.491 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.4 m-30 -77.4 126.65 31.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.218 -178.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 159.04 -96.55 0.15 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.9 ttt85 -110.77 146.42 36.39 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.785 0.326 . . . . 0.0 110.752 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -158.03 143.75 17.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.617 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.579 ' NZ ' ' SG ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -137.34 126.01 23.81 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.997 0.427 . . . . 0.0 110.629 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.427 ' HE1' ' HB2' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -71.94 -28.13 63.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.541 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.62 -6.85 57.16 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.75 -115.61 3.22 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.3 p -90.21 142.81 28.83 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.567 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.67 167.47 27.17 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.182 1.922 . . . . 0.0 112.396 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 1.5 t -103.48 107.18 17.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.958 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.31 -72.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.529 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.402 ' HE ' ' HB3' ' A' ' 9' ' ' ASP . 7.8 mtm-85 -100.08 122.57 43.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.486 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 82.26 109.78 0.43 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.705 ' HE ' ' N ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -102.88 19.34 19.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.661 0.267 . . . . 0.0 110.649 -179.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.02 53.48 4.75 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.561 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 38.0 m -73.97 113.29 10.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.992 0.425 . . . . 0.0 110.501 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.0 tt -126.11 148.03 30.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.084 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.555 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -126.16 168.17 14.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.577 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 31' ' ' MET . 4.3 m -77.44 157.38 30.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.569 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -42.19 -24.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.847 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.431 ' N ' ' O ' ' A' ' 29' ' ' SER . 1.2 mtp -88.28 -50.92 6.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.757 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.83 63.72 0.53 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.6 t -145.04 -17.52 0.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.779 0.323 . . . . 0.0 110.302 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -107.74 51.07 0.75 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.171 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.579 ' SG ' ' NZ ' ' A' ' 14' ' ' LYS . 31.3 m -73.39 86.22 1.5 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.23 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -102.16 152.2 21.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.449 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.561 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -98.98 120.87 40.15 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.616 179.304 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -129.54 159.65 68.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.427 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 38' ' ' LYS . 50.9 Cg_exo . . . . . 0 N--CA 1.493 1.46 0 C-N-CA 122.352 2.035 . . . . 0.0 112.21 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 6' ' ' ILE . 4.6 p . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 121.003 0.43 . . . . 0.0 110.722 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.419 ' N ' ' SG ' ' A' ' 5' ' ' CYS . 1.1 pp -139.26 -172.16 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.446 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.44 -30.19 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.774 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.717 ' H ' ' CD ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -51.7 -42.33 62.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.431 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 10' ' ' TYR . 4.8 m-20 58.92 125.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.47 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 9' ' ' ASP . 66.5 m-85 55.97 160.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.854 0.359 . . . . 0.0 110.795 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.18 -152.04 21.93 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.415 ' N ' ' OE2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -42.24 125.42 3.09 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.657 -0.32 . . . . 0.0 110.944 -179.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 2.9 t -154.73 150.46 27.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.649 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.467 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 25.3 tttp -155.88 103.7 2.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.534 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 13.8 m95 -42.05 154.95 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.412 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.46 -47.5 0.71 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.96 -90.79 0.82 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 19' ' ' PRO . 3.9 p -90.19 112.98 55.61 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-O 119.448 -0.31 . . . . 0.0 110.75 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 18' ' ' THR . 52.0 Cg_exo -51.49 -161.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.12 1.88 . . . . 0.0 112.611 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 6.3 t -171.92 61.18 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.475 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -38.22 -42.4 0.68 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.807 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.4 mtt180 -120.36 99.81 6.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.44 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.499 ' O ' ' SG ' ' A' ' 20' ' ' CYS . . . 130.81 91.95 0.59 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -85.47 -12.43 51.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.85 0.357 . . . . 0.0 110.488 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.17 41.84 1.59 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.3 t -81.87 108.58 15.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.03 0.443 . . . . 0.0 110.685 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.8 tt -145.47 152.09 14.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.318 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.647 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 1.0 OUTLIER -129.84 177.1 7.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.699 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.15 165.93 21.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.417 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.437 HG23 ' HG2' ' A' ' 31' ' ' MET . 6.1 tp -51.76 -25.9 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.64 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.437 ' HG2' HG23 ' A' ' 30' ' ' ILE . 4.9 mtt -86.34 -29.8 22.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.633 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.66 62.78 1.59 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -137.4 -36.06 0.66 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.785 0.326 . . . . 0.0 110.688 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -94.76 54.15 1.71 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.183 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.647 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 1.8 m -85.56 114.4 22.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.622 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.415 ' OE2' ' N ' ' A' ' 12' ' ' ARG . 9.2 mm-40 -137.74 154.3 49.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.803 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -98.76 111.3 23.72 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.191 179.356 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -102.06 147.04 33.36 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.643 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo . . . . . 0 N--CA 1.494 1.547 0 C-N-CA 122.339 2.026 . . . . 0.0 112.325 179.604 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.2 m . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 120.714 0.292 . . . . 0.0 110.497 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.661 ' CD1' ' H ' ' A' ' 9' ' ' ASP . 1.5 pp -106.07 -5.07 9.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.536 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.64 ' N ' HD12 ' A' ' 6' ' ' ILE . . . 73.64 -56.14 0.66 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.639 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 10' ' ' TYR . 30.9 mmtm -49.17 -14.04 0.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.713 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.661 ' H ' ' CD1' ' A' ' 6' ' ' ILE . 19.4 m-20 59.1 -76.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.524 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.538 ' N ' ' O ' ' A' ' 8' ' ' LYS . 52.0 m-85 -108.95 163.68 13.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.505 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.23 -156.67 15.51 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.546 HH12 ' N ' ' A' ' 35' ' ' CYS . 0.2 OUTLIER -39.68 130.66 1.87 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.838 0.351 . . . . 0.0 110.876 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.599 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 26.6 p -157.01 179.17 9.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.587 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -160.64 115.53 2.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.467 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -56.96 -39.63 74.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.762 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -98.91 28.13 16.65 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -147.0 -78.21 0.03 OUTLIER Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.2 p -90.4 148.07 38.12 Favored Pre-proline 0 C--N 1.325 -0.478 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.197 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.64 -31.72 10.42 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.386 2.057 . . . . 0.0 112.422 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 22' ' ' ARG . 17.2 t 58.16 87.26 0.07 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.359 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -37.17 -76.47 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.711 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.402 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -99.81 175.12 5.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.545 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.479 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 50.95 74.87 0.25 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -79.79 10.75 3.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.664 0.269 . . . . 0.0 110.442 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.14 49.84 4.3 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.405 ' SG ' ' C ' ' A' ' 13' ' ' CYS . 5.2 t -68.89 90.77 0.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.949 0.404 . . . . 0.0 110.387 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.2 tt -103.97 147.45 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.405 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 11.3 m -126.79 164.3 21.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.737 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 m -73.18 167.25 21.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.458 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.5 tp -51.55 -28.35 8.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.668 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.6 mtm -80.09 -33.66 38.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.625 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.04 65.22 1.39 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.0 t -150.21 -28.88 0.23 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.768 0.318 . . . . 0.0 110.663 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.426 ' C ' HH12 ' A' ' 12' ' ' ARG . 13.9 t-20 -93.85 53.93 1.88 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.446 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.546 ' N ' HH12 ' A' ' 12' ' ' ARG . 72.5 m -75.04 120.27 20.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.681 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.453 ' C ' ' SG ' ' A' ' 13' ' ' CYS . 56.3 mt-10 -135.56 138.42 42.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.62 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.599 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -83.8 105.38 14.66 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.22 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.52 149.69 40.62 Favored Pre-proline 0 C--O 1.236 0.368 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.574 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo . . . . . 0 N--CA 1.495 1.565 0 C-N-CA 122.597 2.198 . . . . 0.0 111.975 179.412 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.416 ' SG ' ' N ' ' A' ' 6' ' ' ILE . 14.0 p . . . . . 0 CA--C 1.523 -0.089 0 CA-C-O 120.865 0.364 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.537 HD12 ' N ' ' A' ' 7' ' ' ALA . 1.7 pp -104.09 1.33 10.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.902 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.537 ' N ' HD12 ' A' ' 6' ' ' ILE . . . 68.6 -64.56 0.31 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.506 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 6' ' ' ILE . 7.7 mmtp -56.61 -164.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.665 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.409 ' O ' ' O ' ' A' ' 10' ' ' TYR . 3.8 p-10 -139.28 127.87 23.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.471 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.409 ' O ' ' O ' ' A' ' 9' ' ' ASP . 79.4 m-85 54.42 167.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.63 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.07 -113.48 1.75 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.42 ' NH1' HG21 ' A' ' 18' ' ' THR . 1.3 ptm180 -108.91 136.96 47.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.667 0.27 . . . . 0.0 110.823 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 5.9 p -143.48 174.75 10.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.995 0.426 . . . . 0.0 110.935 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -160.4 108.14 1.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.385 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.505 ' C ' ' H ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -41.07 -67.41 0.25 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.849 -179.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.78 28.55 0.91 Allowed Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 15' ' ' TRP . . . -145.34 -92.95 0.14 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.42 HG21 ' NH1' ' A' ' 12' ' ' ARG . 3.2 p -91.45 144.8 30.2 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.093 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.82 -32.7 7.1 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.128 1.885 . . . . 0.0 112.386 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.1 t 67.55 100.93 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.595 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -58.63 -83.97 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.599 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.4 mmt-85 -84.19 117.32 23.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.597 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.508 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 115.24 89.85 1.64 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -86.37 -24.13 25.9 Favored 'General case' 0 N--CA 1.44 -0.939 0 O-C-N 122.532 -0.393 . . . . 0.0 110.268 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.01 58.46 0.79 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.8 t -87.78 113.06 23.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.871 0.367 . . . . 0.0 110.259 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.1 tt -131.15 156.53 42.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.592 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.635 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.5 OUTLIER -135.73 174.62 10.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.541 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.1 t -79.95 158.41 26.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.441 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -42.96 -32.0 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 120.906 0.384 . . . . 0.0 110.092 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 16.6 mtm -79.31 -43.35 23.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.994 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.01 62.85 0.88 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 t -139.47 -35.02 0.55 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.81 0.338 . . . . 0.0 110.64 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -95.15 50.85 1.29 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.142 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.635 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 31.3 m -75.15 102.34 4.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.533 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -109.88 141.25 42.86 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.15 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.3 OUTLIER -97.09 103.49 15.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.227 179.562 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.89 162.1 47.36 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.436 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo . . . . . 0 C--N 1.31 -1.494 0 C-N-CA 122.514 2.143 . . . . 0.0 112.174 179.985 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.529 0.16 0 CA-C-O 120.726 0.298 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.653 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 2.3 pp -141.95 -0.19 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 6' ' ' ILE . . . 80.35 -64.31 0.19 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.728 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 7' ' ' ALA . 10.1 mttp -53.61 -170.28 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.155 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -126.78 -155.22 0.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.66 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -45.01 155.4 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.485 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 144.47 -103.28 0.29 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.466 HH11 ' NZ ' ' A' ' 14' ' ' LYS . 0.9 OUTLIER -123.32 134.7 54.02 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.788 0.328 . . . . 0.0 110.871 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -148.67 179.84 7.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.661 179.463 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.602 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 2.4 tttp -143.73 110.34 5.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.511 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.516 ' C ' ' H ' ' A' ' 17' ' ' GLY . 10.1 m95 -48.19 141.56 6.19 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.552 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.29 -36.31 0.26 Allowed Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 15' ' ' TRP . . . -83.08 -91.29 0.67 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 19' ' ' PRO . 13.5 p -91.73 111.56 50.12 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-O 119.312 -0.375 . . . . 0.0 110.731 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 18' ' ' THR . 42.7 Cg_exo -52.46 -156.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.169 1.912 . . . . 0.0 112.672 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -165.27 92.77 0.57 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.296 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.6 m -41.45 -77.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.657 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 36.1 mtt85 -94.74 115.71 27.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.476 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.55 85.82 1.88 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.9 ptm85 -80.3 0.56 32.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.584 0.231 . . . . 0.0 110.773 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.36 98.25 2.4 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -121.06 108.74 14.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.235 0.54 . . . . 0.0 110.323 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.6 tt -114.58 155.9 15.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.782 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.8 m -132.35 177.58 7.48 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.899 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.685 ' N ' HD21 ' A' ' 34' ' ' ASN . 11.9 t -91.29 159.59 15.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.568 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.4 tp -40.67 -24.75 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.651 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.474 ' N ' ' O ' ' A' ' 29' ' ' SER . 3.1 mtt -80.76 -42.26 22.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.752 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 29' ' ' SER . . . 87.28 63.17 1.44 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 t -150.6 -31.33 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.838 0.352 . . . . 0.0 110.466 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.685 HD21 ' N ' ' A' ' 29' ' ' SER . 0.1 OUTLIER -89.44 32.22 0.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.464 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 90.3 m -51.46 105.11 0.1 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.657 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -107.59 132.83 52.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.309 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -87.48 130.11 34.82 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.544 179.335 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.32 162.28 43.33 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.47 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo . . . . . 0 N--CA 1.493 1.469 0 C-N-CA 122.668 2.245 . . . . 0.0 112.142 179.692 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 7' ' ' ALA . 1.8 m . . . . . 0 N--CA 1.455 -0.206 0 CA-C-O 120.641 0.257 . . . . 0.0 110.313 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 19' ' ' PRO . 1.3 pp -39.49 -28.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.679 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 9' ' ' ASP . . . 68.05 -57.73 0.46 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.818 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.579 ' NZ ' ' CB ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -44.55 -16.57 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.944 0.402 . . . . 0.0 110.998 -179.415 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.504 ' H ' HD12 ' A' ' 6' ' ' ILE . 0.8 OUTLIER 72.6 111.02 0.06 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.501 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 55.87 169.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.478 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.19 -105.68 1.05 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -111.19 145.05 39.35 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.813 0.339 . . . . 0.0 110.503 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.9 p -145.43 168.72 19.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.721 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.63 109.83 3.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.489 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -52.95 -40.88 64.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.943 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.55 27.37 20.6 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -168.54 -126.11 0.83 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -40.45 109.26 0.59 Allowed Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.841 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.558 ' O ' HG23 ' A' ' 6' ' ' ILE . 54.3 Cg_endo -76.1 152.45 35.78 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.96 1.773 . . . . 0.0 112.097 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.73 137.57 51.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.134 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -95.34 -79.47 0.43 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.485 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 70.7 mtt-85 -81.99 109.06 15.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.549 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.499 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 103.47 92.09 2.22 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.37 14.56 10.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.751 0.31 . . . . 0.0 110.643 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.56 56.73 4.17 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.0 t -79.94 113.49 18.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.728 0.299 . . . . 0.0 110.659 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.5 tt -126.02 148.44 30.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.315 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.1 m -126.33 174.15 8.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.605 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.12 169.44 17.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.49 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.415 HG23 ' HG2' ' A' ' 31' ' ' MET . 0.6 OUTLIER -52.36 -27.41 10.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.929 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.415 ' HG2' HG23 ' A' ' 30' ' ' ILE . 1.6 mtp -85.5 -25.58 26.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.66 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.84 66.04 1.66 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.0 t -145.18 -34.15 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.846 0.355 . . . . 0.0 110.547 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.62 53.8 2.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.324 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.7 m -72.13 98.29 2.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -105.31 140.64 38.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.819 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 0.7 OUTLIER -93.03 111.22 22.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.344 179.488 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.52 158.01 63.29 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.828 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo . . . . . 0 N--CA 1.494 1.555 0 C-N-CA 122.682 2.255 . . . . 0.0 112.07 179.72 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.547 ' SG ' ' N ' ' A' ' 6' ' ' ILE . 31.0 p . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 120.759 0.314 . . . . 0.0 110.413 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.663 HD13 ' H ' ' A' ' 9' ' ' ASP . 2.6 pp -119.76 -174.26 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.509 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.35 -1.57 2.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.575 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.429 ' HZ2' HG12 ' A' ' 6' ' ' ILE . 1.4 pttm -83.93 -12.36 55.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.593 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.663 ' H ' HD13 ' A' ' 6' ' ' ILE . 0.1 OUTLIER 60.11 133.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.549 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.432 ' O ' ' O ' ' A' ' 9' ' ' ASP . 52.5 m-85 44.29 -170.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.686 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.95 -153.96 18.69 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.2 ttt-85 -80.15 153.59 28.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.737 0.303 . . . . 0.0 110.556 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.556 ' SG ' ' N ' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -156.3 -178.74 7.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.664 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.556 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -139.47 118.21 12.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.394 179.758 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -60.01 -11.28 5.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.728 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.419 ' H ' ' HD3' ' A' ' 14' ' ' LYS . . . -128.2 25.84 4.81 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -170.28 -144.64 4.4 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.1 p -38.32 102.59 0.25 Allowed Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 121.314 -0.154 . . . . 0.0 110.916 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -79.97 -163.03 0.2 Allowed 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.403 2.069 . . . . 0.0 112.237 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.505 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 31.7 p -144.64 112.37 6.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.573 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -51.64 -81.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.636 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.419 ' H ' ' HD2' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -77.03 118.4 19.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.58 -179.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.504 ' O ' ' SG ' ' A' ' 20' ' ' CYS . . . 96.14 66.95 0.96 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -78.43 25.01 0.25 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 120.838 0.351 . . . . 0.0 110.6 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . -98.83 75.85 0.54 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -96.73 104.0 15.96 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.561 0.695 . . . . 0.0 110.784 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.615 ' O ' HG23 ' A' ' 27' ' ' ILE . 10.6 tt -97.39 110.61 25.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.282 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.03 156.66 17.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.669 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.3 m -80.09 161.0 25.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.705 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.8 tp -44.27 -27.51 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.652 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.9 mtt -86.12 -40.46 15.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.601 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.22 65.06 0.74 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.8 t -158.74 -0.66 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.592 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -109.93 23.86 13.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.632 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.4 m -54.74 104.83 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.512 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -115.72 107.38 15.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.911 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 1.1 m -72.34 109.44 6.06 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.457 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.433 ' CB ' ' CD ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -125.48 177.5 1.87 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.877 -179.799 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' A' ' 38' ' ' LYS . 23.3 Cg_exo . . . . . 0 N--CA 1.496 1.631 0 C-N-CA 122.779 2.319 . . . . 0.0 112.231 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.5 m . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 121.006 0.431 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.54 HD13 ' H ' ' A' ' 9' ' ' ASP . 0.6 OUTLIER -120.95 -20.98 4.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.428 -179.522 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 6' ' ' ILE . . . 68.61 -37.82 0.36 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.039 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.513 ' H ' ' C ' ' A' ' 6' ' ' ILE . 3.5 mttm -64.34 -30.67 71.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.661 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.54 ' H ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER 56.92 126.23 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.117 -179.52 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.564 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 2.4 m-30 64.11 114.56 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.433 0.635 . . . . 0.0 110.534 178.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 158.66 -144.51 10.43 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.791 -0.923 . . . . 0.0 110.791 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.516 ' O ' ' NH2' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -83.52 156.34 22.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.878 0.37 . . . . 0.0 110.707 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.444 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 28.2 p -158.62 170.07 22.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.537 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.79 114.3 3.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.617 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -62.71 -11.8 19.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.707 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.33 10.28 14.84 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -139.56 -98.96 0.42 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.2 p -90.11 145.62 33.32 Favored Pre-proline 0 C--N 1.327 -0.399 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.918 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.9 -160.84 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.466 2.111 . . . . 0.0 112.155 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -165.27 103.01 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.54 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.43 -89.31 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.785 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -82.65 121.49 26.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.606 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.511 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 99.11 69.18 0.91 Allowed Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -79.45 27.89 0.26 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.982 0.42 . . . . 0.0 110.529 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 36' ' ' GLU . . . -93.37 66.56 1.76 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.582 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 56.4 m -84.6 87.56 7.28 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.348 0.594 . . . . 0.0 110.697 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.648 ' O ' HG23 ' A' ' 27' ' ' ILE . 1.7 tt -80.07 96.96 2.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.495 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 94.4 m -92.16 154.99 18.33 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.472 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.407 ' C ' ' N ' ' A' ' 31' ' ' MET . 1.2 m -91.77 171.31 9.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.767 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 tp -51.8 -14.82 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.571 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . 0.407 ' N ' ' C ' ' A' ' 29' ' ' SER . 4.7 mtm -106.98 -42.9 4.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.761 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.38 56.13 0.74 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 t -133.84 -22.44 1.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 0.0 110.446 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -94.26 13.18 24.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.576 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.6 m -49.49 91.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.681 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 34' ' ' ASN . 2.9 tt0 -107.31 123.2 47.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.582 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.582 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -77.73 99.6 5.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.361 179.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.413 ' HZ3' ' HB2' ' A' ' 38' ' ' LYS . 23.9 mtmm -95.82 148.71 34.99 Favored Pre-proline 0 C--O 1.237 0.398 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.88 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo . . . . . 0 N--CA 1.493 1.479 0 C-N-CA 122.538 2.159 . . . . 0.0 112.146 179.653 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.234 0.237 0 CA-C-O 120.846 0.355 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.426 HD12 ' C ' ' A' ' 6' ' ' ILE . 2.6 pp -130.96 -166.18 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.325 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.448 ' C ' ' H ' ' A' ' 9' ' ' ASP . . . -131.86 -24.93 2.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.758 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.696 ' H ' ' CD ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -71.76 12.52 0.37 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.79 -179.66 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.52 ' OD2' ' N ' ' A' ' 10' ' ' TYR . 6.7 p-10 36.2 -121.52 0.15 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.523 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.52 ' N ' ' OD2' ' A' ' 9' ' ' ASP . 60.5 m-85 -72.04 168.64 17.66 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.459 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.24 -145.86 17.46 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.447 ' NH1' ' NZ ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -37.74 119.26 0.73 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.853 0.358 . . . . 0.0 111.081 -179.688 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.488 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 26.9 p -151.9 171.54 17.62 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.688 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.447 ' NZ ' ' NH1' ' A' ' 12' ' ' ARG . 7.4 mttp -159.85 153.72 23.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.603 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.476 ' CZ2' ' SG ' ' A' ' 28' ' ' CYS . 0.9 OUTLIER -83.13 -52.57 6.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.783 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.48 -24.72 41.93 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.82 -119.88 0.17 Allowed Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.56 151.64 48.35 Favored Pre-proline 0 C--N 1.326 -0.416 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.663 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.52 -170.19 0.36 Allowed 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.568 2.179 . . . . 0.0 112.306 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.46 96.06 2.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.57 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 70.1 m -40.71 -84.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.582 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.515 ' O ' ' CE2' ' A' ' 10' ' ' TYR . 19.4 mtt85 -90.85 41.31 1.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.518 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.45 145.82 17.74 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.85 -25.62 0.5 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.749 0.309 . . . . 0.0 110.555 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.49 67.29 0.52 Allowed Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.426 ' O ' ' NE1' ' A' ' 15' ' ' TRP . 13.3 t -79.75 85.68 5.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.924 0.392 . . . . 0.0 110.348 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.9 tt -96.2 150.86 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.528 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.476 ' SG ' ' CZ2' ' A' ' 15' ' ' TRP . 3.7 m -130.56 177.73 7.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.769 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.92 174.7 11.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.664 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -53.79 -28.33 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.671 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.0 mtt -83.65 -46.14 12.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.721 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.9 62.38 0.82 Allowed Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.9 t -142.86 -25.73 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.796 0.332 . . . . 0.0 110.615 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -100.41 46.58 0.95 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.569 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.8 m -63.24 124.68 21.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.698 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.447 ' C ' ' SG ' ' A' ' 13' ' ' CYS . 41.3 mt-10 -130.62 138.68 50.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.52 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.488 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -87.1 122.87 31.52 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.173 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.59 148.06 63.07 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.805 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 N--CA 1.495 1.586 0 C-N-CA 122.452 2.102 . . . . 0.0 111.996 179.49 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.475 ' C ' ' H ' ' A' ' 3' ' ' LYS . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.511 ' NZ ' ' NH2' ' A' ' 22' ' ' ARG . 10.4 mmtm 55.7 5.4 0.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.696 0.284 . . . . 0.0 110.647 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.475 ' H ' ' C ' ' A' ' 1' ' ' GLY . 4.7 mttp -76.09 10.38 1.97 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.616 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.03 -9.51 8.71 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.673 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.519 ' SG ' ' N ' ' A' ' 6' ' ' ILE . 23.5 p -135.05 -118.59 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.625 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.651 ' C ' HD12 ' A' ' 6' ' ' ILE . 2.5 pp -127.25 174.0 11.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.522 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.414 ' O ' ' OD1' ' A' ' 9' ' ' ASP . . . -114.3 -11.59 12.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.615 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 10' ' ' TYR . 51.1 mttt -58.14 -25.62 61.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.517 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.424 ' H ' HD13 ' A' ' 6' ' ' ILE . 1.5 m-20 68.07 -66.68 0.21 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.456 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.413 ' N ' ' O ' ' A' ' 8' ' ' LYS . 47.5 m-85 -137.22 162.31 33.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.436 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.499 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 99.1 -135.95 12.42 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.661 ' HE ' ' H ' ' A' ' 12' ' ' ARG . 0.5 OUTLIER -39.61 111.06 0.16 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.731 0.301 . . . . 0.0 110.829 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.552 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 24.3 p -147.26 148.71 31.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.689 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -145.23 119.67 9.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.574 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.36 -34.98 71.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.529 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -96.85 1.85 61.6 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -141.22 -134.07 2.99 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 19' ' ' PRO . 6.6 p -39.07 102.74 0.26 Allowed Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 110.633 -0.136 . . . . 0.0 110.633 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 18' ' ' THR . 53.1 Cg_exo -50.89 -170.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 121.902 1.734 . . . . 0.0 112.48 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 6.5 t -153.44 80.93 1.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.236 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -40.1 -67.97 0.2 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.654 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.511 ' NH2' ' NZ ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -104.08 140.59 37.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.45 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.501 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 79.76 88.81 0.5 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.48 ' CZ ' ' O ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -81.94 -7.35 59.6 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.986 -0.286 . . . . 0.0 110.684 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.65 67.23 0.17 Allowed Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 24' ' ' ARG . 8.6 t -96.92 101.16 12.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.873 0.368 . . . . 0.0 110.352 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 15.6 tt -124.43 151.08 29.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.289 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 5.4 m -120.01 161.12 21.47 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.813 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.6 m -64.97 -177.03 0.32 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.554 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.8 tp -62.86 -30.79 50.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.822 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.3 mtm -80.35 -26.35 38.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.767 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.53 62.1 1.9 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.2 t -147.39 -29.53 0.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.846 0.355 . . . . 0.0 110.6 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -90.47 53.73 2.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.511 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.5 m -73.64 103.67 4.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.695 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -117.51 144.5 45.01 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.975 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.552 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -91.91 117.48 29.84 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.494 179.631 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.6 148.9 40.74 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.332 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.77 -28.41 25.24 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 122.176 1.917 . . . . 0.0 111.983 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.4 mtp85 -64.8 141.83 58.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.666 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.998 ' H ' HD22 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -81.44 -160.56 0.35 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.558 -179.647 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.11 -36.87 39.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.499 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -61.01 109.07 0.98 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.622 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -80.71 23.99 0.5 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.708 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -168.19 -91.07 0.08 OUTLIER Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.828 ' H ' HD12 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -129.39 -62.26 0.99 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.828 0.347 . . . . 0.0 110.66 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -165.92 49.6 0.27 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.0 tt -93.25 -45.3 7.91 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.455 0 CA-C-O 117.992 -1.004 . . . . 0.0 110.483 179.845 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 69.48 149.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.904 0.383 . . . . 0.0 110.601 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.0 ttpp 66.09 62.95 0.58 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.525 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.408 ' NZ ' ' SG ' ' A' ' 21' ' ' CYS . 0.0 OUTLIER -134.62 -24.56 1.53 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.706 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.449 ' HB2' ' H ' ' A' ' 21' ' ' CYS . 7.8 m -55.89 -78.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.694 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.67 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -118.96 6.59 6.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.766 -179.182 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' A' ' 6' ' ' ILE . . . 79.37 -55.57 0.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.303 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 24.2 pttm -80.6 -142.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.207 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 9' ' ' ASP . 7.1 p-10 -131.9 -112.65 0.24 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.09 0.471 . . . . 0.0 111.043 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.478 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.8 m-30 -58.29 147.38 30.96 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.565 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.442 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 164.51 -157.61 30.04 Favored Glycine 0 CA--C 1.525 0.668 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.318 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.41 HH21 ' HB3' ' A' ' 12' ' ' ARG . 5.0 ptm85 -71.61 125.23 26.56 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.815 0.34 . . . . 0.0 111.072 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -145.36 142.5 29.43 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.644 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.95 130.26 33.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.531 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -48.76 -34.39 12.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.568 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -112.92 24.69 12.55 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.64 -127.37 2.89 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.2 p -85.14 146.93 46.39 Favored Pre-proline 0 CA--C 1.534 0.362 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.369 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -74.07 -159.61 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.444 2.096 . . . . 0.0 112.142 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -171.97 95.47 0.16 Allowed 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.905 179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.449 ' H ' ' HB2' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -42.52 -85.07 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.294 -179.358 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.83 122.32 22.27 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.273 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 101.41 87.19 1.97 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.872 -0.891 . . . . 0.0 110.872 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 -85.1 -23.58 28.42 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 120.885 0.374 . . . . 0.0 110.131 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.05 75.48 0.12 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 4.6 t -92.48 111.78 23.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.115 0.483 . . . . 0.0 110.25 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.469 ' CG1' ' N ' ' A' ' 28' ' ' CYS . 10.7 tt -125.76 162.5 28.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.656 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 1.7 t -144.76 -171.86 3.71 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.777 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.08 170.65 9.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.513 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.401 ' HA ' HD12 ' A' ' 30' ' ' ILE . 9.0 tp -52.06 -27.24 9.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.576 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.8 mtp -83.56 -38.91 21.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.608 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.26 48.0 2.7 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.644 HG23 ' N ' ' A' ' 34' ' ' ASN . 10.1 t -122.97 -50.7 1.92 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.757 0.313 . . . . 0.0 110.45 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.644 ' N ' HG23 ' A' ' 33' ' ' THR . 2.9 t-20 -76.77 51.66 0.78 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.201 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.623 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 3.7 m -84.66 123.53 30.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.988 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -139.77 148.5 42.32 Favored 'General case' 0 C--O 1.233 0.213 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.732 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 11' ' ' GLY . 0.7 OUTLIER -91.17 117.51 29.68 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.796 178.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.56 164.53 41.99 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.203 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -73.07 176.38 9.18 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.564 2.176 . . . . 0.0 112.253 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.6 mtm180 -71.31 -172.36 0.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.486 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.1 mp -122.57 33.73 5.35 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.712 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.52 142.27 43.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.28 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.443 ' SD ' ' N ' ' A' ' 43' ' ' MET . 2.1 mpt? -102.71 108.72 20.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.499 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.07 -41.62 94.89 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.63 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.439 ' H ' ' H ' ' A' ' 46' ' ' LEU . . . 178.8 10.15 0.02 OUTLIER Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.439 ' H ' ' H ' ' A' ' 45' ' ' GLY . 1.6 mp -89.17 -43.73 10.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.524 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.19 35.55 12.19 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.657 HD23 ' N ' ' A' ' 49' ' ' ALA . 0.8 OUTLIER -150.04 -40.78 0.14 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.793 0.33 . . . . 0.0 110.456 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.657 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.456 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -153.74 84.31 1.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.698 0.285 . . . . 0.0 110.527 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -177.56 20.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.617 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.574 ' N ' ' CD ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -111.35 -37.87 5.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.371 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.425 ' O ' ' O ' ' A' ' 4' ' ' LYS . 2.9 p -45.54 -96.64 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.656 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.4 pp -112.99 -174.36 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.272 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -106.63 -5.19 18.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.456 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.504 ' NZ ' ' O ' ' A' ' 12' ' ' ARG . 4.9 pttt -111.84 -119.73 0.29 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.561 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.489 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 23.9 p-10 -173.72 -42.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.45 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.469 ' CZ ' ' O ' ' A' ' 22' ' ' ARG . 69.0 m-85 -140.98 165.36 27.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.757 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 105.58 -152.58 17.2 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.244 -0.743 . . . . 0.0 111.244 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.504 ' O ' ' NZ ' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -37.42 130.31 0.96 Allowed 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.848 0.356 . . . . 0.0 111.022 -179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.586 ' SG ' ' N ' ' A' ' 14' ' ' LYS . 0.8 OUTLIER -160.28 157.58 28.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.606 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.586 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 8.3 tttm -156.7 108.67 2.47 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.382 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 33.1 m95 -48.97 -27.3 3.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.623 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.12 -31.7 16.42 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -95.96 -104.38 2.07 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.0 p -90.22 144.02 30.48 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.597 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.1 -160.43 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.287 1.992 . . . . 0.0 111.956 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.421 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 12.8 t -160.98 90.45 0.83 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.933 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -49.81 -83.01 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.817 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.469 ' O ' ' CZ ' ' A' ' 10' ' ' TYR . 1.1 mpt_? -78.41 101.33 7.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.839 0.352 . . . . 0.0 110.431 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.493 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 112.83 116.45 3.4 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.421 ' C ' ' H ' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -110.91 4.81 20.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.782 0.325 . . . . 0.0 110.363 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -74.6 40.93 1.15 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.888 -0.885 . . . . 0.0 110.888 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 56.2 m -71.73 88.88 1.0 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.786 0.327 . . . . 0.0 110.296 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.3 tt -115.54 156.81 16.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.545 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.629 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.5 OUTLIER -137.45 -172.47 3.23 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.829 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 31' ' ' MET . 1.6 t -98.55 161.01 13.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.553 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.3 tp -42.19 -24.57 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.445 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.44 ' N ' ' O ' ' A' ' 29' ' ' SER . 2.8 mtt -81.66 -47.37 13.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.507 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.18 50.59 1.72 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.819 -0.913 . . . . 0.0 110.819 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.621 HG23 ' N ' ' A' ' 34' ' ' ASN . 8.9 t -131.15 -49.54 1.01 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.769 0.319 . . . . 0.0 110.659 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.621 ' N ' HG23 ' A' ' 33' ' ' THR . 72.0 m-80 -77.12 46.27 0.48 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.443 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.629 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 7.9 m -75.86 121.4 22.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.671 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -135.42 155.7 50.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.004 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 1.2 t -98.75 114.73 27.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.257 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.3 mtmt -113.44 146.81 36.14 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.547 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -70.56 -162.84 0.1 Allowed 'Trans proline' 0 N--CA 1.495 1.616 0 C-N-CA 122.384 2.056 . . . . 0.0 112.147 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.3 ptm180 -101.96 170.42 8.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.5 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.9 mp -51.25 123.06 8.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.641 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -88.37 -50.69 13.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.606 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 20.7 mtm -137.82 131.21 30.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.54 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -63.04 -106.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.542 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -103.67 -18.02 15.4 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.463 ' H ' HD12 ' A' ' 46' ' ' LEU . 2.1 mp -91.67 173.1 8.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.663 0.268 . . . . 0.0 110.589 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -118.29 63.02 0.43 Allowed Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -153.78 -41.21 0.09 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.856 0.36 . . . . 0.0 110.472 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.655 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.221 -0.432 0 CA-C-O 118.09 -0.957 . . . . 0.0 110.419 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.475 ' NZ ' ' NH1' ' A' ' 22' ' ' ARG . 1.5 mmmp? 53.76 15.52 0.82 Allowed 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 121.089 -0.245 . . . . 0.0 110.587 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.6 mmtm -119.05 28.85 8.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.631 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.32 -28.75 38.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.371 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -85.72 -100.54 0.06 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.135 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.785 HD13 ' H ' ' A' ' 9' ' ' ASP . 2.4 pp -135.23 -167.65 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.376 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -127.56 -17.56 4.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.752 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.497 ' CD ' ' N ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -61.42 -42.48 98.81 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.856 -0.337 . . . . 0.0 110.289 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.785 ' H ' HD13 ' A' ' 6' ' ' ILE . 15.5 m-20 61.18 135.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.83 0.348 . . . . 0.0 110.108 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 9' ' ' ASP . 15.2 m-85 49.99 176.35 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.529 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.521 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 83.21 -153.52 30.7 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -42.48 143.73 0.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.816 0.341 . . . . 0.0 110.82 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.591 ' SG ' ' N ' ' A' ' 36' ' ' GLU . 28.9 p -147.33 168.91 20.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.526 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -160.72 104.88 1.39 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.287 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -53.75 -19.16 3.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.37 . . . . 0.0 110.744 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -99.55 -8.54 52.16 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -147.72 -112.62 0.7 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.9 p -38.84 101.88 0.24 Allowed Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 110.453 -0.202 . . . . 0.0 110.453 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -79.1 -22.88 8.19 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.195 1.93 . . . . 0.0 112.567 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.438 ' O ' ' C ' ' A' ' 21' ' ' CYS . 0.4 OUTLIER 66.17 91.05 0.09 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.565 -179.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.497 ' SG ' ' O ' ' A' ' 6' ' ' ILE . 89.3 m -36.25 -73.08 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.521 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.475 ' NH1' ' NZ ' ' A' ' 2' ' ' LYS . 1.6 mpt_? -94.66 125.34 39.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.491 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 103.7 100.9 2.62 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.5 ppt_? -96.16 -2.22 46.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.745 0.307 . . . . 0.0 110.482 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' A' ' 38' ' ' LYS . . . -68.4 64.26 0.41 Allowed Glycine 0 CA--C 1.522 0.492 0 N-CA-C 111.191 -0.764 . . . . 0.0 111.191 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 47.1 t -85.39 71.23 10.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.288 0.566 . . . . 0.0 110.452 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.6 tt -86.27 145.56 7.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.754 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.572 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -126.93 166.17 18.02 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.965 -179.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.0 168.75 18.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.656 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.3 tp -54.38 -26.86 16.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.674 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.2 mtm -85.14 -41.19 15.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.463 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 106.64 59.91 0.59 Allowed Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.0 t -142.25 -30.43 0.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.336 . . . . 0.0 110.576 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -84.5 46.34 1.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.367 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.572 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 23.5 m -75.26 110.97 10.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.655 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.591 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 9.4 mt-10 -143.21 136.64 28.31 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.462 179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' A' ' 11' ' ' GLY . 0.5 OUTLIER -74.26 120.65 20.12 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.429 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 25' ' ' GLY . 0.7 OUTLIER -101.53 146.91 33.05 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.387 -179.594 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -68.91 163.54 37.09 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.452 2.101 . . . . 0.0 112.198 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.547 ' HE ' HD13 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -140.22 -176.84 4.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.602 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.42 ' N ' HD12 ' A' ' 41' ' ' LEU . 10.8 mp -97.83 76.04 2.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.458 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.547 HD13 ' HE ' ' A' ' 40' ' ' ARG . 1.4 tp -69.55 152.06 9.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.611 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.536 ' N ' ' SD ' ' A' ' 43' ' ' MET . 1.2 mpt? -43.38 166.24 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.573 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -48.33 -14.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.585 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.451 ' N ' ' C ' ' A' ' 43' ' ' MET . . . 171.89 -45.6 0.18 Allowed Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.859 -0.897 . . . . 0.0 110.859 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.408 ' O ' ' CB ' ' A' ' 43' ' ' MET . 1.6 mp -106.34 128.88 54.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.776 0.322 . . . . 0.0 110.351 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.53 59.28 1.61 Allowed Glycine 0 CA--C 1.52 0.357 0 N-CA-C 110.59 -1.004 . . . . 0.0 110.59 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.642 ' C ' HD23 ' A' ' 48' ' ' LEU . 0.9 OUTLIER -121.6 -39.39 2.65 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.855 0.36 . . . . 0.0 110.491 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.64 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.459 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.6 ptpt -141.8 -89.88 0.15 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.766 0.317 . . . . 0.0 110.597 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -164.03 -159.57 0.5 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.66 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 0.1 OUTLIER -82.76 -171.03 3.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.53 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 4' ' ' LYS . 0.5 OUTLIER 77.77 171.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.473 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.675 HG23 ' O ' ' A' ' 19' ' ' PRO . 2.6 pp -51.34 -172.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.969 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -149.26 63.45 1.03 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.628 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.408 ' H ' ' H ' ' A' ' 9' ' ' ASP . 39.3 pttt -169.11 -13.72 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.779 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.513 ' H ' HD13 ' A' ' 6' ' ' ILE . 2.7 m-20 65.04 127.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.41 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.411 ' O ' ' O ' ' A' ' 9' ' ' ASP . 18.9 m-85 50.0 178.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.563 -179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.95 -109.82 2.77 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.7 ttp85 -114.76 137.97 51.29 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.811 0.339 . . . . 0.0 110.403 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.2 p -143.01 178.3 7.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.658 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -157.18 116.97 3.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.988 0.423 . . . . 0.0 110.689 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.522 ' NE1' ' SG ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -51.19 139.36 18.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.363 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 71.88 -37.17 0.62 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.492 ' H ' ' C ' ' A' ' 15' ' ' TRP . . . -93.19 -145.0 16.01 Favored Glycine 0 CA--C 1.521 0.418 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.401 ' C ' ' O ' ' A' ' 17' ' ' GLY . 31.2 p -36.02 95.66 0.09 OUTLIER Pre-proline 0 CA--C 1.536 0.405 0 O-C-N 123.579 0.223 . . . . 0.0 110.696 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.675 ' O ' HG23 ' A' ' 6' ' ' ILE . 24.5 Cg_exo -61.87 156.88 46.17 Favored 'Trans proline' 0 N--CA 1.497 1.725 0 C-N-CA 122.105 1.87 . . . . 0.0 112.023 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -111.82 102.49 10.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.375 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -50.35 -71.67 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.544 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.9 mmp_? -104.25 107.77 18.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.273 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.47 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 133.68 77.83 0.11 Allowed Glycine 0 CA--C 1.52 0.381 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -79.39 5.37 12.78 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 120.934 0.397 . . . . 0.0 110.512 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -96.88 66.88 0.92 Allowed Glycine 0 CA--C 1.522 0.527 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.497 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 19.2 m -97.26 102.78 14.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.0 0.428 . . . . 0.0 110.643 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.2 tt -109.31 157.08 9.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.802 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -132.52 175.92 8.89 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.681 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.2 166.81 14.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.645 179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.492 HG23 ' HG2' ' A' ' 31' ' ' MET . 4.6 tp -47.29 -27.48 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.904 0.383 . . . . 0.0 110.623 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.492 ' HG2' HG23 ' A' ' 30' ' ' ILE . 1.3 mtt -89.5 -46.07 8.96 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.589 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.92 68.93 1.01 Allowed Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 2.8 t -146.23 -12.15 0.48 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.714 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -118.05 40.62 3.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.378 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.522 ' SG ' ' NE1' ' A' ' 15' ' ' TRP . 3.6 m -56.14 105.82 0.22 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.739 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.7 mt-10 -103.67 134.88 46.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.661 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.497 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 4.3 t -84.78 97.09 9.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.215 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -97.53 148.75 34.89 Favored Pre-proline 0 C--O 1.235 0.341 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.971 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_exo -39.56 -66.55 0.13 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 122.482 2.121 . . . . 0.0 112.407 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.6 ptp85 -135.9 -167.86 2.11 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.59 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.685 ' N ' HD12 ' A' ' 41' ' ' LEU . 8.1 mp -88.38 -173.51 4.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.552 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.6 tp -68.49 -19.45 24.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.442 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.51 ' N ' ' SD ' ' A' ' 43' ' ' MET . 0.0 OUTLIER -52.13 143.13 14.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.581 179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -75.26 38.1 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.525 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.441 ' H ' ' C ' ' A' ' 43' ' ' MET . . . 73.51 66.64 1.96 Allowed Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.726 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.9 mp 39.46 55.44 2.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.816 0.341 . . . . 0.0 110.735 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -139.53 -28.22 0.23 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.954 -0.858 . . . . 0.0 110.954 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.643 ' C ' HD23 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -103.8 -39.76 6.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.711 0.291 . . . . 0.0 110.507 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.618 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.054 -0.974 . . . . 0.0 110.505 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.9 mtmt 47.56 -168.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.806 0.336 . . . . 0.0 110.605 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.46 169.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.557 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.455 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 0.5 OUTLIER -81.2 -80.82 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.531 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.455 ' SG ' ' O ' ' A' ' 4' ' ' LYS . 7.2 p 35.87 -110.4 0.06 Allowed 'General case' 0 N--CA 1.461 0.083 0 O-C-N 123.253 0.346 . . . . 0.0 110.817 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.436 ' N ' ' SG ' ' A' ' 5' ' ' CYS . 2.2 pp -129.62 176.23 8.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.512 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.44 -19.0 10.28 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.017 0.437 . . . . 0.0 110.488 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.1 pptp? -89.54 58.39 4.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.925 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 10' ' ' TYR . 1.1 m-20 -36.62 133.9 0.52 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.782 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.436 ' O ' ' O ' ' A' ' 9' ' ' ASP . 88.3 m-85 56.51 158.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.512 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 118.05 -105.25 1.21 Allowed Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -99.46 144.72 28.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.901 0.382 . . . . 0.0 110.853 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -158.35 141.97 15.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.553 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.1 tptm -147.71 120.94 8.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.485 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -62.93 -17.97 62.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.445 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -108.73 9.72 34.81 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -134.85 -113.23 1.32 Allowed Glycine 0 CA--C 1.523 0.55 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 p -88.78 151.36 47.44 Favored Pre-proline 0 CA--C 1.533 0.294 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.473 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.07 -159.86 0.08 OUTLIER 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.394 2.063 . . . . 0.0 112.017 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.6 t -160.93 81.72 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.221 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -39.45 -68.82 0.15 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.803 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.8 mtt-85 -104.7 88.0 2.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.606 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.491 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 157.4 94.95 0.1 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.801 -0.92 . . . . 0.0 110.801 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.61 -7.79 27.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.71 0.291 . . . . 0.0 110.554 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -87.89 53.55 4.26 Favored Glycine 0 CA--C 1.521 0.44 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.567 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 91.8 m -75.98 93.72 3.3 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.1 tt -104.35 149.3 8.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.143 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.623 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.2 OUTLIER -134.52 -179.36 5.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.795 -179.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.88 172.59 8.06 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.293 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.423 HG23 ' HG2' ' A' ' 31' ' ' MET . 7.3 tp -55.2 -24.88 15.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.725 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.423 ' HG2' HG23 ' A' ' 30' ' ' ILE . 3.9 mtp -87.89 -16.81 32.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.617 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.42 64.5 3.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.6 t -140.77 -33.66 0.53 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.78 0.324 . . . . 0.0 110.533 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.422 ' ND2' ' OE1' ' A' ' 36' ' ' GLU . 3.2 t30 -95.71 47.58 1.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.331 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.623 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 59.4 m -69.79 107.91 3.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.728 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.422 ' OE1' ' ND2' ' A' ' 34' ' ' ASN . 10.9 mt-10 -111.66 146.66 37.08 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.055 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.567 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -94.44 116.41 28.77 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.557 179.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.431 ' CB ' ' CD ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -126.85 179.46 1.2 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.562 -179.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' A' ' 38' ' ' LYS . 22.1 Cg_exo -62.16 -148.4 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.592 0 C-N-CA 122.483 2.122 . . . . 0.0 112.028 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -101.61 -179.09 3.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.506 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.6 mp -49.95 -67.67 0.24 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.544 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 5.3 pt -74.15 152.3 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.567 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 10.1 mtt -66.88 139.15 57.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.55 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -65.02 -23.82 67.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.634 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 161.08 -38.29 0.42 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mp -97.67 156.02 16.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.73 0.3 . . . . 0.0 110.571 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.4 45.2 2.57 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.663 HD23 ' N ' ' A' ' 49' ' ' ALA . 0.7 OUTLIER -88.47 -40.2 13.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.808 0.337 . . . . 0.0 110.378 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.663 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.221 -0.446 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.605 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.3 mttp 50.54 90.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.732 0.301 . . . . 0.0 110.668 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -106.66 5.6 29.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.55 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.501 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -105.39 -165.21 1.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.486 179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 4' ' ' LYS . 11.5 p 37.21 -119.56 0.17 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.631 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.656 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 1.1 pp -108.43 0.83 9.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.772 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.656 ' HB3' ' O ' ' A' ' 6' ' ' ILE . . . 79.27 -61.95 0.31 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.514 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -65.55 -164.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.542 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -139.53 133.33 30.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.354 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 52.38 178.38 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.622 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 109.14 -123.99 7.13 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.446 ' NH1' ' O ' ' A' ' 33' ' ' THR . 3.9 tpt180 -98.31 146.94 25.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.64 0.257 . . . . 0.0 110.551 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.455 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 3.7 p -145.89 175.71 10.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.478 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.425 ' O ' ' N ' ' A' ' 17' ' ' GLY . 24.9 tttm -151.51 96.73 2.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.334 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -45.87 -21.62 0.14 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.76 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -110.76 36.28 4.33 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 14' ' ' LYS . . . 169.43 -124.72 1.18 Allowed Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.232 -0.747 . . . . 0.0 111.232 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 19' ' ' PRO . 71.6 p -37.28 100.01 0.19 Allowed Pre-proline 0 N--CA 1.464 0.269 0 O-C-N 123.443 0.143 . . . . 0.0 110.84 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.464 ' O ' ' O ' ' A' ' 18' ' ' THR . 39.6 Cg_exo -54.32 -145.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.529 2.152 . . . . 0.0 112.516 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.98 90.31 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.201 0.524 . . . . 0.0 110.709 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -45.68 -79.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.423 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 -95.04 126.73 40.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.358 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.499 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 99.88 82.02 1.64 Allowed Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.49 ' CD ' ' H ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -85.76 11.88 10.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.637 0.256 . . . . 0.0 110.603 -179.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.96 49.74 4.29 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 8.8 t -81.46 103.42 11.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.923 0.392 . . . . 0.0 110.913 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.7 tt -113.77 148.18 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.288 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.612 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -129.71 161.65 30.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.77 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.51 165.68 14.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.746 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.1 tp -52.3 -28.44 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.919 0.39 . . . . 0.0 110.635 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.6 mtt -83.49 -40.64 18.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.76 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.41 62.97 0.73 Allowed Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.446 ' O ' ' NH1' ' A' ' 12' ' ' ARG . 3.5 t -143.51 -24.36 0.59 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.762 0.315 . . . . 0.0 110.746 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -98.74 54.44 1.03 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.429 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.612 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 60.4 m -77.68 94.97 4.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.391 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -110.2 138.0 47.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.785 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -92.8 118.73 31.41 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.679 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -127.84 150.64 73.94 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.754 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.29 175.17 4.28 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.554 2.17 . . . . 0.0 112.106 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -90.96 -133.67 0.12 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.426 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.8 mp -133.93 -173.5 3.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.49 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.44 -53.91 41.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.559 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 11.0 mtt -46.69 151.69 0.56 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.497 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -90.21 -8.1 51.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.619 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 156.21 -42.33 0.56 Allowed Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.459 ' H ' HD12 ' A' ' 46' ' ' LEU . 0.8 OUTLIER -99.55 174.81 6.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.786 0.327 . . . . 0.0 110.571 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.54 57.9 1.14 Allowed Glycine 0 CA--C 1.522 0.521 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.628 ' C ' HD23 ' A' ' 48' ' ' LEU . 1.2 tt -129.18 -40.18 1.49 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.791 0.329 . . . . 0.0 110.515 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.593 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.059 -0.972 . . . . 0.0 110.584 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.2 tttt 54.46 39.0 30.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.824 0.345 . . . . 0.0 110.586 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -92.05 58.68 3.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.55 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 0.3 OUTLIER -132.59 -129.56 0.18 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.54 -179.775 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 4' ' ' LYS . 5.7 p 37.87 -119.2 0.2 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.665 179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.662 HD12 ' N ' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -101.24 -13.73 8.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.664 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.662 ' N ' HD12 ' A' ' 6' ' ' ILE . . . 71.4 -55.45 0.65 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.868 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 10' ' ' TYR . 9.3 pttt -52.86 -4.51 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.815 0.34 . . . . 0.0 111.188 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.543 ' H ' ' C ' ' A' ' 7' ' ' ALA . 26.8 t0 63.44 -75.36 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.503 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.534 ' CE1' ' OD1' ' A' ' 9' ' ' ASP . 82.9 m-85 -115.92 159.52 21.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.586 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 134.57 -154.94 21.68 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.484 ' NH1' HG21 ' A' ' 18' ' ' THR . 0.0 OUTLIER -55.57 117.18 3.37 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.589 0.233 . . . . 0.0 110.796 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.604 ' SG ' ' N ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -119.02 168.57 10.69 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.711 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.604 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -141.58 96.09 2.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.484 -179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -54.95 120.36 6.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.956 0.408 . . . . 0.0 110.443 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 96.83 -20.64 49.9 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -103.32 -68.81 0.79 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.484 HG21 ' NH1' ' A' ' 12' ' ' ARG . 44.2 p -89.89 144.52 31.65 Favored Pre-proline 0 CA--C 1.534 0.348 0 C-N-CA 120.572 -0.451 . . . . 0.0 110.777 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.41 -18.25 18.03 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.156 1.904 . . . . 0.0 112.342 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 44.2 t 47.41 90.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.341 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -39.4 -86.0 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.878 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.517 ' O ' ' CZ ' ' A' ' 10' ' ' TYR . 41.0 mtm180 -109.14 106.55 16.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.9 0.381 . . . . 0.0 110.386 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.509 ' H ' ' NH1' ' A' ' 24' ' ' ARG . . . 155.5 70.87 0.01 OUTLIER Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.514 ' CZ ' ' H ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -80.67 6.09 13.76 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.537 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -103.74 55.19 0.63 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.0 t -83.13 109.29 17.04 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.06 0.457 . . . . 0.0 110.683 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 20.3 tt -109.84 143.93 18.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.409 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.9 m -125.05 167.58 14.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.745 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.41 178.7 1.48 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.58 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.3 tp -61.32 -28.85 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.69 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 5.9 mtt -84.64 -35.98 22.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.544 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.39 62.51 0.77 Allowed Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.447 HG23 ' N ' ' A' ' 34' ' ' ASN . 8.9 t -142.63 -38.59 0.36 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.776 0.322 . . . . 0.0 110.615 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.447 ' N ' HG23 ' A' ' 33' ' ' THR . 4.1 t-20 -79.64 49.68 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.534 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 93.9 m -72.71 123.71 23.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.644 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -138.17 121.02 16.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.898 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.507 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 0.1 OUTLIER -70.14 115.1 8.95 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.338 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -125.27 149.89 65.51 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.716 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 40' ' ' ARG . 40.5 Cg_endo -68.61 -164.93 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.599 2.2 . . . . 0.0 112.09 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.484 ' C ' ' H ' ' A' ' 42' ' ' ILE . 85.9 mtt180 -46.08 172.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.536 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.593 ' N ' HD12 ' A' ' 41' ' ' LEU . 9.7 mp -72.21 16.02 0.15 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.532 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.484 ' H ' ' C ' ' A' ' 40' ' ' ARG . 1.6 tp -49.66 142.62 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.575 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.466 ' C ' ' N ' ' A' ' 45' ' ' GLY . 1.7 mpt? -95.46 127.52 41.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.613 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -47.9 -13.88 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.563 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.466 ' N ' ' C ' ' A' ' 43' ' ' MET . . . -172.2 -70.45 0.04 OUTLIER Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.967 ' H ' HD12 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -119.61 -62.56 1.48 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.736 0.303 . . . . 0.0 110.535 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -168.44 43.86 0.23 Allowed Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.623 ' C ' HD23 ' A' ' 48' ' ' LEU . 0.9 OUTLIER -94.88 -39.94 9.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.738 0.304 . . . . 0.0 110.535 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.623 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.633 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt -59.51 141.81 53.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.863 0.363 . . . . 0.0 110.626 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.4 ' H ' ' HG2' ' A' ' 3' ' ' LYS . 0.5 OUTLIER -82.82 133.6 35.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.56 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.508 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 0.4 OUTLIER -79.81 -112.16 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.212 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.508 ' SG ' ' O ' ' A' ' 4' ' ' LYS . 11.2 p 37.48 -121.61 0.21 Allowed 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 120.633 0.254 . . . . 0.0 110.735 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.574 ' CD1' ' H ' ' A' ' 9' ' ' ASP . 1.8 pp -129.61 -170.71 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.27 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.15 -30.78 5.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.437 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.456 ' O ' ' CB ' ' A' ' 9' ' ' ASP . 8.5 mtmt -43.71 -67.06 0.31 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.6 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.574 ' H ' ' CD1' ' A' ' 6' ' ' ILE . 6.9 t0 78.82 117.35 0.06 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.48 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.562 ' N ' ' SG ' ' A' ' 20' ' ' CYS . 42.4 m-85 53.76 168.32 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.468 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.415 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 100.21 -127.69 9.33 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.1 ttt-85 -72.41 140.6 48.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.838 0.351 . . . . 0.0 110.615 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.617 ' SG ' ' N ' ' A' ' 14' ' ' LYS . 0.7 OUTLIER -152.08 158.93 43.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.653 -179.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.617 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 6.9 mttt -157.65 123.83 4.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.241 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.528 ' CZ2' ' SG ' ' A' ' 28' ' ' CYS . 1.0 OUTLIER -52.47 -24.87 8.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.582 -179.649 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -112.34 14.08 25.59 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -127.07 -117.15 2.07 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.9 p -90.2 141.19 27.51 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 120.825 -0.35 . . . . 0.0 110.762 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 20' ' ' CYS . 58.9 Cg_endo -74.0 -32.69 6.8 Favored 'Trans proline' 0 N--CA 1.496 1.665 0 C-N-CA 122.554 2.17 . . . . 0.0 112.273 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.602 ' O ' ' N ' ' A' ' 22' ' ' ARG . 1.6 t 80.73 27.39 0.24 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.6 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 1.1 t 34.4 -84.1 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.608 0.567 . . . . 0.0 111.431 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.602 ' N ' ' O ' ' A' ' 20' ' ' CYS . 76.2 mtt180 -99.93 122.77 43.35 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.698 ' H ' ' HE ' ' A' ' 24' ' ' ARG . . . 130.06 79.43 0.21 Allowed Glycine 0 CA--C 1.522 0.5 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.698 ' HE ' ' H ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -79.51 1.05 27.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.76 0.314 . . . . 0.0 110.421 -179.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -75.86 35.27 1.23 Allowed Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.446 ' H ' ' C ' ' A' ' 24' ' ' ARG . 20.4 m -67.17 82.78 0.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.775 0.321 . . . . 0.0 110.593 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.3 tt -122.21 153.55 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.535 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.528 ' SG ' ' CZ2' ' A' ' 15' ' ' TRP . 6.6 m -118.75 165.84 13.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.771 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.7 170.48 7.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.403 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 30' ' ' ILE . 10.3 tp -54.12 -25.72 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.817 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 4.4 mtt -81.19 -37.39 28.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.646 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.68 58.48 0.94 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.5 t -148.76 -32.33 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 0.0 110.609 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -81.16 50.46 1.42 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.51 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.0 m -74.81 110.48 9.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.783 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -138.7 149.47 45.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.741 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.415 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.7 OUTLIER -89.73 107.28 19.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.117 179.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -97.28 148.05 33.85 Favored Pre-proline 0 C--N 1.329 -0.323 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.555 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 40' ' ' ARG . 52.8 Cg_endo -69.55 -91.92 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.251 1.967 . . . . 0.0 112.114 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.472 ' O ' ' O ' ' A' ' 39' ' ' PRO . 5.9 mtt180 47.57 103.4 0.0 OUTLIER 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.561 0.696 . . . . 0.0 110.578 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.911 ' H ' HD12 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -137.44 134.05 35.4 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.853 -179.656 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.4 tp -47.67 145.59 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.701 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.459 ' SD ' ' HB2' ' A' ' 49' ' ' ALA . 9.3 ptt? -75.25 130.6 39.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.615 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -89.32 -18.82 26.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.579 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 131.72 -24.51 4.09 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 mp -114.03 -2.85 13.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.786 0.327 . . . . 0.0 110.656 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.82 -64.24 1.98 Allowed Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.654 HD23 ' N ' ' A' ' 49' ' ' ALA . 0.9 OUTLIER -130.17 -40.75 1.29 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.843 0.354 . . . . 0.0 110.354 179.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.654 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.439 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.3 pttt -87.27 -176.56 5.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.85 0.357 . . . . 0.0 110.465 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.47 156.66 37.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.405 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -79.22 -65.57 0.98 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.465 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.444 ' SG ' ' C ' ' A' ' 4' ' ' LYS . 0.1 OUTLIER 33.68 -88.72 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.162 0 O-C-N 123.741 0.651 . . . . 0.0 111.161 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.642 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 2.0 pp -133.71 1.43 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.974 0.416 . . . . 0.0 110.006 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 6' ' ' ILE . . . 82.52 -62.41 0.14 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.067 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -60.73 -140.05 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.712 -0.395 . . . . 0.0 110.5 -179.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 10' ' ' TYR . 11.8 m-20 -140.39 -149.97 0.3 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.533 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.423 ' O ' ' O ' ' A' ' 9' ' ' ASP . 9.5 m-85 -40.95 163.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.529 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.543 ' N ' ' SG ' ' A' ' 37' ' ' CYS . . . 138.51 -138.95 9.86 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 19.5 ttt180 -79.92 127.44 32.26 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.679 0.276 . . . . 0.0 110.706 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.3 p -134.81 -172.18 2.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.597 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -160.01 115.66 2.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.354 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 32.3 m95 -57.7 -12.9 3.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.507 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -134.81 31.84 2.68 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -176.1 -133.64 1.81 Allowed Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.468 ' O ' ' N ' ' A' ' 14' ' ' LYS . 63.4 p -39.82 104.59 0.33 Allowed Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 110.472 -0.196 . . . . 0.0 110.472 -179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -79.02 -163.93 0.25 Allowed 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.958 1.772 . . . . 0.0 112.429 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -153.4 105.06 2.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.867 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.8 m -38.15 -75.36 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.682 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 mtp85 -95.75 120.94 36.9 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.415 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.703 ' H ' HH11 ' A' ' 24' ' ' ARG . . . 122.72 92.85 1.12 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.791 -0.924 . . . . 0.0 110.791 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.703 HH11 ' H ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -88.39 -8.37 55.13 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.742 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.44 66.85 3.85 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.3 m -81.78 80.72 8.02 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.28 0.562 . . . . 0.0 110.229 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.2 tt -80.65 139.18 18.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.495 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.604 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -132.27 175.94 8.83 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.819 -179.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.65 169.49 15.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.528 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 5.4 tp -53.45 -24.91 9.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.655 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.2 mtm -92.16 -35.61 13.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.574 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.26 56.98 0.86 Allowed Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 t -131.95 -33.54 1.35 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.798 0.332 . . . . 0.0 110.524 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -86.49 42.52 1.01 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.344 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.604 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 45.6 m -69.2 120.11 14.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.585 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -142.54 129.11 20.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.882 0.373 . . . . 0.0 111.057 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.543 ' SG ' ' N ' ' A' ' 11' ' ' GLY . 0.8 OUTLIER -80.15 127.47 32.37 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.522 179.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 7.4 ptpt -137.29 149.7 66.56 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.402 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -68.3 -168.75 0.22 Allowed 'Trans proline' 0 N--CA 1.494 1.552 0 C-N-CA 122.308 2.005 . . . . 0.0 112.211 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.559 ' C ' HD12 ' A' ' 41' ' ' LEU . 33.4 ptt85 -162.13 130.46 4.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.567 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.559 HD12 ' C ' ' A' ' 40' ' ' ARG . 10.9 mp -109.6 103.61 12.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.462 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.735 ' H ' HD13 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -144.61 -171.34 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.643 -179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -127.79 141.58 51.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.504 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -69.39 -11.75 61.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.586 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 136.49 -21.03 3.46 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.871 -0.892 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.677 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.3 mp -58.82 -113.26 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.74 0.305 . . . . 0.0 110.623 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -179.7 30.93 0.06 OUTLIER Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.657 HD23 ' N ' ' A' ' 49' ' ' ALA . 0.9 OUTLIER -147.37 -41.1 0.18 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.729 0.299 . . . . 0.0 110.567 179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.657 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.582 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 18.9 mtmm 55.6 60.43 3.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.771 0.32 . . . . 0.0 110.549 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -100.77 -2.47 32.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.673 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -91.61 -40.47 11.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.531 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.428 ' O ' ' O ' ' A' ' 6' ' ' ILE . 7.2 p -54.15 -172.57 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.399 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.478 HG13 ' H ' ' A' ' 21' ' ' CYS . 2.1 pp -50.02 -178.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.331 179.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 6' ' ' ILE . . . -35.59 -89.94 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.872 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.445 ' O ' ' CB ' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -175.7 73.28 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 120.9 0.381 . . . . 0.0 110.371 179.669 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.47 ' C ' ' CD1' ' A' ' 10' ' ' TYR . 0.8 OUTLIER 162.38 -109.33 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.997 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.552 ' CZ ' ' O ' ' A' ' 22' ' ' ARG . 43.6 m-85 -142.48 -162.4 1.41 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.199 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 118.42 -119.9 4.52 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 111.049 -0.821 . . . . 0.0 111.049 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.03 151.32 21.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.717 0.294 . . . . 0.0 110.554 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.568 ' SG ' ' SG ' ' A' ' 20' ' ' CYS . 1.5 t -123.05 179.96 4.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.334 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.6 ttmt -160.12 91.89 0.97 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.428 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.402 ' C ' ' N ' ' A' ' 17' ' ' GLY . 4.9 m0 -49.51 -81.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.451 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.77 -14.68 1.11 Allowed Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.402 ' N ' ' C ' ' A' ' 15' ' ' TRP . . . -95.07 -134.4 7.65 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.993 -0.843 . . . . 0.0 110.993 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -89.18 152.75 48.36 Favored Pre-proline 0 CA--C 1.531 0.249 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.592 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.54 178.34 6.83 Favored 'Trans proline' 0 N--CA 1.492 1.428 0 C-N-CA 122.319 2.013 . . . . 0.0 112.364 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.568 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -102.78 127.54 49.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.388 179.635 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.478 ' H ' HG13 ' A' ' 6' ' ' ILE . 59.8 m -50.85 -97.2 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.916 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.552 ' O ' ' CZ ' ' A' ' 10' ' ' TYR . 4.7 mtt180 -83.65 24.8 0.83 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.428 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.91 151.13 17.7 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.95 -14.34 0.53 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.796 0.331 . . . . 0.0 110.701 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.26 47.75 3.89 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 95.4 m -77.19 105.86 8.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.723 0.297 . . . . 0.0 110.633 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.3 tt -119.36 145.73 25.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.293 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.9 m -131.8 -178.6 4.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.759 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.83 168.75 15.84 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.652 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.5 tp -49.64 -25.56 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.578 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 1.5 mtt -86.93 -47.41 9.01 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.484 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.66 57.03 0.75 Allowed Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.056 -0.818 . . . . 0.0 111.056 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.0 t -136.12 -24.78 1.25 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.749 0.309 . . . . 0.0 110.522 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -101.44 50.89 0.85 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.383 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 97.7 m -68.63 122.81 19.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.806 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -119.77 127.87 53.21 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.079 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.512 ' N ' ' O ' ' A' ' 11' ' ' GLY . 6.1 t -84.82 97.45 9.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.363 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.4 mtmt -107.96 147.0 34.62 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.743 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.88 -167.96 0.26 Allowed 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.371 2.047 . . . . 0.0 112.084 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.9 ptp180 -62.35 152.09 34.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.6 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 9.5 mp -87.5 -179.98 6.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.517 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.2 tp -76.49 145.04 10.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.511 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 27.5 mtt -81.1 104.65 11.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.523 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.45 -27.96 20.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.509 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.43 -99.27 0.71 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.409 HD12 ' H ' ' A' ' 46' ' ' LEU . 1.0 OUTLIER -115.51 -67.38 1.0 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.821 0.343 . . . . 0.0 110.577 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -172.6 37.94 0.15 Allowed Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.64 HD23 ' N ' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -96.64 -41.26 8.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.868 0.366 . . . . 0.0 110.513 179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.64 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.52 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.6 tptm 63.41 1.95 1.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.778 0.323 . . . . 0.0 110.644 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -96.36 -4.88 41.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.604 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.408 ' O ' ' O ' ' A' ' 5' ' ' CYS . 6.1 ttpt -79.36 -55.71 4.87 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.484 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.408 ' O ' ' O ' ' A' ' 4' ' ' LYS . 4.7 p -47.09 174.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.218 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.838 HD12 ' N ' ' A' ' 7' ' ' ALA . 2.5 pp -54.92 -25.78 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.015 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.838 ' N ' HD12 ' A' ' 6' ' ' ILE . . . 66.82 -36.6 0.27 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.52 ' H ' ' C ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -72.57 15.74 0.17 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 122.119 0.961 . . . . 0.0 110.726 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.508 ' H ' ' C ' ' A' ' 7' ' ' ALA . 2.9 p-10 42.95 -110.39 0.15 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.924 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.491 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 3.4 m-30 -77.4 126.65 31.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.218 -178.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 159.04 -96.55 0.15 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.119 -0.793 . . . . 0.0 111.119 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.9 ttt85 -110.77 146.42 36.39 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.785 0.326 . . . . 0.0 110.752 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -158.03 143.75 17.07 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.617 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.579 ' NZ ' ' SG ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -137.34 126.01 23.81 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.997 0.427 . . . . 0.0 110.629 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.427 ' HE1' ' HB2' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -71.94 -28.13 63.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.541 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.62 -6.85 57.16 Favored Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.666 -0.974 . . . . 0.0 110.666 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -113.75 -115.61 3.22 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.3 p -90.21 142.81 28.83 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.567 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.67 167.47 27.17 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.182 1.922 . . . . 0.0 112.396 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 1.5 t -103.48 107.18 17.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.958 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.31 -72.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.529 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.402 ' HE ' ' HB3' ' A' ' 9' ' ' ASP . 7.8 mtm-85 -100.08 122.57 43.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.486 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.458 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 82.26 109.78 0.43 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.919 -0.873 . . . . 0.0 110.919 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.705 ' HE ' ' N ' ' A' ' 24' ' ' ARG . 0.0 OUTLIER -102.88 19.34 19.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.661 0.267 . . . . 0.0 110.649 -179.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -82.02 53.48 4.75 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.561 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 38.0 m -73.97 113.29 10.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.992 0.425 . . . . 0.0 110.501 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.0 tt -126.11 148.03 30.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.084 179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.555 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -126.16 168.17 14.4 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.577 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 31' ' ' MET . 4.3 m -77.44 157.38 30.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.569 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -42.19 -24.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.847 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.431 ' N ' ' O ' ' A' ' 29' ' ' SER . 1.2 mtp -88.28 -50.92 6.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.757 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 109.83 63.72 0.53 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.6 t -145.04 -17.52 0.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.779 0.323 . . . . 0.0 110.302 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -107.74 51.07 0.75 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.171 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.579 ' SG ' ' NZ ' ' A' ' 14' ' ' LYS . 31.3 m -73.39 86.22 1.5 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.23 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -102.16 152.2 21.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.449 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.561 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.2 OUTLIER -98.98 120.87 40.15 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.616 179.304 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.455 ' O ' ' O ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -129.54 159.65 68.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.427 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.455 ' O ' ' O ' ' A' ' 38' ' ' LYS . 50.9 Cg_exo -46.05 -178.34 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.352 2.035 . . . . 0.0 112.21 179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -135.69 -176.02 4.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.461 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.436 ' H ' HD12 ' A' ' 41' ' ' LEU . 2.7 mp -65.96 166.79 10.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.988 0.423 . . . . 0.0 110.43 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.554 ' N ' HD13 ' A' ' 42' ' ' ILE . 0.0 OUTLIER -52.09 -171.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.808 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.409 ' C ' ' H ' ' A' ' 45' ' ' GLY . 8.4 ptt? -139.71 -19.7 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.552 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -78.76 33.18 0.21 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.553 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' A' ' 43' ' ' MET . . . -145.43 -45.22 0.04 OUTLIER Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.654 ' N ' HD12 ' A' ' 46' ' ' LEU . 7.5 mp -56.47 -24.02 43.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.756 0.312 . . . . 0.0 110.505 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.2 25.26 9.01 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.068 -0.813 . . . . 0.0 111.068 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.659 HD23 ' N ' ' A' ' 49' ' ' ALA . 1.1 tt -88.46 -42.09 12.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.713 0.292 . . . . 0.0 110.451 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.659 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.957 -1.021 . . . . 0.0 110.566 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.803 ' HZ3' HH11 ' A' ' 22' ' ' ARG . 21.1 tptp -171.06 90.49 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.788 0.327 . . . . 0.0 110.611 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.1 mttp 46.09 -160.94 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.452 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 5' ' ' CYS . 3.6 tmtt? -106.96 -39.81 5.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.369 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.447 ' O ' ' O ' ' A' ' 4' ' ' LYS . 4.6 p -46.33 -99.43 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.003 0.43 . . . . 0.0 110.722 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.419 ' N ' ' SG ' ' A' ' 5' ' ' CYS . 1.1 pp -139.26 -172.16 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.446 -179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -136.44 -30.19 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.774 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.717 ' H ' ' CD ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -51.7 -42.33 62.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.431 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 10' ' ' TYR . 4.8 m-20 58.92 125.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.47 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 9' ' ' ASP . 66.5 m-85 55.97 160.6 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.854 0.359 . . . . 0.0 110.795 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 90.18 -152.04 21.93 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.415 ' N ' ' OE2' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -42.24 125.42 3.09 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.657 -0.32 . . . . 0.0 110.944 -179.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 2.9 t -154.73 150.46 27.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.649 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.467 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 25.3 tttp -155.88 103.7 2.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.534 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 13.8 m95 -42.05 154.95 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.412 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.46 -47.5 0.71 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -84.96 -90.79 0.82 Allowed Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.449 ' O ' ' O ' ' A' ' 19' ' ' PRO . 3.9 p -90.19 112.98 55.61 Favored Pre-proline 0 CA--C 1.535 0.4 0 CA-C-O 119.448 -0.31 . . . . 0.0 110.75 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.449 ' O ' ' O ' ' A' ' 18' ' ' THR . 52.0 Cg_exo -51.49 -161.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.501 1.936 0 C-N-CA 122.12 1.88 . . . . 0.0 112.611 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 6.3 t -171.92 61.18 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.475 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.1 OUTLIER -38.22 -42.4 0.68 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.807 -179.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.803 HH11 ' HZ3' ' A' ' 2' ' ' LYS . 26.4 mtt180 -120.36 99.81 6.79 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.44 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.499 ' O ' ' SG ' ' A' ' 20' ' ' CYS . . . 130.81 91.95 0.59 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -85.47 -12.43 51.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.85 0.357 . . . . 0.0 110.488 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -76.17 41.84 1.59 Allowed Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.3 t -81.87 108.58 15.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.03 0.443 . . . . 0.0 110.685 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.8 tt -145.47 152.09 14.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.318 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.647 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 1.0 OUTLIER -129.84 177.1 7.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.699 -179.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.15 165.93 21.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.417 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.437 HG23 ' HG2' ' A' ' 31' ' ' MET . 6.1 tp -51.76 -25.9 6.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.64 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.437 ' HG2' HG23 ' A' ' 30' ' ' ILE . 4.9 mtt -86.34 -29.8 22.71 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.633 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 85.66 62.78 1.59 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -137.4 -36.06 0.66 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.785 0.326 . . . . 0.0 110.688 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -94.76 54.15 1.71 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.183 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.647 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 1.8 m -85.56 114.4 22.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.622 -179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.415 ' OE2' ' N ' ' A' ' 12' ' ' ARG . 9.2 mm-40 -137.74 154.3 49.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.803 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -98.76 111.3 23.72 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.191 179.356 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 5.0 mtmp? -102.06 147.04 33.36 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.643 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.31 -168.14 0.16 Allowed 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.339 2.026 . . . . 0.0 112.325 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.412 HH21 ' HB3' ' A' ' 40' ' ' ARG . 28.9 mtm105 -78.1 -167.94 1.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.53 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 mp -83.57 -47.92 10.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.66 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.6 pp -117.44 156.79 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.553 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.534 ' N ' ' SD ' ' A' ' 43' ' ' MET . 2.2 mpt? -93.12 141.21 28.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.518 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -87.06 123.95 32.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.691 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' A' ' 46' ' ' LEU . . . 66.83 11.13 57.26 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.944 -0.863 . . . . 0.0 110.944 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.736 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.8 mp 43.59 96.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.815 0.341 . . . . 0.0 110.787 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.84 52.95 0.52 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.626 HD23 ' N ' ' A' ' 49' ' ' ALA . 0.8 OUTLIER -157.71 -39.7 0.07 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.665 0.269 . . . . 0.0 110.49 179.896 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.626 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--N 1.327 -0.408 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.707 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 7' ' ' ALA . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -132.84 169.7 16.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.88 0.371 . . . . 0.0 110.48 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 33.6 mttt 55.09 -179.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.501 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.467 ' CG ' ' H ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER -86.18 -105.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.617 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.467 ' H ' ' CG ' ' A' ' 4' ' ' LYS . 35.2 m 38.55 -118.91 0.23 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.497 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.661 ' CD1' ' H ' ' A' ' 9' ' ' ASP . 1.5 pp -106.07 -5.07 9.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.536 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.64 ' N ' HD12 ' A' ' 6' ' ' ILE . . . 73.64 -56.14 0.66 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.639 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.538 ' O ' ' N ' ' A' ' 10' ' ' TYR . 30.9 mmtm -49.17 -14.04 0.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.713 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.661 ' H ' ' CD1' ' A' ' 6' ' ' ILE . 19.4 m-20 59.1 -76.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.524 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.538 ' N ' ' O ' ' A' ' 8' ' ' LYS . 52.0 m-85 -108.95 163.68 13.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.505 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.23 -156.67 15.51 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.546 HH12 ' N ' ' A' ' 35' ' ' CYS . 0.2 OUTLIER -39.68 130.66 1.87 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.838 0.351 . . . . 0.0 110.876 -179.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.599 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 26.6 p -157.01 179.17 9.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.587 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -160.64 115.53 2.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.467 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -56.96 -39.63 74.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.762 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -98.91 28.13 16.65 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -147.0 -78.21 0.03 OUTLIER Glycine 0 CA--C 1.52 0.38 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.2 p -90.4 148.07 38.12 Favored Pre-proline 0 C--N 1.325 -0.478 0 C-N-CA 120.471 -0.492 . . . . 0.0 111.197 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.64 -31.72 10.42 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.386 2.057 . . . . 0.0 112.422 179.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.402 ' SG ' ' O ' ' A' ' 22' ' ' ARG . 17.2 t 58.16 87.26 0.07 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.359 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.401 ' C ' ' O ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -37.17 -76.47 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.711 -179.766 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.402 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -99.81 175.12 5.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.545 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.479 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 50.95 74.87 0.25 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -79.79 10.75 3.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.664 0.269 . . . . 0.0 110.442 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -83.14 49.84 4.3 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.405 ' SG ' ' C ' ' A' ' 13' ' ' CYS . 5.2 t -68.89 90.77 0.44 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.949 0.404 . . . . 0.0 110.387 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 14.2 tt -103.97 147.45 10.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.405 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 11.3 m -126.79 164.3 21.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.737 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 m -73.18 167.25 21.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.458 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.5 tp -51.55 -28.35 8.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.668 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.6 mtm -80.09 -33.66 38.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.625 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 87.04 65.22 1.39 Allowed Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.876 -0.889 . . . . 0.0 110.876 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.0 t -150.21 -28.88 0.23 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.768 0.318 . . . . 0.0 110.663 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.426 ' C ' HH12 ' A' ' 12' ' ' ARG . 13.9 t-20 -93.85 53.93 1.88 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.446 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.546 ' N ' HH12 ' A' ' 12' ' ' ARG . 72.5 m -75.04 120.27 20.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.681 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.453 ' C ' ' SG ' ' A' ' 13' ' ' CYS . 56.3 mt-10 -135.56 138.42 42.99 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.62 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.599 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -83.8 105.38 14.66 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.22 179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -110.52 149.69 40.62 Favored Pre-proline 0 C--O 1.236 0.368 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.574 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.85 -85.05 0.01 OUTLIER 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.597 2.198 . . . . 0.0 111.975 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -127.81 -120.76 0.24 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.646 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.404 ' N ' HD12 ' A' ' 41' ' ' LEU . 10.9 mp -85.05 126.59 33.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.677 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.7 pt -82.3 -42.56 18.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.528 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 3.6 mtt -68.38 99.75 0.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.503 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -83.53 -24.53 31.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.456 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -80.61 -102.81 0.3 Allowed Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.886 -0.886 . . . . 0.0 110.886 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -116.11 -54.15 2.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.783 0.325 . . . . 0.0 110.542 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -176.25 12.69 0.03 OUTLIER Glycine 0 CA--C 1.521 0.435 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.638 ' C ' HD23 ' A' ' 48' ' ' LEU . 1.4 tt -101.85 -41.81 6.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.689 0.28 . . . . 0.0 110.593 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.623 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.589 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.93 -76.79 0.28 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.834 0.35 . . . . 0.0 110.49 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.1 mmmm -74.41 -163.31 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.339 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.05 -28.89 6.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.349 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.416 ' SG ' ' N ' ' A' ' 6' ' ' ILE . 14.0 p -71.87 -120.71 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.516 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.537 HD12 ' N ' ' A' ' 7' ' ' ALA . 1.7 pp -104.09 1.33 10.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.902 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.537 ' N ' HD12 ' A' ' 6' ' ' ILE . . . 68.6 -64.56 0.31 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.506 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 6' ' ' ILE . 7.7 mmtp -56.61 -164.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.665 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.409 ' O ' ' O ' ' A' ' 10' ' ' TYR . 3.8 p-10 -139.28 127.87 23.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.471 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.409 ' O ' ' O ' ' A' ' 9' ' ' ASP . 79.4 m-85 54.42 167.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.63 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 127.07 -113.48 1.75 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.42 ' NH1' HG21 ' A' ' 18' ' ' THR . 1.3 ptm180 -108.91 136.96 47.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.667 0.27 . . . . 0.0 110.823 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 5.9 p -143.48 174.75 10.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.995 0.426 . . . . 0.0 110.935 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.5 ttmm -160.4 108.14 1.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.385 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.505 ' C ' ' H ' ' A' ' 17' ' ' GLY . 0.1 OUTLIER -41.07 -67.41 0.25 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.849 -179.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.78 28.55 0.91 Allowed Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 15' ' ' TRP . . . -145.34 -92.95 0.14 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.42 HG21 ' NH1' ' A' ' 12' ' ' ARG . 3.2 p -91.45 144.8 30.2 Favored Pre-proline 0 CA--C 1.537 0.456 0 C-N-CA 120.765 -0.374 . . . . 0.0 111.093 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.82 -32.7 7.1 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.128 1.885 . . . . 0.0 112.386 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 5.1 t 67.55 100.93 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.595 -179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -58.63 -83.97 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.599 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.4 mmt-85 -84.19 117.32 23.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.597 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.508 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 115.24 89.85 1.64 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 11.7 tpp180 -86.37 -24.13 25.9 Favored 'General case' 0 N--CA 1.44 -0.939 0 O-C-N 122.532 -0.393 . . . . 0.0 110.268 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -70.01 58.46 0.79 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 37.8 t -87.78 113.06 23.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.871 0.367 . . . . 0.0 110.259 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.1 tt -131.15 156.53 42.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.592 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.635 ' SG ' ' N ' ' A' ' 35' ' ' CYS . 0.5 OUTLIER -135.73 174.62 10.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.541 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.1 t -79.95 158.41 26.61 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.441 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -42.96 -32.0 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-O 120.906 0.384 . . . . 0.0 110.092 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 16.6 mtm -79.31 -43.35 23.76 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.994 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.01 62.85 0.88 Allowed Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.731 -0.947 . . . . 0.0 110.731 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.3 t -139.47 -35.02 0.55 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.81 0.338 . . . . 0.0 110.64 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -95.15 50.85 1.29 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.142 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.635 ' N ' ' SG ' ' A' ' 28' ' ' CYS . 31.3 m -75.15 102.34 4.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.533 -179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -109.88 141.25 42.86 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.15 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.526 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 0.3 OUTLIER -97.09 103.49 15.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.227 179.562 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.89 162.1 47.36 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.436 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.45 -172.95 1.01 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.514 2.143 . . . . 0.0 112.174 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.527 ' H ' HD12 ' A' ' 41' ' ' LEU . 0.4 OUTLIER -142.21 -88.14 0.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.75 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.527 HD12 ' H ' ' A' ' 40' ' ' ARG . 5.4 mp 52.19 170.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.072 0.463 . . . . 0.0 110.62 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.54 ' C ' ' H ' ' A' ' 44' ' ' GLU . 1.8 tp -99.47 165.27 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.386 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.512 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 27.9 ttp 57.1 0.92 0.09 Allowed 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.83 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.54 ' H ' ' C ' ' A' ' 42' ' ' ILE . 41.5 tt0 -60.27 -55.46 33.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.509 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.81 -34.61 5.91 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 48' ' ' LEU . 0.8 OUTLIER -114.22 -156.15 0.59 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.74 0.305 . . . . 0.0 110.503 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 67.49 -63.47 0.27 Allowed Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.641 HD23 ' N ' ' A' ' 49' ' ' ALA . 1.2 tt -159.34 -42.05 0.05 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.692 0.282 . . . . 0.0 110.433 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.641 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.221 -0.421 0 CA-C-O 118.024 -0.988 . . . . 0.0 110.553 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.442 ' O ' ' C ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -55.5 113.23 1.35 Allowed 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 121.119 -0.233 . . . . 0.0 110.495 -179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 2' ' ' LYS . 10.6 pttm 31.22 -109.74 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 O-C-N 123.639 0.587 . . . . 0.0 110.944 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.799 ' HZ2' ' H ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER -140.65 -45.29 0.4 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.512 179.486 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.799 ' H ' ' HZ2' ' A' ' 4' ' ' LYS . 0.5 OUTLIER 29.15 -92.36 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 O-C-N 123.812 0.695 . . . . 0.0 111.239 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.653 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 2.3 pp -141.95 -0.19 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 6' ' ' ILE . . . 80.35 -64.31 0.19 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.728 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.424 ' O ' ' O ' ' A' ' 7' ' ' ALA . 10.1 mttp -53.61 -170.28 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.155 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -126.78 -155.22 0.68 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.66 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -45.01 155.4 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.485 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 144.47 -103.28 0.29 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.466 HH11 ' NZ ' ' A' ' 14' ' ' LYS . 0.9 OUTLIER -123.32 134.7 54.02 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.788 0.328 . . . . 0.0 110.871 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.602 ' SG ' ' N ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -148.67 179.84 7.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.661 179.463 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.602 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 2.4 tttp -143.73 110.34 5.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.511 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.516 ' C ' ' H ' ' A' ' 17' ' ' GLY . 10.1 m95 -48.19 141.56 6.19 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.552 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.29 -36.31 0.26 Allowed Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.516 ' H ' ' C ' ' A' ' 15' ' ' TRP . . . -83.08 -91.29 0.67 Allowed Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.293 -0.723 . . . . 0.0 111.293 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 19' ' ' PRO . 13.5 p -91.73 111.56 50.12 Favored Pre-proline 0 CA--C 1.54 0.574 0 CA-C-O 119.312 -0.375 . . . . 0.0 110.731 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 18' ' ' THR . 42.7 Cg_exo -52.46 -156.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.169 1.912 . . . . 0.0 112.672 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -165.27 92.77 0.57 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.296 -179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 61.6 m -41.45 -77.62 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.657 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 36.1 mtt85 -94.74 115.71 27.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.476 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 100.55 85.82 1.88 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.9 ptm85 -80.3 0.56 32.33 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.584 0.231 . . . . 0.0 110.773 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.36 98.25 2.4 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.738 -0.945 . . . . 0.0 110.738 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -121.06 108.74 14.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.235 0.54 . . . . 0.0 110.323 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 9.6 tt -114.58 155.9 15.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.782 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.8 m -132.35 177.58 7.48 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.899 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.685 ' N ' HD21 ' A' ' 34' ' ' ASN . 11.9 t -91.29 159.59 15.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.568 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.4 tp -40.67 -24.75 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.651 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.474 ' N ' ' O ' ' A' ' 29' ' ' SER . 3.1 mtt -80.76 -42.26 22.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.752 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 29' ' ' SER . . . 87.28 63.17 1.44 Allowed Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.3 t -150.6 -31.33 0.19 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.838 0.352 . . . . 0.0 110.466 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.685 HD21 ' N ' ' A' ' 29' ' ' SER . 0.1 OUTLIER -89.44 32.22 0.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.464 179.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 90.3 m -51.46 105.11 0.1 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.657 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -107.59 132.83 52.86 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.309 -179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.1 OUTLIER -87.48 130.11 34.82 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.544 179.335 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.32 162.28 43.33 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.47 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -71.3 -166.12 0.22 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.668 2.245 . . . . 0.0 112.142 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -72.63 -139.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.582 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 4.0 mp -93.68 122.83 36.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.642 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.5 pt -46.89 142.07 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.509 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.6 mpt? -64.1 154.25 35.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.543 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -72.51 -3.26 23.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.586 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 144.77 -39.98 1.17 Allowed Glycine 0 CA--C 1.524 0.618 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.632 ' H ' HD12 ' A' ' 46' ' ' LEU . 9.1 mp -40.61 -58.95 1.48 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.863 0.363 . . . . 0.0 110.611 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.82 27.72 9.38 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.641 HD23 ' N ' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -141.41 -40.98 0.38 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.776 0.322 . . . . 0.0 110.423 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.641 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.457 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.6 mmtt -61.63 151.46 33.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.819 0.342 . . . . 0.0 110.617 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.71 100.87 11.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.621 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.419 ' O ' ' O ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER -97.1 -26.39 14.99 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.666 -179.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 7' ' ' ALA . 1.8 m -59.77 -145.03 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.313 179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.558 HG23 ' O ' ' A' ' 19' ' ' PRO . 1.3 pp -39.49 -28.04 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.679 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.496 ' O ' ' N ' ' A' ' 9' ' ' ASP . . . 68.05 -57.73 0.46 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.818 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.579 ' CB ' ' NZ ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -44.55 -16.57 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.944 0.402 . . . . 0.0 110.998 -179.415 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.504 ' H ' HD12 ' A' ' 6' ' ' ILE . 0.8 OUTLIER 72.6 111.02 0.06 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.501 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 55.87 169.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.478 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.19 -105.68 1.05 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -111.19 145.05 39.35 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.813 0.339 . . . . 0.0 110.503 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.9 p -145.43 168.72 19.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.721 -179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -153.63 109.83 3.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.489 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -52.95 -40.88 64.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.943 -179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -102.55 27.37 20.6 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -168.54 -126.11 0.83 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -40.45 109.26 0.59 Allowed Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 121.011 -0.276 . . . . 0.0 110.841 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.558 ' O ' HG23 ' A' ' 6' ' ' ILE . 54.3 Cg_endo -76.1 152.45 35.78 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 C-N-CA 121.96 1.773 . . . . 0.0 112.097 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.73 137.57 51.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.134 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -95.34 -79.47 0.43 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.485 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 70.7 mtt-85 -81.99 109.06 15.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.549 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.499 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 103.47 92.09 2.22 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.37 14.56 10.92 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.751 0.31 . . . . 0.0 110.643 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.56 56.73 4.17 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 9.0 t -79.94 113.49 18.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.728 0.299 . . . . 0.0 110.659 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.5 tt -126.02 148.44 30.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.315 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.1 m -126.33 174.15 8.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.605 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.12 169.44 17.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.49 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.415 HG23 ' HG2' ' A' ' 31' ' ' MET . 0.6 OUTLIER -52.36 -27.41 10.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.929 -179.897 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.415 ' HG2' HG23 ' A' ' 30' ' ' ILE . 1.6 mtp -85.5 -25.58 26.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.66 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.84 66.04 1.66 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.933 -0.867 . . . . 0.0 110.933 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.0 t -145.18 -34.15 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.846 0.355 . . . . 0.0 110.547 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.62 53.8 2.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.324 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.7 m -72.13 98.29 2.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -105.31 140.64 38.14 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.819 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 23' ' ' GLY . 0.7 OUTLIER -93.03 111.22 22.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.344 179.488 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.52 158.01 63.29 Favored Pre-proline 0 CA--C 1.532 0.256 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.828 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -70.08 -165.05 0.15 Allowed 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.682 2.255 . . . . 0.0 112.07 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -94.26 -155.21 0.44 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.552 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 41' ' ' LEU . 10.1 mp -92.31 56.5 2.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.621 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.2 tp -82.37 -27.64 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.592 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.489 ' O ' ' N ' ' A' ' 45' ' ' GLY . 5.8 ptt? -156.63 -6.15 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.596 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.401 ' H ' ' H ' ' A' ' 43' ' ' MET . 3.8 mt-10 -63.35 72.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.547 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.616 ' H ' ' HB3' ' A' ' 49' ' ' ALA . . . 138.86 -52.03 0.74 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.971 -0.852 . . . . 0.0 110.971 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.969 ' H ' HD12 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -122.95 107.03 11.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.863 0.363 . . . . 0.0 110.535 -179.752 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 140.37 -51.45 0.72 Allowed Glycine 0 CA--C 1.523 0.591 0 N-CA-C 110.768 -0.933 . . . . 0.0 110.768 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.648 ' C ' HD23 ' A' ' 48' ' ' LEU . 1.2 tt -136.6 -40.44 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.693 0.282 . . . . 0.0 110.619 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.616 ' HB3' ' H ' ' A' ' 45' ' ' GLY . . . . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 118.039 -0.982 . . . . 0.0 110.713 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.465 ' CG ' ' O ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -155.58 99.58 2.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.788 0.328 . . . . 0.0 110.496 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -60.87 -15.86 35.18 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.733 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.55 115.18 29.95 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.704 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.547 ' SG ' ' N ' ' A' ' 6' ' ' ILE . 31.0 p -162.28 -130.12 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.413 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.663 HD13 ' H ' ' A' ' 9' ' ' ASP . 2.6 pp -119.76 -174.26 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.509 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -134.35 -1.57 2.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.575 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.429 ' HZ2' HG12 ' A' ' 6' ' ' ILE . 1.4 pttm -83.93 -12.36 55.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.593 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.663 ' H ' HD13 ' A' ' 6' ' ' ILE . 0.1 OUTLIER 60.11 133.85 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.549 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.432 ' O ' ' O ' ' A' ' 9' ' ' ASP . 52.5 m-85 44.29 -170.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.686 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 101.95 -153.96 18.69 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 28.2 ttt-85 -80.15 153.59 28.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.737 0.303 . . . . 0.0 110.556 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.556 ' SG ' ' N ' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -156.3 -178.74 7.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.664 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.556 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -139.47 118.21 12.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.394 179.758 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -60.01 -11.28 5.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.728 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.419 ' H ' ' HD3' ' A' ' 14' ' ' LYS . . . -128.2 25.84 4.81 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -170.28 -144.64 4.4 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.1 p -38.32 102.59 0.25 Allowed Pre-proline 0 CA--C 1.535 0.392 0 C-N-CA 121.314 -0.154 . . . . 0.0 110.916 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -79.97 -163.03 0.2 Allowed 'Trans proline' 0 N--CA 1.489 1.22 0 C-N-CA 122.403 2.069 . . . . 0.0 112.237 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.505 ' O ' ' SG ' ' A' ' 20' ' ' CYS . 31.7 p -144.64 112.37 6.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.573 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -51.64 -81.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.636 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.419 ' HD2' ' H ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -77.03 118.4 19.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.58 -179.901 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.504 ' O ' ' SG ' ' A' ' 20' ' ' CYS . . . 96.14 66.95 0.96 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 -78.43 25.01 0.25 Allowed 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 120.838 0.351 . . . . 0.0 110.6 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 23' ' ' GLY . . . -98.83 75.85 0.54 Allowed Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -96.73 104.0 15.96 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.561 0.695 . . . . 0.0 110.784 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.615 ' O ' HG23 ' A' ' 27' ' ' ILE . 10.6 tt -97.39 110.61 25.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.282 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.03 156.66 17.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.669 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.3 m -80.09 161.0 25.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.705 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 9.8 tp -44.27 -27.51 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.652 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 7.9 mtt -86.12 -40.46 15.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.601 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.22 65.06 0.74 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.8 t -158.74 -0.66 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.592 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -109.93 23.86 13.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.632 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.4 m -54.74 104.83 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.512 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -115.72 107.38 15.01 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.911 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.558 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 1.1 m -72.34 109.44 6.06 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.457 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.433 ' CB ' ' CD ' ' A' ' 39' ' ' PRO . 0.0 OUTLIER -125.48 177.5 1.87 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.877 -179.799 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' A' ' 38' ' ' LYS . 23.3 Cg_exo -63.66 -64.8 0.06 OUTLIER 'Trans proline' 0 N--CA 1.496 1.631 0 C-N-CA 122.779 2.319 . . . . 0.0 112.231 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.431 ' O ' ' O ' ' A' ' 39' ' ' PRO . 62.3 mtp180 54.09 166.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.489 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.998 ' H ' HD22 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -83.23 103.32 12.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.619 -179.53 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.0 pp -136.26 132.31 49.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.417 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 8.7 mtt -132.79 138.31 47.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.55 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -89.16 -49.07 6.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.506 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.438 ' H ' ' H ' ' A' ' 46' ' ' LEU . . . 175.78 -6.71 0.03 OUTLIER Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.438 ' H ' ' H ' ' A' ' 45' ' ' GLY . 2.4 mp -104.3 47.68 0.87 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.843 0.354 . . . . 0.0 110.658 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -162.17 -53.51 0.02 OUTLIER Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.644 HD23 ' N ' ' A' ' 49' ' ' ALA . 1.0 OUTLIER -159.47 -41.42 0.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.692 0.282 . . . . 0.0 110.441 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.644 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.546 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 163.79 5.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.724 0.297 . . . . 0.0 110.619 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -136.22 57.32 1.78 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.471 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.541 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -107.79 -170.3 1.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.628 -179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.5 m 59.72 -73.87 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.687 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' A' ' 4' ' ' LYS . 0.6 OUTLIER -120.95 -20.98 4.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.428 -179.522 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 6' ' ' ILE . . . 68.61 -37.82 0.36 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.039 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.513 ' H ' ' C ' ' A' ' 6' ' ' ILE . 3.5 mttm -64.34 -30.67 71.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.661 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.54 ' H ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER 56.92 126.23 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.117 -179.52 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.564 ' N ' ' CD1' ' A' ' 10' ' ' TYR . 2.4 m-30 64.11 114.56 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.433 0.635 . . . . 0.0 110.534 178.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.438 ' O ' ' N ' ' A' ' 37' ' ' CYS . . . 158.66 -144.51 10.43 Favored Glycine 0 CA--C 1.522 0.506 0 N-CA-C 110.791 -0.923 . . . . 0.0 110.791 -179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.516 ' NH2' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -83.52 156.34 22.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.878 0.37 . . . . 0.0 110.707 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.444 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 28.2 p -158.62 170.07 22.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.537 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -155.79 114.3 3.44 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.617 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 20.0 m95 -62.71 -11.8 19.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.707 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -117.33 10.28 14.84 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -139.56 -98.96 0.42 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.2 p -90.11 145.62 33.32 Favored Pre-proline 0 C--N 1.327 -0.399 0 C-N-CA 120.614 -0.435 . . . . 0.0 110.918 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -71.9 -160.84 0.09 OUTLIER 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 122.466 2.111 . . . . 0.0 112.155 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -165.27 103.01 0.74 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.54 179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.443 ' SG ' ' C ' ' A' ' 4' ' ' LYS . 1.2 m -65.43 -89.31 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 120.225 -0.59 . . . . 0.0 110.785 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.5 mtp180 -82.65 121.49 26.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.606 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.511 ' O ' ' SG ' ' A' ' 37' ' ' CYS . . . 99.11 69.18 0.91 Allowed Glycine 0 CA--C 1.52 0.403 0 N-CA-C 111.223 -0.751 . . . . 0.0 111.223 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -79.45 27.89 0.26 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 120.982 0.42 . . . . 0.0 110.529 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 36' ' ' GLU . . . -93.37 66.56 1.76 Allowed Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.757 -0.937 . . . . 0.0 110.757 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.582 ' SG ' ' SG ' ' A' ' 37' ' ' CYS . 56.4 m -84.6 87.56 7.28 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.348 0.594 . . . . 0.0 110.697 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.648 ' O ' HG23 ' A' ' 27' ' ' ILE . 1.7 tt -80.07 96.96 2.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.495 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 94.4 m -92.16 154.99 18.33 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.472 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.407 ' C ' ' N ' ' A' ' 31' ' ' MET . 1.2 m -91.77 171.31 9.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.767 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 2.2 tp -51.8 -14.82 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.571 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . 0.407 ' N ' ' C ' ' A' ' 29' ' ' SER . 4.7 mtm -106.98 -42.9 4.78 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.761 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.38 56.13 0.74 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.986 -0.845 . . . . 0.0 110.986 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 t -133.84 -22.44 1.86 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 0.0 110.446 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.453 ' O ' ' N ' ' A' ' 36' ' ' GLU . 1.0 OUTLIER -94.26 13.18 24.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.576 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.6 m -49.49 91.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.681 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 34' ' ' ASN . 2.9 tt0 -107.31 123.2 47.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.582 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.582 ' SG ' ' SG ' ' A' ' 26' ' ' CYS . 0.0 OUTLIER -77.73 99.6 5.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.361 179.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.413 ' HZ3' ' HB2' ' A' ' 38' ' ' LYS . 23.9 mtmm -95.82 148.71 34.99 Favored Pre-proline 0 C--O 1.237 0.398 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.88 -179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.88 177.66 4.07 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.538 2.159 . . . . 0.0 112.146 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -166.28 160.2 15.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.48 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.88 HD13 ' N ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -128.49 -169.93 2.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.742 -179.231 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.1 pt -134.77 -25.67 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.514 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 6.8 mtt -91.07 133.8 35.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.904 0.383 . . . . 0.0 110.668 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -43.84 -37.42 2.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.468 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 156.17 -25.6 0.54 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.408 HD12 ' H ' ' A' ' 46' ' ' LEU . 2.8 mp -73.54 -78.77 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.755 0.312 . . . . 0.0 110.58 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.22 19.21 0.09 OUTLIER Glycine 0 CA--C 1.522 0.509 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 49' ' ' ALA . 1.2 tt -105.72 -42.06 5.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.742 0.306 . . . . 0.0 110.602 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.624 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.221 -0.396 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.676 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 41.2 tttp -88.89 -10.54 47.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.862 0.363 . . . . 0.0 110.634 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.526 ' CD ' ' N ' ' A' ' 3' ' ' LYS . 0.1 OUTLIER 45.45 -110.64 0.24 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.388 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.98 8.97 3.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.832 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -130.31 -95.59 0.38 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.425 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.426 ' C ' HD12 ' A' ' 6' ' ' ILE . 2.6 pp -130.96 -166.18 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.325 -179.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.448 ' C ' ' H ' ' A' ' 9' ' ' ASP . . . -131.86 -24.93 2.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.758 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.696 ' H ' ' CD ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -71.76 12.52 0.37 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.79 -179.66 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.52 ' OD2' ' N ' ' A' ' 10' ' ' TYR . 6.7 p-10 36.2 -121.52 0.15 Allowed 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.523 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.52 ' N ' ' OD2' ' A' ' 9' ' ' ASP . 60.5 m-85 -72.04 168.64 17.66 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.459 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.24 -145.86 17.46 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.447 ' NH1' ' NZ ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -37.74 119.26 0.73 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.853 0.358 . . . . 0.0 111.081 -179.688 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.488 ' SG ' ' N ' ' A' ' 37' ' ' CYS . 26.9 p -151.9 171.54 17.62 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.688 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.447 ' NZ ' ' NH1' ' A' ' 12' ' ' ARG . 7.4 mttp -159.85 153.72 23.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.603 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.476 ' CZ2' ' SG ' ' A' ' 28' ' ' CYS . 0.9 OUTLIER -83.13 -52.57 6.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.783 -179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.48 -24.72 41.93 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -76.82 -119.88 0.17 Allowed Glycine 0 CA--C 1.52 0.406 0 N-CA-C 110.928 -0.869 . . . . 0.0 110.928 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.56 151.64 48.35 Favored Pre-proline 0 C--N 1.326 -0.416 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.663 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.52 -170.19 0.36 Allowed 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.568 2.179 . . . . 0.0 112.306 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.46 96.06 2.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.57 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 70.1 m -40.71 -84.32 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.582 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.515 ' O ' ' CE2' ' A' ' 10' ' ' TYR . 19.4 mtt85 -90.85 41.31 1.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.518 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.45 145.82 17.74 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.85 -25.62 0.5 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.749 0.309 . . . . 0.0 110.555 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.49 67.29 0.52 Allowed Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.426 ' O ' ' NE1' ' A' ' 15' ' ' TRP . 13.3 t -79.75 85.68 5.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.924 0.392 . . . . 0.0 110.348 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.9 tt -96.2 150.86 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.528 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.476 ' SG ' ' CZ2' ' A' ' 15' ' ' TRP . 3.7 m -130.56 177.73 7.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.769 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.92 174.7 11.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.664 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -53.79 -28.33 16.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.671 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' MET . . . . . . . . . . . . . 2.0 mtt -83.65 -46.14 12.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.721 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.9 62.38 0.82 Allowed Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.9 t -142.86 -25.73 0.61 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.796 0.332 . . . . 0.0 110.615 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -100.41 46.58 0.95 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.569 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.8 m -63.24 124.68 21.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.698 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.447 ' C ' ' SG ' ' A' ' 13' ' ' CYS . 41.3 mt-10 -130.62 138.68 50.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.52 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.488 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -87.1 122.87 31.52 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.173 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.59 148.06 63.07 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.805 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.71 179.38 2.68 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.452 2.102 . . . . 0.0 111.996 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -75.27 144.94 42.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.582 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 41' ' ' LEU . 10.8 mp 45.42 94.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.613 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.1 tp -67.86 -29.16 44.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.624 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 8.5 mtt -43.06 156.8 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.547 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -87.37 -39.31 15.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.559 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 47' ' ' GLY . . . -96.19 29.28 10.34 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.738 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.6 mp 39.51 26.05 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.873 0.368 . . . . 0.0 110.614 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 45' ' ' GLY . . . 149.3 61.75 0.01 OUTLIER Glycine 0 CA--C 1.523 0.545 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.638 ' C ' HD23 ' A' ' 48' ' ' LEU . 1.0 OUTLIER -148.92 -40.14 0.15 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.79 0.329 . . . . 0.0 110.59 179.939 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.637 ' N ' HD23 ' A' ' 48' ' ' LEU . . . . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.715 -179.902 . . . . . . . . 1 1 . 1 stop_ save_